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Abstract 
 
Primary cell culture is limited by the increase in cellular levels of p16INK4a in 
response to an in vitro culture environment and, in conjunction with telomere 
shortening following cell division, presents a barrier to cellular proliferation. The 
use of transformed cell lines is limited for studies wherein the aim is to generate 
data akin to an in vivo environment as commonly such cell lines achieve their 
immortal benefits by down regulating important tumour suppressive mechanisms 
and inhibiting cell cycle checkpoints.  
Normal Human Oral Keratinocyte (NHOK) cells expressing shp16+hTERT were 
generated and compared to NHOK cells expressing Bmi1 +hTERT using an optimized 
retroviral transduction protocol and compared simultaneously to an epidermal 
control. Population doubling assessment of cell lines revealed that shp16+hTERT 
was not sufficient to extend replicative lifespan in the absence of p53 whilst cell 
lifespan extension was observed not only in cells expressing Bmi1+hTERT, but also 
in cells transduced with Bmi1 alone. Upon characterization, cells showed expression 
of p53 and responsiveness to UVB-induced apoptosis as demonstrated by an 
increase in p53 expression. NHOKBmi1+hTERT displayed adaptability to serum free 
culture when weaned into keratinocyte serum free media (KSFM) and retained the 
ability to stratify into multiple layers when supported by feeders on polycarbonate 
membrane inserts.  
The cell line NHOKBmi1+hTERT will be beneficial for in vitro studies looking to utilise an 
alternative to transformed or spontaneously derived cell lines and holds potential 
for further development and optimization into a well characterized SSE in a user 
friendly, and reproducible system for the testing for oral products.  
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OD Optical Density 
OGG1 8-Oxoguanine glycosylase; involved in base excision 
repair 
-OH Hydroxyl radical 
OKF4 Immortalized Oral keratinocyte cell line 
OKF6 Immortalized Oral keratinocyte cell line 
p14ARF INK4A alternative reading frame protein 
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p15INK4b Cyclin-dependent kinase inhibitor 2B 
p16INK4a Cyclin-dependent kinase inhibitor 2A 
p21WAF Cyclin dependent kinase inhibitor 1A 
p53 Tumour suppressor protein  
PAGE Polyacrylamide Gel Electrophoresis 
PBS Phosphate-Buffered Saline 
PCR Polymerase Chain Reaction 
PD  Population Doubling 
PE PBS/EDTA 
Ph E Phoenix E 
PI Propidium Iodide 
POT1 Protection Of Telomeres protein 1; part of shelterin 
complex proteins ; binds the telomeric double stranded 
TTAGGG repeat and negatively regulates telomere 
length and protects from chromosome instability 
pRb  Retinoblastoma protein 
PS phosphatidylserine 
PT67 Packaging cell line 
Puro Puromycin 
PVDF 
Membrane 
Polyvinylidene fluoride membrane 
Q1234 Quadrant 1/2/3/4 
Rad3 protein kinase; ; activated by DNA double strand breaks 
and involved in DNA damage response 
RAP1 Ras related protein 1 
Ras and 
HRAS 
Harvey rat sarcoma virus oncogene 
RIPA Radioimmunoprecipitation assay 
RNA Ribonucleic acid 
RNase Ribonuclease 
ROS Reactive oxygen species 
RS Replicative senescence 
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RT Room temperature 
S    Synthesis phase of the cell cycle 
SB Stratum Basale 
SC Stratum Corneum 
SCC Squamous Cell Carcinomas 
SD Seeding Density 
SDS Sodium Dodecyl Sulfate 
SEM Standard Error of the Mean 
Ser Serine 
SG Stratum Granulosum 
sh RNA Small hairpin RNA 
SMC-1 Structural Maintenance of Chromosome protein 1 
SOD Superoxide Dismutase 
SS Stratum Spinosum 
SSB Single strand break 
SSE Stratified Squamous Epithelium 
SV40 Simian Virus-40 
SVFHK Immortalized cell line 
Sw3T3 Swiss 3T3 cell line 
T/EDTA Trypsin/EDTA 
TBS/TBS-T Tris Buffered Saline (TBS-Tween 20) 
TERT Telomerase Reverse Transcriptase 
TGF Transforming Growth Factor 
TEWL Transepidermal waterloss 
TIF Telomere-dysfunction Induced Foci 
TIN2 TRF1-interacting protein 2 
TPP1 Tripeptidyl peptidase 1 
TRAP Telomere Repeat Amplification Protocol 
TRF1 Telomere repeat binding factor 1 ; part of shelterin 
complex proteins ; binds the telomeric double stranded 
TTAGGG repeat and negatively regulates telomere 
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length and protects from chromosome instability 
TRF2 Telomere repeat binding factor 2 ; part of shelterin 
complex proteins ; binds the telomeric double stranded 
TTAGGG repeat and negatively regulates telomere 
length and protects from chromosome instability  
TRIS Tris(hydroxymethyl)aminomethane 
TTAGGG Tandem repeats of telomerase base sequence 
UVB Ultraviolet B 
UVC Ultraviolet C 
WB Western Blot 
γ IR Gamma irradiation 
β-Gal Beta-galactosidase 
γH2AX Phosphorylated form of H2AX 
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1.1 Cell culture 
Cell culture is a complex, multi step process by which cells are cultivated externally 
under controlled conditions outside their natural environment. The term cell 
culture has now come to refer to the culturing of animal cells derived from 
multicellular eukaryotes, in particular the culture of animal cells, but other cultures 
include plants, fungi and microbes including viruses, bacteria and protists (Abbott 
2003). Animal cell culture became a common lab practice in the mid 1900’s when 
techniques were advanced significantly to support research in virology for the 
manufacture of vaccines, with the polio vaccine being one of the first mass-
produced product using cell culture techniques (Kevles and Geison 1995). Other 
research areas for which cell culture is used include drug discovery, cancer biology, 
regenerative medicine and basic life sciences. Cells can be isolated from tissues for 
ex vivo culture by either purification from blood (blood cells), released from soft 
tissue by enzymatic digestion (mononuclear cells) or explant culture (Abbott 2003). 
Cells cultured directly from an individual are known as ‘primary’ cells and these 
generally have limited lifespan in culture, known as the Hayflick limit, after which 
they stop dividing yet remain metabolically active, a phenomenon known as 
senescence (Campisi and d'Adda di Fagagna 2007). To overcome this barrier to cell 
lifespan and allow for the long term use of cell lines in research with little or no 
variation between samples, immortalized cell lines are used as they have the ability 
to proliferate indefinitely either through random mutation or deliberate 
modification of gene expression (Lee, Choi et al. 2004). In order to generate 
immortalized cell lines, it is important to understand the important proteins that 
regulate the cell cycle and the complex interplay that takes place between them to 
maintain cell homeostasis. 
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1.2  Cell cycle  
DNA replication between cell generations occurs in an organised and orderly 
manner regulated by the cell cycle to ensure correct cell division.  The standard cell 
cycle is comprised of four phases: the gap phase prior to mitosis, the gap phase 
post mitosis, the synthesis phase and the mitotic phase,  known as G1, G2, S and M 
respectively  (Vermeulen, Van Bockstaele et al. 2003)  . G1 , G2 and S phases 
collectively comprise the ‘interphase’ part of cell division, at times including periods 
of inactivity termed Gap phase zero ( G0), wherein the cell is constantly synthesizing 
RNA, producing protein and growing in size prior to advancing into M phase where 
it divides (Vermeulen, Van Bockstaele et al. 2003). The cell cycle is regulated tightly 
by key regulatory proteins called cyclin-dependent kinases (cdks), a family of 
serine/threonine protein kinases that are activated at specific points of the cell 
cycle (Kahl and Means 2003). Cdks regulate the cell cycle by inducing downstream 
processes and phosphorylating selected proteins and are constantly being activated 
and deactivated by association with regulatory subunits known as ‘cyclins’ 
(Denicourt and Dowdy 2004) . It is this sequential activation and inactivation of cdks 
through the periodic synthesis and destruction of cyclins that provides the primary 
means of the cell cycle regulation (Johnson and Walker 1999); (Fig 1.1) and the 
various functions (table 1.1) 
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Cyclin CDK Function 
Cyclin D1,2,3 CDK2,6 Required for cell entry into 
G1 phase 
Cyclin E CDK 2 Progression from G1 into S 
phase 
Cyclin A CDK1 Permits entry into M phase 
Cyclin B CDK1 Regulation of G2/M phase 
Cyclin C CDK8 Assumed to be involved in 
mammalian transcription 
apparatus 
Table 1.1: Functions of cyclin-CDK complexes within the cell cycle. 
All cyclins contain a common region of homology involved in binding and activating 
cdks, known as the cyclin box (Johnson and Walker 1999). Apart from regulating 
progression through the phases of the cell cycle, some cyclins form complexes that 
regulate their own proteolysis, for example cyclins A and E contain a ‘destruction 
box’ whilst cyclins D and E contain a PEST sequence rich in proline, glutamic acid, 
serine and threonine residues, which is required for efficient ubiquitin-mediated 
cyclin proteolysis at the end of a cell cycle phase (Vermeulen, Van Bockstaele et al. 
2003). Not all cyclin-CDK have cell cycle regulatory functions, however, and other 
roles include regulation of transcription, DNA repair, differentiation and apoptosis 
for example; several cyclin-cdk complexes such as cyclin C-cdk8 and cyclin H-cdk7 
have been found to be components of the basal transcription machinery (Johnson 
and Walker 1999).  
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Cdk activity is regulated by cdk inhibitors (CKI) which bind to cdk-cyclin complexes 
or cdk alone and inhibit their function. Based on their sequence homology and 
functions within the cell cycle, CKI are divided into two distinct families; the CIP/KIP 
family that includes p21 and the INK4 family that includes p16INK4a (Denicourt and 
Dowdy 2004). The INK4 family includes p15 (INK4b), p16 (INK4a), p18 (INK4c) and 
p19 (INK4d), which specifically interact with cdk4 and cdk6 but not the other cdks 
(Sherr 2000). Binding of INK4 proteins prevents the association of cdk4 and cdk6 
with the D type cyclins thereby preventing entry into G1 phase of interphase. The 
second family of inhibitors, the Cip/Kip family includes p21 (Waf1, Cip1), p27 (Cip2), 
p57 (Kip2) (Johnson and Walker 1999). Whilst the INK4 family of CKI form stable 
complexes with the CDK enzyme before cyclin binding, thereby preventing 
association with cyclin D, the Cip/Kip CKI inactivate CDK-cyclin complexes by acting 
on a wider spectrum of cyclin-CDK complexes (Denicourt C, 2004).  
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Figure 1.1: Role of cdk-cyclins and CKI in cell cycle regulation. 
Each phase of the cell cycle is regulated by a particular cdk-cyclin complex. G1, G2 and S are part of 
‘interphase’, regulated predominantly by cyclin D and E, followed by cellular division in M under 
regulation of cyclin A.  CKI from INK4 family interact specifically with cdk4 /6, preventing association 
with cyclin D and subsequent entry into G1, whilst members of the Cip/Kip family act as negative 
regulators of G1 by acting upon a wider spectrum of cyclin-cdk complexes (Figure obtained from 
Johnson and Walker 1999). 
 
 
 
 
 
   Chapter 1: Introduction 
31 
 
1.3  INK4a locus: p16INK4a and p14ARF 
The CDKN2A locus on human chromosome 9p21 (mouse chromosome 4) encodes 
two distinct proteins translated from alternatively spliced mRNAs. The products of 
the α transcript is p16INK4a, a recognized tumour suppressor and inhibitor of G1 
through cyclin D-dependent kinases cdk4 and cdk6. p16INK4a is responsible for 
inducing a G1 cell cycle arrest by inhibiting the phosphorylation of the 
retinoblastoma protein (protein Rb) through the actions of cdk4 and cdk6 (Sherr 
2000). In contrast, the product of human CDKN2A β transcript, designated as 
originating from the ‘Alternative Reading Frame’ (ARF), p14ARF, activates a p53-
dependent response causing cell cycle arrest in both G1 and G2/M through its 
actions on MDM2 and p21WAF1  (Sherr 2001).  p14ARF requires a functional p53 gene 
to exert its cell cycle regulatory effects and seems to work by affecting p53 stability, 
causing it to accumulate, resulting in cell cycle arrest. p14ARF has also been shown in 
the direct accumulation of p53 in response to senescence induced by oncogene 
activation (Zuckerman, Wolyniec et al. 2009). Although functionally similar, the 
primary amino acid sequences of both p16INK4a and p14ARF are completely unrelated 
and bear no homology, with p14ARF functioning as a distinct gene (Sherr 2006).  As 
the coding regions of these two genes have been found to overlap, homozygous 
deletions of p16INK4a simultaneously appear to disrupt p14ARF functions as well, 
emphasizing the importance of the INK4a locus in carcinogenesis.  
 
The involvement of p16INK4a in the development of human tumours was implied by 
the observation that the INK4a locus is mutated in many tumour derived cell lines 
and maps to a chromosomal region frequently altered in human malignancies 
(Serrano, Lee et al. 1996). One of the main and critically important substrates of the 
cyclin D-dependent kinases is the retinoblastoma protein (pRb) that is able to 
prevent entry into the S phase of the cell cycle by blocking the E2F transcription 
factors (Sherr 2001). Phosphorylation of pRb, catalysed by cdks D and E, allows the 
progression into S phase by disrupting the suppression of the E2F transcription 
factors and permitting activation of genes needed for DNA replication and 
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nucleotide metabolism, thereby allowing G1 exit (Sherr 2001). p16
INK4a directly 
inhibits the activities of cdk4 and cdk6 that maintain pRb in its active and non-
proliferative state. The functional disruption of these tumour suppressors along 
with the over-expression of cyclin D1 and cdk4, occurs in many human cancers 
(Geradts and Wilson 1996, Tanaka, Fujii et al. 1998, Chen, Chen et al. 2001). The 
majority of point mutations found in the INK4a locus are nonsense  whilst a second 
type of p16INK4a inactivation consists of large homozygous deletions that eliminate 
the INK4a locus with INK4b partly involved in some cases (Serrano, Lee et al. 1996).  
 
P16INK4a is now recognized as a major tumour suppressor because of its regulation 
of the oncogene cyclin D1 and loss of INK4a function seems to provide cells with a 
proliferative advantage and p16INK4a is frequently inactivated in a variety of human 
cancers (Azechi, Nishida et al. 2000). Furthermore, inherited INK4a mutant alleles 
that inactivate p16INKa predispose individuals to the development of malignancies 
(Serrano, Lee et al. 1996) . p16INK4a has also been shown to accumulate when 
primary cells are propagated in culture, suggesting that it participates in the G1 cell 
cycle arrest in replicative senescence.  
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1.4 p53 tumour suppression pathway 
The importance of the p53 protein in suppressing tumour development is 
illustrated by the fact that it is disrupted in approximately 50% of human cancers 
(Hofseth, Hussain et al. 2004) and acts to prevent aberrant cell proliferation. p53 is 
one of the most extensively studied tumour suppressors and acts in response to 
various DNA stressors, such as DNA damage and hypoxia, to mediate many anti-
proliferative processes  (Levine 1997). Owing to a relatively short half life, p53 levels 
are usually low within the cell and rapidly increase in response to intra and extra 
cellular stress signals. This in turn promotes the stabilization and activation of p53 
bringing about tumour suppressive processes such as cell cycle checkpoints, cellular 
senescence and apoptosis. Conversely, disruption in p53 regulation promotes 
checkpoint defects, cellular immortalization, genomic instability and inappropriate 
cell survival by allowing continued proliferation and evolution of damaged cells 
(Levine 1997). Furthermore, it is important to note that apart from inactivation, 
chronic activation of p53 is also deleterious since hyperactivation of p53 is 
associated with many degernative diseases such arthritis and multiple sclerosis 
(Michael and Oren 2002). Considering the lethal affects of incorrect p53 levels, it is 
not surprising that there is a tightly regulated system in place that is responsible for 
maintaining p53 homeostasis.  
 
As mentioned, p53 expression is induced by both intra and extra cellular stress 
signals however both these utilize different pathways to bring about p53 
expression. In response to DNA damage and strand breaks following ionizing or 
ultraviolet radiation, p53 is activated via the ataxia telangiectasia mutated (ATM) 
pathway. ATM is an kinase whose substrates include CHK1 and CHK2 proteins, 
which, upon phosphorylation by ATM, phosphorylate their own targets, including 
p53 (El-Deiry 1998). Activated p53 transactivates downstream target genes 
including p21WAF1, responsible for inhibiting CDK2 and obstructing the activity of 
CDK2-Cyclin E complexes, thereby preventing the cell cycle progression from G1 to S 
phase (Meek 2004). 
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Apart from ATM pathway, p53 is also activated by the p14ARF-MDM2-p53 pathway 
(Fig 1.2) where internal aberrations such as abnormal oncogene activation stabilizes 
and activates p53. The cyclin-dependent kinase inhibitor p21WAF1 is encoded in 
humans by the CDKN1A gene, located on chromosome 6 and it binds to and inhibits 
the activity of CDK1, thereby functioning as a regulator of cell cycle progression at 
G1 checkpoint. The expression of p21
WAF1 is tightly controlled by p53 and it 
mediates cellular senescence by directly inhibiting the activity of cyclin E /cdk2 and 
cyclin D cdk4/6 complexes and blocking cell cycle progression from G1 into S 
(Itahana, Dimri et al. 2001). p21WAF1 is thought to be a major executor of the p53-
dependent cell cycle arrest in response to DNA damage and past studies have 
shown that disruption of p21WAF1 extends the lifespan of human diploid fibroblasts 
(Kaul, Reddel et al. 2000). p53 also transcribes its own negative regulator called 
MDM2 ( referred to as HDM2 in humans) that is responsible for terminating the p53 
response. Overexpression of certain oncogenes can induce expression of p14ARF, 
which inactivates MDM2 and blocks the degradation of p53, thereby activating it 
and inducing either cell cycle arrest or apoptosis (Itahana, Dimri et al. 2001). The 
binding of MDM2 to p53 induces its ubiquitylation, followed by its exportation from 
the nucleus to the cytoplasm and subsequent degradation, thus preventing 
unnecessary cell death by antagonizing its transcriptional activity (Kamijo, Weber et 
al. 1998). MDM2, in turn, is subject to negative control by p14ARF that directly 
associates with MDM2, blocking its ability to interact with p53 through the 
localization of MDM2 within the nucleolus and inhibition of its ubiquitin protein 
ligase activity (Sherr 2001). This negative feedback loop blocks progression of the 
cell cycle until the DNA can be repaired or alternatively, if the damage is extensive 
then the cell enters apoptosis. Loss of p14ARF by homozygous mutation of the INK4a 
gene will lead to elevated levels in MDM2 and therefore loss of p53 function and 
cell cycle control (Kamijo, Weber et al. 1998).  
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Figure 1.2 : Cell cycle arrest via the INK4a/ARF tumour suppressive pathway. 
Tumour suppressive activity of p53 and pRb is regulated by the products of the INK4a/ARF locus.     
A) Under normal cellular conditions p53 is maintained at relatively low levels but rapidly 
accumulates in response to cellular stress, triggering either cell cycle arrest or cell suicide.  (Levine 
1997). p53 is negatively regulated by p53-responsive gene MDM2 which in turn is under regulation 
by p14
ARF
, that gets activated in response to DNA damage signals and blocks the ability of MDM2 to 
bind to p53 B) In response to stimuli such as telomere shortening, ATM/Chk2 is activated to 
phosphorylated p53 and its downstream targets, mainly p21
WAF1
 tumour suppressor to inhibit cyclin 
E/Cdk2 complex that prevents phosphorylation of pRb, resulting in a G1 cell cycle arrest.                      
C) Phosphorylation of pRb by cyclin-D dependent kinases permit the cell to progress into S phase. 
The up regulation of p16
INK4a
 in response to DNA signals and its subsequent inhibition of cyclin-D 
dependent kinases prevents pRb phosphorylation and thus results in G1 cell cycle arrest.   
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In relation to cancer, MDM2 is over expressed in 5%-10% of human cancers 
whereas ARF is silenced or deleted in many others, highlighting the importance of 
the ARF-MDM2-p53 signalling pathway (Michael and Oren 2002). ARF is induced by 
oncogenes such as Myc, mutated Ras and v-Abl which results in p53 activation,     
re-routing cells that have acquired oncogenic damage to alternative fates such as 
growth arrest or apoptosis. Subsequently, the loss of ARF or p53 eliminates this 
‘tumour surveillance’ mechanism , instead allowing oncogenes to drive proliferation 
in a manner that favours uncontrolled cell growth and rapid tumour formation 
(Sherr 2001).  
 
1.5 Bmi1  
B-cell-specific moloney murine leukemia virus integration site 1, Bmi1, is part of the 
polycomb group of genes that are epigenetic suppressors of gene expression and 
play a central role in mammalian development  (Lee, Adhikary et al. 2007). Bmi1 is 
expressed in the basal and suprabasal layers of the epidermis and is located in the 
nucleus of cultured keratinocytes where it promotes cell survival and protects 
against stress mediated apoptosis (Ross, Parker et al. 2008).  Bmi1 appears to work 
by suppressing the INK4a/ARF locus expression, increasing levels of cyclin D1 and 
selected cdks at the same time as reducing caspase activity.  Disruption of Bmi1 
action has profound effects on development, for example; it has been suggested 
that Bmi1 may enhance tumour cell proliferation/cell survival by repressing 
transcription of p16INK4a  and p14ARF  (Dimri, Martinez et al. 2002).  Bmi1 has also 
been shown to induce telomerase activity, suggesting a role in the  regulation of 
normal cell physiology as well as a pro-survival proliferation factor in 
hyperproliferative diseases and epithelial cancer (Dimri, Martinez et al. 2002). A 
study conducted by Kang et al (2007) demonstrated enhanced levels of Bmi1 
protein and RNA expression in cells of oral squamous cell carcinomas when 
compared to normal human oral keratinocytes, thus reinforcing its role in 
carcinogenesis (Kang, Kim et al. 2007).  
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1.6 Senescence 
Senescence is the permanent, irreversible state of growth arrest wherein cells lose 
the ability to proliferate and divide yet remain metabolically active. Senescent cells 
display altered morphological and physiological properties and are part of the 
tumour suppression mechanism (Campisi and d'Adda di Fagagna 2007).   
 
1.6.1  The hayflick limit 
Normal cells have a limited ability to proliferate in culture and after initial cell 
division the growth rate gradually starts to decline until all cells in the culture lose 
their ability to divide, and this is referred to as the ‘hayflick limit’ (Campisi and 
d'Adda di Fagagna 2007).  The hayflick limit is named after Lenoard Hayflick who 
demonstrated in 1961 that embryonic stem cells can divide only a finite number of 
times in culture with an average of 50 cumulative population doublings (CPD) 
whereby they were termed as having reached replicative senescence (RS) (Campisi 
and d'Adda di Fagagna 2007). Although senescence was initially demonstrated in 
fibroblasts, it has since been observed and characterized in a variety of other cell 
types such as keratinocytes, lymphocytes and endothelial cells (Erusalimsky and 
Kurz 2005). Senescence appears to have been derived as a tumour suppressive 
mechanism along with a simultaneous role in cellular ageing where it slows down 
tissue regeneration. This phenomenon is known as antagonistic pleiotropy, wherein 
genes or processes that were selected to benefit the health and fitness of young 
organisms can have unselected, deleterious effects that manifest in older organisms 
and promotes ageing (Campisi and d'Adda di Fagagna 2007).  
 
One of the main hallmarks of senescence is the inability to progress through the cell 
cycle as the cells fail to initiate DNA replication despite adequate growth 
conditions. Senescent cells also acquire resistance to certain apoptotic signals  such 
as those caused by growth factor deprivation and oxidative stress but are not able 
to resist apoptosis caused by the engagement of the FAS death receptors (Higami 
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and Shimokawa 2000). The senescence phenotype is induced by multiple stimuli, 
also known as ‘stressors’, that include dysfunctional telomeres, non-telomeric DNA 
damage, excessive mitogenic signals and non-genotoxic stress (Lloyd 2002). Despite 
such a tightly regulated senescence mechanism, cells have been found to evade 
senescence and exhibit an infinite lifespan. These cells are termed ‘immortal’ and 
are generally thought to have been derived from tumours. 
 
1.6.2  Replicative senescence  
Replicative senescence (RS) is an fundamental feature of all somatic cells and the 
number of division a cell undergoes is determined by species, age, genetic 
background and cell types, for example human keratinocytes generally have a 
replicative lifespan of between 30–50 population doublings (PD) whilst human 
foetal cells have been shown to reach upto 60-80 PD before senescing (Harley and 
Sherwood 1997). The senescence growth arrest occurs with a G1 DNA content and 
cells are prevented from entering the S phase of the cell cycle, turning unresponsive 
to growth-promoting stimuli yet remain metabolically active for long periods 
(Cristofalo and Pignolo 1993). Morphologically, senescent cells demonstrate a large 
and flattened morphology with enlarged nucleoli and an increased number of 
lysosomes and golgi apparatus (Cristofalo, Lorenzini et al. 2004). Senescent cells 
have been shown to express acidic β galactosidase (β gal) enzymatic activity and 
express high levels of cell cycle inhibitory proteins, used as markers of senescence 
activity within cells (Dimri, Lee et al. 1995).   
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Figure 1.3 : Relationship between population doublings and cellular Senescence. 
As cells are sub-cultured in vitro, they undergo a finite number of cell divisions before entering a 
state of irreversible growth arrest termed as senescence, caused by telomere shortening with each 
cell division. Senescence can also be induced prematurely by cellular stress on the cell such as 
oncogene activation, DNA damage and oxidative stress. Senescent cells can be recognised in a mixed 
population by their large and flat morphology; senescence associated heterochromatin foci (DAPI 
foci in blue); and senescence associated β gal staining (blue). Immortal cells such as cancer cell lines 
are capable of by-passing senescence and proliferating indefinitely (image obtained from (Ohtani, 
Mann et al. 2009). 
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1.6.3 Telomere dependent senescence 
Telomeres are stretches of repetitive DNA and associated proteins that cap the 
ends of linear chromosomes and allow for the cell to distinguish between a 
chromosome end and a potentially catastrophic double strand break (DSB) (Bailey, 
Meyne et al. 1999). In the absence of telomeres, chromosomes tend to be highly 
unstable thus leading to potential loss of heterozygosity, chromosomal deletions 
and translocations, hence telomeres act to stabilize chromosomes by protecting 
them from degradation, recombination or random fusion by cellular DNA repair 
systems  (Campisi, Kim et al. 2001).  
 
Telomere-dependent senescence is the inevitable result of the progressive 
shortening of telomeres that occurs after each cell division. Mammalian telomeres 
are thought to end in large circular structures termed the ‘t-loop’ due to the ‘end 
replication problem’, wherein standard DNA polymerases cannot completely 
replicate these DNA ends and cells end up losing 50-200 base pairs of telomeric 
DNA in each S phase of cell cycle (Bolzán and Bianchi 2006).  These ‘critically short’ 
telomeres are able to trigger the DNA damage response (DDR) by forming DNA 
damage foci containing γH2AX, enabling cells to sense damaged DNA and respond 
by arresting cell-cycle progression to repair the damage. These foci, when co-
localised with dysfunctional telomeres, are called telomere dysfunction induced 
foci, (TIFs) (Takai, Smogorzewska et al. 2003). Other proteins involved in the DDR 
include protein kinase ataxia telangiectasia mutated (ATM) and adaptor proteins 
such as p53 binding protein 1 (53BP1), with many of these proteins localising to the 
DNA damage foci detected in senescent cells (Campisi and d'Adda di Fagagna 2007). 
 
It was first proposed in the early 70’s by Olovnikov that chromosomal ends are 
unable to proliferate without the presence of the specific enzyme telomerase 
(Olovnikov 1996) but it was not until later that senescent cells were shown to have 
shorter telomeres as compared to their pre-senescent counter parts (Harley and 
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Sherwood 1997). As mentioned, RS is a feature of somatic cell lines, and in contrast 
germ lines exhibit longer telomeres due to the presence of telomerase, thus 
accounting for their long telomeric length despite rapid cell turnover rates (Kim, 
Kaminker et al. 2002). Evidence that telomere shortening can induce RS was 
provided by the introduction of the human telomerase catalytic protein unit, 
hTERT, into normal human cells resulting in telomerase activity, telomere 
maintenance and indefinite cell proliferation (Campisi, Kim et al. 2001, Kim, 
Kaminker et al. 2002, Minty, Thurlow et al. 2008, Cesare and Reddel 2010) . 
Evidence has also been provided in vivo, with telomerase deficient mice supporting 
the idea that short telomeres promote senescence (Campisi 2003). In keeping with 
the idea of short telomeres determining cellular lifespan, studies have also 
suggested a link between senescence and ageing, with studies showing a 
correlation between in vitro lifespan of cells with the age of the donor, the 
correlation between in vitro lifespan with the average life expectancy of the species 
and the reduced in vitro life span of cells from patients afflicted with premature 
ageing syndromes (Sedivy 1998). 
 
It is important to distinguish senescence from quiescence, which is the normal 
physiological withdrawal of the cell from the cell cycle that is displayed by almost all 
cells. Unlike senescence, quiescence is a reversible process whereby stimulation 
with proper growth factors results in resumption of proliferation (Sedivy 1998).  
 
1.6.4 Telomere-independent senescence 
Although extensive evidence has confirmed the presence of a ‘mitotic clock’ 
monitoring cell divisions and initiating senescence, it is clear that senescence is not 
simply the end result of shortened telomeres. A variety of physiological stimuli can 
also provoke a cell to enter senescence independent of telomere length including 
extensive passage in culture, exposure to oxidative DNA damage or activation of an 
oncogene (Hanahan and Weinberg 2000). Furthermore, telomere shortening is not 
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a consistent measure of senescence as the rate of telomere erosion varies between 
cells during in vitro culture and there is no consistent telomere length at which 
senescence occurs  (Hanahan and Weinberg 2000). Perhaps major evidence in 
support of an alternative senescence mechanism came from studies with hTERT, in 
which ectopic expression of hTERT in keratinocytes and other epithelial cell types 
restored telomerase enzymatic activity and telomere length but still did not allow 
the cells to evade senescence (Sharpless 2004). Apart from the factors mentioned 
above, non-telomere related inducers of senescence include DNA damage such as 
ultraviolet radiation, oxidative damage resulting in the generation of ROS  as well as 
oxygen tension whereby the culture of cells in conditions of mild hyperoxia 
shortens replicative lifespan and conversely cells cultured in low oxygen exhibit 
extended lifespan and delayed senescence (Ben-Porath and Weinberg 2005). In 
keeping with its proposed role in tumour suppression, activation of oncogenes such 
as Ras has been shown to illicit a senescent-like state in cells wherein the cells are 
phenotypically similar to senesced cells with a flattened morphology and presence 
of β gal activity along with the induction of cell cycle inhibitory proteins (Cristofalo, 
Lorenzini et al. 2004). 
 
A number of regulatory proteins have been proposed to be involved in the non-
telomere dependent senescence mechanism. In keratinocytes and other epithelial 
cell types, senescence has been found to be associated with the expression and 
accumulation of p16INK4a during culture and indicates an increase in p16INK4a levels 
with passage in culture. Studies of cells that have bypassed senescence 
demonstrate loss of p16INK4a expression and have established that immortalization 
of human skin keratinocytes cannot be achieved by expression of telomerase alone, 
but requires the additional inactivation of the p16INK4a/pRb pathway (Rheinwald, 
Hahn et al. 2002). Another gene implicated in senescence is p14ARF and as discussed 
previously, p14ARF contributes to senescence by directly binding to and sequestering 
MDM2 and inhibiting its capacity to induce degradation of tumour suppressor p53, 
inducing a p53-mediated growth arrest or apoptosis. Bmi1 over expression has 
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been shown to down regulate both p16INK4a and p14ARF , resulting in the 
immortalization of mouse embryonic fibroblasts and suggesting that Bmi1 may co-
operate with hTERT in immortalization of human epithelial cells (Haga, Ohno et al. 
2007). The involvement of the p16INK4a and pRb pathway is brought about in 
response to cellular stresses and signalling imbalances irrespective of telomere 
status (Guney, Wu et al. 2006). The important role of the INK4a locus in senescence 
and cell immortalization is illustrated by repeated findings in cancers and human 
immortalized cell lines wherein this locus is frequently deleted or silenced and both 
the p16INK4a/pRb and the p14ARF/p53 pathways are inactivated in a single event, 
promoting unlimited cell proliferation.  
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1.7 Oral Mucosa 
Human epithelia are tissues composed of cells which line the surfaces of the body 
and are classified into different groups according to their structural properties and 
the amount of layers they are composed of. The oral mucosa consists of squamous 
(flat and thin) epithelial cells arranged in a multilayer and therefore classified as a 
stratified squamous epithelium (SSE) (Squier and Kremer 2001). The main cell type 
of the oral mucosa is the keratinocyte, cells filled with cytokeratins and tightly 
linked with each other by desmosomes. The complex, multilayered epithelia part of 
this SSE is a direct result of the cell proliferation and differentiation pattern across 
the multiple cell layers. This proliferation occurs mainly in the cells located at the 
lowermost layers of the epithelium and is gradually restricted as cells migrate 
upwards towards the outermost epithelial layers (Squier and Brogden 2011). 
Differentiation is said to be initiated as soon as the cells start migrating upwards 
throughout the layers of the SSE, ultimately giving rise to terminally differentiated 
squames which line the outer visible surfaces of the tissue (Squier and Kremer 
2001).  
 
The oral mucosa has two layers: the oral epithelium and the lamina propria, also 
known as oral connective tissue. In certain areas of the oral cavity such as the lips 
and cheeks there is a layer of loose fatty or glandular connective tissue called the 
submucosa. This contains the major blood vessels and nerves of the oral mucosa 
and therefore determines the flexibility of its attachment to the underlying 
structures (Squier and Brogden 2011). In contrast, other areas of the oral mucosa 
such as the gingival lack the submucosa thus creating a  firm and inelastic 
attachment to the surface of the bone, the periosteum, which is called the 
mucoperiosteum (Liu, Bian et al. 2010).  
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Figure 1.4 : The structure of the oral mucosa. 
The diagram illustrates the multi layered human oral epithelium consisting of the epithelium, the 
lamina propria and in some subtypes, the submucosa (Image obtained from Squier and Brogden 
2011). 
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The human oral mucosa can be divided into three functionally and structurally 
different subtypes: 
1. Masticatory Mucosa (keratinized): found in areas that come into primary 
contact with food and therefore subjected to mechanical forces associated 
with mastication, such as the hard palate and gingival. The keratinized 
masticatory mucosa is tightly attached to the underlying tissues by the 
collagenous lamina propria.  
2. Lining Mucosa (non-keratinized): found in areas that require flexibility for 
proper functioning such as the mouth and cheeks (buccal), the non 
keratinized lining mucosa consists of elastic connective tissue to facilitate 
functions such as chewing and swallowing.  
3. Specialized Mucosa (keratinized and non-keratinized): Located on the 
dorsum of the tongue, the specialized mucosa consists of more specialized 
structures such as taste receptors.  
The average surface area of the oral mucosa is 214 cm2, of which the lining mucosa 
represents ~ 60% , while masticatory and specialized mucosa cover ~25% and ~15% 
respectively (Collins and Dawes 1987). The anatomical distribution of the oral 
mucosa is shown in Figure 1.5. 
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Figure 1.5 : The distribution of the different types of oral mucosal epithelium within the 
oral cavity. 
The diagram shows the anatomic locations and extent of the masticatory (keratinized epithelium), 
lining (non-keratinized epithelium) and specialized mucosa ( keratinized and non-keratinized ) in the 
oral cavity (Allam, Stojanovski et al. 2008) . 
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Apart from epithelial cells, many regions of the oral epithelium contain other cell 
types including melanocytes, langerhans cells and inflammatory cells such as 
lymphocytes (table 1.2). These cell types represent approximately 10% of the cell 
population in the oral epithelium (Allam, Stojanovski et al. 2008). 
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Cell Type Location within Oral 
Mucosa 
Function 
Melanocytes Basal layer Specialized pigment 
cells that produce 
melanin which 
contribute to the colour 
of the oral mucosa and 
blood haemoglobin. 
Langerhans’ Cells Suprabasal layer These are dendritic cells 
originating from the 
bone marrow with the 
ability to penetrate the 
oral mucosa and 
migrate to lymph nodes. 
They are immune cells 
that recognise and 
process antigens which 
enter the epithelium and 
present them to helper 
T-lymphocytes. 
Merkel Cells Basal layer These are sensory cells 
responding to touch and 
are characterized by 
small, membrane-bound 
vesicles in their 
cytoplasm. 
Inflammatory Cells Nucleated cell layers These include mainly 
lymphocytes along with 
macrophages, 
leukocytes and mast 
cells. 
Table 1.2: Functions of different cell types present in the oral epithelium (Squier and Kremer 
2001). 
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1.7.1 Epithelium Differentiation 
The differentiation process of the human oral mucosa shares many similarities with 
the human epidermis in terms of structure and sequential differentiation and hence 
oral epithelial differentiation is often understood with reference to the epidermal 
model of epithelial cell renewal.  
 
The human oral SSE is composed of four distinct cell layers which show 
considerable site and type-related variability between the different mucosal linings 
(table 1.3). The cell layers include the basal layer (stratum basale, or SB), spinal 
layer (stratum spinosum, or SS), granular layer (stratum granulosum, or SG) and the 
surface cornified layer (stratum corneum, or SC) (Fig 1.6). All epithelial cells mature 
to terminally differentiated squames although the differentiation paths can vary 
between the types of mucosa (Squier and Kremer 2001).  
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Type of 
Epithelium 
Differentiation 
Pattern 
Stratification 
Masticatory Mucosa 
eg: hard palate, 
gingival 
 
Keratinized 4-layered; SB, SS, SG, SC 
The cuboidal/columnar SB 
cells are separated from the 
connective tissue by basal 
lamina membrane; the SS is 
characterized by many layers 
of oval to polygonal cells; the 
cells of the SG contain 
keratohyalin granuoles; the SC 
has thin flat cells devoid of 
nuclei and filled with soft 
keratin. 
Lining Mucosa 
Eg; buccal 
Non keratinized 3-layered; SB,SS, SF 
SB and SS cells (as above); 
cells of the SF are small with 
flat oval nuclei with a papillary 
and recticular layered filled 
lamina propria. 
Specialized Mucosa 
Eg; tongue 
Non keratinized Epithelial papillae organization; 
vast majority of papillae is 
filiform papillae (thread-like 
extensions of the epithelium); 
fungiform papillae (few 
mushroom shaped structures 
near tip of tongue); foliate 
papillae (approximately 4-11 
located on the lateral posterior 
side of the tongue and these 
contain taste buds). 
Table 1.3: The differentiation pattern of human oral epithelia according to their anatomical site 
(Squier and Brogden 2011). 
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The multi layered oral epithelium represents a progressive process of cell 
maturation. As cells move upwards through the layers they undergo a constant 
process of maturation and differentiation with the keratinocytes in the basal layer 
of the SSE retaining the ability for DNA synthesis and mitosis (Squier and Brogden 
2011). As soon as the basal cells start to migrate upwards through the suprabasal 
layers towards the outer epithelial tissue surfaces there is the onset cessation of 
cell proliferation through the layers. This process of keratinization is called 
epithelial turnover that begins with mitotic division of basal keratinocytes and 
continuously occurs within the epithelial tissue (Liu, Bian et al. 2010). The turn over 
time varies between the different mucosal surfaces with the lining mucosa having a 
turnover time of approximately 10 days, the masticulatory mucosa slightly more 
than 10 days and the specialized mucosa having turnover of around 5 days (Shellis 
and Berkovitz 2009).  
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Figure 1.6 : The structure of the oral mucosa. 
a) The diagram shows the structure of the oral mucosa and the different layers of the oral 
epithelium.  
b) Stratum Basale (SB) (A), Stratum Spinosum (SS) (B), Stratum Granulosum (SG) (C), Stratum 
Corneum (SC) (D). The basal layer contains the keratinocytes that retain the ability for continuous 
DNA mitosis and synthesis (Fuchs, 1993). 
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1.8 Epidermis  
The mature epidermis is a SSE, composed of proliferating basal and differentiated 
suprabasal keratinocytes which form the outermost skin surface. This outer 
covering of the skin contains the hair follicles, sebaceous glands and sweat glands 
and functions as a waterproof protective barrier against environmental pathogens 
as well as regulating the body’s water release into the atmosphere through 
transepidermal waterloss (TEWL) (Alonso and Fuchs 2003). The epidermis is 
composed of four main type of cells; the keratinocyte, which is the predominant 
cell type, melanocytes, langerhans cells and merkel cells (Moll, Moll et al. 1984). 
The epidermis is divided into many layers and as the cells move up the strata from 
the innermost levels they differentiate and undergo changes in shape and 
composition and become keratin filled (Fig 1.7). Upon reaching the topmost layer, 
the cells slough off and are replaced by inner cells moving outwards in a process 
called keratinization, with the outermost layer of the epidermis consisting of 
approximately 25-30 layers of dead skin (Jones, Harper et al. 1995). As in the case 
for the oral mucosa, the keratinization process time can vary between species, with 
the average time for humans being 28-30 days compared to 14 days in mice 
(Morgan and Mulligan 1989).  
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Figure 1.7 : Epidermis structure. 
Diagram showing multi layered structure of human epidermis 
http://www.rci.rutgers.edu/~uzwiak/AnatPhys/APFallLect7.html 
 
 
The epidermis is maintained by epidermal stem cells which reside in the basal layer 
and generate daughter cells that move upward towards the surface of the skin 
(Koster 2009). Keratinocytes undergoes a complex process of differentiation 
through a series of cellular layers to provide its protective barrier function (Koster 
2009). The epidermis is composed of four to five layers, depending on the region of 
skin being considered (Fig 1.8). The five layers of the skin are the stratum basale 
(SB, or basal layer) and the suprabasal layers consisting of the stratum spinosum 
(SS, or spinal layer), stratum granulosum (SG, or granular layer), stratum lucideum 
(SL, or clear layer) and the outermost stratum corneum (SC, or cornified layer) 
(Alonso and Fuchs 2003). Whilst the clear layer is only found in thicker areas of the 
epidermis which lack hair follicles such as the soles of the feet and palm of the 
hands, the other four layers are found in both thick and thin skin (Montagna and 
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Ellis 1960). The single layer of undifferentiated cells known as the stratum basale, 
contains the epidermal stem cell population that provides a continuous supply of 
new cells for epidermal differentiation (Eckert, Efimova et al. 2002). Following 
division, cells migrate upwards towards the stratum spinosum, characterized with 
extensive network of desmosomal connections between the cells and early markers 
of differentiation (Eckert, Efimova et al. 2002). The third layer, the stratum 
granulosum, is distinguished by the presence of granules containing products of 
keratinocyte differentiation to be used subsequently in the assembly of the 
corneocyte membrane (Koster 2009). The stratum lucidum is a layer of intense 
enzymatic activity in which cellular organelles and nucleic acid are destroyed by the 
actions of proteases, nucleases and other enzymes  (Liu, Bian et al. 2010). The 
development of the cornified envelop represents the terminal stage in keratinocyte 
differentiation in the stratum corneum, forming a mass of dead, flattened cells that 
are uniquely adapted to provide a protective surface, constantly being shed and 
replaced (Eckert, Efimova et al. 2002).  
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Figure 1.8 : Keratinization of the epidermis. 
a) The epidermis consists of five different layers of keratinocytes 
b) The keratinization process whereby the cells move upwards throughout the layers of the 
epidermis is associated with a series of morphological and biochemical changes as cells 
migrate from the proliferative and mitotic basal layer through the non-proliferative 
suprabasal layers, at the end of which maturation is complete. In each layer keratinocytes 
express different molecular markers such as keratins, involucrin, filaggrin and loricrin 
(Image obtained from (Liu, Bian et al. 2010).  
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1.8.1 The keratinocyte 
The most abundant cell type of the epidermis, the keratinocyte, undergoes a 
complex process of differentiation through a series of cellular layers to provide its 
protective barrier function in the production of hair follicles, sweat and sebaceous 
glands (Eckert, Crish et al. 1997). Keratinocytes are named after the filamentous 
keratin family of proteins that make up a major part of its distinctive cytoskeleton. 
This network of keratin intermediate filaments (IFs) is a useful marker of epidermal 
differentiation as the expression of keratins change in each of the stratified 
epidermal layers (Eckert, Crish et al. 1997). The basal layer is typified by the 
expression of K4 and K14 as well as keratin K5 (expressed in the embryo), whilst the 
intermediate suprabasal layers express K1 and K10 (Lloyd, Yu et al. 1995). 
 
1.8.2 Dermis 
The layer beneath the epidermis is formed of connective tissue and known as the 
dermis, and its main role is to provide support to the epidermis and cushion the 
body from stress and strain (Eckert, Crish et al. 1997). Dermal tissue is made up of 
80% water, elastin fibres and collagen and is heavily vascularised with blood 
vessels, enabling it to regulate body temperature, store much of the body’s water 
supply as well as provide both the dermis and epidermis with nutrient-rich blood 
and waste removal (Koster 2009).  The dermis is tightly connected to the epidermis 
by a basement membrane and contains many nerve endings and mechanoreceptors 
that allow for the sense of touch and heat. Collagen fibres compose of upto 70% of 
the dermal proteins, providing characteristic resistance to strain and mechanical 
injury whilst the presence of elastin fibres allow for elasticity (Koster 2009).  
 
The dermis is divided into two layers, the superficial area adjacent to the epidermis 
called the papillary region and a deep, thicker area known as the reticular dermis 
(Sorrell and Caplan 2004).  The papillary region is composed of loose connective 
tissue with elastic fibres, and it contains the dermal papillae filled with finger –like 
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fibrous, vascular nerve projections called the papillae filled with blood-rich 
capillaries that extend towards the epidermis (Eckert, Crish et al. 1997). This 
specialized surface at the junction with the epidermis acts to strengthen the 
connection between the two layers of the skin. The second layer of the dermis is 
the much thicker reticular layer, situated below the papillary and composed of 
dense, irregular connective tissue with bundles of collagen and some elastic fibres 
that weave through it (Sorrell and Caplan 2004). Together these protein fibres 
provide the dermis with its properties of strength, elasticity and extendibility. The 
reticular region is also the location of hair follicles, sebaceous glands, sweat glands, 
blood vessels and nerve endings (Kanitakis 2002). The dermis contains most of the 
skins specialized cells including adipose cells, mast cells, schwan cells and its main 
cell type, the fibroblast (Eckert, Crish et al. 1997). The most common cell type of 
connective tissues in animal cells, fibroblasts, specialize in producing collagen and 
elastin fibres which constitute the extracellular matrix (ECM) and have a key role in 
tissue maintenance and metabolism as well as in wound healing (Marionnet, 
Pierrard et al. 2006). The main function of the fibroblast is to maintain the 
structural integrity of the connective tissue by secreting ECM precursors and a 
variety of protein fibres. In the dermis, fibroblasts are primarily located in the 
dermal papillary layer, although they can be found in lesser amounts in the reticular 
region as well (Cha and Purslow 2010).  
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1.8.3 Keratinocytes in vitro 
Human diploid epidermal cells were first serially cultivated by James Rheinwald and 
Howard Green in 1975, prior to which cultivation of mammalian cells in vitro was 
difficult, and numerous attempts to culture disaggregated epidermal keratinocytes 
in monolayer had proved unsuccessful. Rheinwald and Green demonstrated that 
epidermal cells were dependent on fibroblast products to initiate colony formation 
and subsequent co-culture with the fibroblast ‘feeders’ resulted in keratinocyte 
growth and differentiation. Furthermore, these studies concluded that for optimum 
keratinocyte growth, fibroblasts must be lethally irradiated to inhibit proliferation 
and they must be present at the correct density to prevent overpopulation of the 
epidermal cells. Upon inoculation of epidermal cell suspension with lethally 
irradiated fibroblasts, the feeder cells quickly formed a monolayer on the dish 
surface whilst epidermal cells took several days to attach but upon making contact 
with the dish they grew as expanding colonies on the vessel surface, pushing away 
the  feeders at the periphery (Green, Rheinwald et al. 1977, Rheinwald and Green 
1977).       
 
In the absence of fibroblast feeders and despite high seeding densities, human 
keratinocytes could not initiate colony formation and the use of medium 
conditioned by the growth of 3T3 cells could not substitute for the cells themselves 
(Green, Rheinwald et al. 1977). In contrast, another study by Rheinwald and Green 
on a tumourigenic keratinocyte cell line showed successful proliferation in 3T3 
conditioned medium, highlighting the fact that tumourigenic cell lines are less 
dependent on growth factors (Rheinwald and Green 1975). Irradiated mouse-3T3 
cells were found to be more effective then irradiated human diploid fibroblasts in 
supporting growth of human epidermal keratinocytes since in the presence of 
human fibroblasts, keratinocyte growth was slow and the cells did not stratify as 
much. 3T3 cells were established in 1962, when they were derived from Swiss 
mouse embryo by Howard Green, and since then it has become a standard 
fibroblast cell line. It is spontaneously immortalized with stable growth rates and its 
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name is derived from the protocol established for its generation, an abbreviation 
for ‘3-day transfer, inoculums 3 x 105 cells’ (3T3) (Green, Rheinwald et al. 1977).  
 
The successful culture of keratinocyte in vitro showed that, like most cells, 
keratinocytes also exhibit a finite replicative lifespan as a result of the Hayflick limit, 
ceasing growth between 20-50 population doublings and senescing. Improvement 
in cell culture conditions can extend lifespan although it still cannot compare to the 
proliferative potential of cells in vivo, as the removal of cells from the dividing 
population affects its maximum growth potential. The age of the donor from which 
the cell population was obtained also affects replicative lifespan as the use of 
epidermal cells from older donors have reduced growth potential with 
keratinocytes of donors of ages 3-34 years growing through a total of 20-27 
generations, whereas newborn cells grew through 25-51 generations (Green and 
Rheinwald 1975b).  
 
The plating efficiency also differs between donors as those cells from older donors 
have a plating efficiency of less than 1% whilst cells from younger donors are in the 
range of 2%-10%. Prior to human diploid epidermal cell culture, only fibroblasts 
were readily available for experiments and the pioneering work of Rheinwald and 
Green illustrated that previous limitations in epidermal cell culture were due to the 
complex relation of epidermal cells to fibroblasts and in doing so revolutionalized 
the way into mammalian cell-based research.  
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Keratinocytes are heterogeneous in their proliferative potential and three 
classifications have been established (Barrandon and Green 1987b):   
i) Holoclone; Cells forming part of the holoclone have the highest 
reproductive capacity. Less than 5% of colonies formed by the cells of the 
holoclone abort and terminally differentiate.   
ii) Paraclone; Cells in this subset have short replicative lifespan, rarely 
exceeding 15 cell generations before aborting and terminally differentiating.  
iii) Meroclone; This is often the stage between holoclone and paraclone and 
consists of cells with a variety of replicative potentials. 
 
The relative proportion of different clonal types is affected by aging as cells 
originating from the epidermis of older donors subsequently give rise to a lower 
proportion of holoclones and a higher proportion of paraclones (Barrandon and 
Green 1987). Each of the keratinocyte colonies ultimately forms a SSE in which the 
dividing cells are restricted to the lower layer (Rheinwald and Green 1977).  
 
The addition of hydrocortisone, cholera toxin and epidermal growth factor (EGF) 
contribute to increased cell growth rates and proliferation in culture. 
Hydrocortisone makes keratinocyte colonies more orderly and distinctive, 
maintaining proliferation at a slightly higher rate whilst the use cholera toxin causes 
an increase in cyclic AMP levels, again increasing rates of cellular proliferation and 
increasing number of cells in smaller colonies (Rheinwatd and Green 1975).  The 
addition of EGF extends the culture lifespan of epithelial cells from neonatal 
foreskin (Rheinwald and Green 1977) by contributing to the rate of migration of the 
cells that is essential for sustained growth of the keratinocyte colonies (Barrandon 
and Green 1987). Intracellular levels of calcium are important for keratinocyte 
stratification and adhesion (mediated by calcium-dependent desmosomes and non-
disjunction cadherins) and standard tissue culture concentrations of calcium range 
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from 1.2 – 1.8 mM in which keratinocytes are able to stratify in contrast to levels 
ranging between 0.05 – 0.10 mM wherein keratinocytes proliferate but are unable 
to stratify or form a monolayer (Hennings, Michael et al. 1980). 
 
1.9  Serum free culture 
Despite good culture conditions and increased rates of proliferation, the fibroblast 
feeder system is complicated and time consuming, as well as difficult to adapt 
universally. The problems associated with the feeder layer approach led to the 
development of a well defined serum free culture system for cell culture. The 
presence of animal serum in cell medium is believed to be a source for nutrients 
and other ‘factors’ essential for cell growth in vitro. Perhaps the main drawback of 
animal serum is that by nature, serum is largely undefined, complex mixture of 
multiple constituents and the effects of many of these on cultured cells remain 
unclear, with suggestions that cytotoxins present in the serum have a detrimental 
effect on primary and established cell lines (Mujaj, Manton et al. 2010). Due to high 
batch to batch inconsistency of serum, laboratories have to undergo a highly costly 
and time consuming screening process before use, with such variation making it 
hard to control culture conditions and different serum batches can illicit varying 
effects in different cell assays (Do 2003). High costs, presence of contaminants such 
as virus, bacteria and mycoplasma and ethical concerns for animal welfare add to 
the disadvantages associated with animal sera and highlight the importance of 
developing and using a well defined and consistent serum free system. The switch 
over from serum to serum free can vary between cell types but in general cells can 
be gradually weaned to grow in a serum free system with relative ease and some 
companies offer their own cells already adapted to grow in serum free media (Do 
2003). Such systems are suggested to have better comparable cell growth rates and 
produce higher yields of end products since they allow for more control of culture 
conditions, elimination of contaminants and serum cytotoxicity, improved 
reproducibility between cultures and consistency of media that avoids the need to 
screen batches  (Gstraunthaler 2003). 
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1.10 DNA damage response 
The DNA of eukaryotic cells is constantly exposed to endogenous and exogenous 
DNA-damaging agents. To prevent accumulation of genomic damage and retain 
normal genome integrity, cells have evolved a complex response mechanism known 
as the DNA Damage Response (DDR) (Nyberg, Michelson et al. 2002). This inhibition 
of further DNA synthesis following DNA damage is critical for avoiding genetic 
lesions that may later contribute to cellular transformation and results in 
premature cell growth arrest (Kastan, Onyekwere et al. 1991). If DNA damage is not 
repaired prior to the cell entering mitosis, the use of a damaged DNA template 
results in the permanent fixation of the mutated lesion, ultimately leading to 
cellular transformation in cells deficient in this inhibitory process (Kastan, 
Onyekwere et al. 1991). The different types of DNA damage as a result of acute or 
chronic stress on cells include oxidation of bases, DNA single strand breaks ( SSBs) 
and DNA double strand breaks (DSBs), with the latter considerably more lethal, 
resulting in senescence via the p53 and p21WAF1 tumour suppressors (Funayama 
and Ishikawa 2007). Oxidative stress and radiation-induced DNA DSBs can also lead 
to chromosomal instability by erroneous joining of DNA ends or the deletion or 
amplification of tumourigenic mutations (Banin 1998). In response, the cell recruits 
primary DNA damage proteins ataxia telangiectasia mutated (ATM) and Rad3-
related protein (ATR) to the site of damage. Upon recruitment of ATM and ATR, the 
histone protein variant, H2AX, is phosphorylated to γH2AX that facilitates the 
assembly of DNA repair factors such as 53BP1 and MDC1, in turn leading to the 
phosphorylation of p53 activating proteins, Chk1 and Chk2 (Fernandez-Capetillo, 
Lee et al. 2004). Stabilization of p53 is achieved through phosphorylation of p53 at 
ser-15 by ATM and at ser-20 by Chk2 and thus prevents the binding of p53 with 
MDM2 (Khanna, Lavin et al. 2001) .  
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 1.10.1 Markers of DNA damage 
The DNA damage response involves a large number of checkpoint and repair 
proteins that are responsible for damage detection, check point activation, damage 
repair and post repair resumption of the cell cycle. In eukaryotic cells these multi 
protein complexes are organized into centres called ‘foci’ and such DNA damaged 
induced foci formation is a tightly regulated multi-step process involving diverse 
protein-protein interaction, post-translational modifications and enzymatic 
reactions (Lisby and Rothstein 2004).   
 
One such protein involved in the DNA damage response is p53 binding protein 1, 
(53BP1), initially identified as a protein that binds to the central DNA binding 
domain of p53 thereby enhancing p53 mediated transcriptional activation (Ward, 
Minn et al. 2003). Inconjunction with ATM, 53BP1 creates a positive feedback loop 
that is activated upon DNA damage whereby 53BP1 phosphorylates ATM at ser-25 
and in return is a target of phosphorylation by ATM itself. 53BP1 is essential for 
DNA repair through nonhomologous end joining (NHEJ) and has been shown to 
influence chromatin mobility around DNA damage-induced foci, allowing for 
separated DNA ends to come together for repair (Dimitrova, Chen et al. 2008). 
Consequently, knock out studies of 53BP1 have demonstrated an increase in 
genomic instability and chromosomal aberrations as well as accumulation of 
chromatin breaks  (Fitzgerald, Grenon et al. 2009).  
 
In response to genomic stress 53BP1 becomes hyperphosphorylated and has been 
shown to co-localise with γH2AX into distinct nuclear foci at sites of DNA lesions, 
suggesting its involvement in DNA damage response (Kastan, Onyekwere et al. 
1991)(Fig 1.9). H2AX becomes rapidly phosphorylated upon exposure of cells to 
DNA damage due to a highly conserved serine residue located 4 amino acids from 
the COOH terminus and has been shown to rapidly form ionizing radiation induced 
foci (IRIF) in the chromatin surrounding the DSB and to co-localise with other 
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proteins involved in the DNA response such as ATM, BRCA1 and 53BP1 (Fernandez-
Capetillo, Lee et al. 2004). Presence of γH2AX has been shown to be essential for 
the recruitment of repair/signalling proteins to DNA damage and in the formation 
of foci for numerous factors including 53BP1. It has been suggested that 
phosphorylation of H2AX increases the likelihood of assembling a functional repair 
complex by increasing the local concentration of repair factors near the lesion           
(Fernandez-Capetillo, Lee et al. 2004). The DNA damage response is crucial to the 
proper functioning of the cell and a defect in this pathway results in chromosomal 
instability disorders and genetic diseases such as ataxia telangiectasia wherein a 
defective ATM leads to immunodeficiency and severe disability.   
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             G1 cell cycle arrest  
 S-phase checkpoint activation 
Figure 1.9 : Involvement of 53BP1 and γH2AX in DDR. 
In response to double strand breaks following DNA damage, H2AX is phosphorylated by the 
checkpoint kinase ATM and acts as a marker for DNA damage. After its subsequent phosphorylation, 
53BP1 co-localizes with γH2AX to form nuclear foci and is responsible for coupling ATM with 
downstream targets such as p53 and SMC1 (Abraham 2002). Following damage, ATM targets the     
ser-15 residue of p53 for phosphorylation and leads to p53 mediated G1 cell cycle arrest.  Structural 
maintenance of chromosome protein 1, SMC-1, is involved in DNA repair and is a downstream 
effector of ATM-dependent S –phase checkpoint pathway. Following recruitment of 53BP1 to γH2AX 
nuclear foci, ATM phosphorylates serine 966 in vivo that activates the S-phase checkpoint in 
response to DNA damage leading to a decrease in the rate of DNA synthesis (Yazdi, Wang et al. 
2002) (Figure modified from (Abraham 2002). 
 
 
DNA Damage 
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1.10.2  Oxidative Damage to DNA 
Living cells are constantly exposed to potentially damaging free radical species that 
may arise from normal cellular metabolism or be produced following exposure to 
ultra violet or ionizing radiation (Cooke et al., 2004). Oxidative stress has been 
established as the source of endogenous reactive species (ROS) resulting in DNA 
base damage and strand breaks, both of which, unless repaired, may be mutagenic, 
cytotoxic or both to the cell (Cooke, Evans et al. 2003). In view of the damage 
caused by ROS and the significance in cancer and ageing, oxidative DNA damage 
and its repair pathways have attracted much research (Cheng, Cahill et al. 1992). 
ROS are the by-products of oxygen metabolism, cell injury, phagocytosis and 
environmental oxidants and are released from the mitochondria during cellular 
respiration or generated by ionizing or ultraviolet radiation. The most important 
ROS includes the relatively unreactive superoxide anion radical (O2·¯) which is 
converted by superoxide dismutase into hydrogen peroxide ,H2O2,  that in turn can 
take part in the fenton reaction to produce the  very reactive hydroxyl radical, ·OH 
(Halliwell 2003). Additionally, endogenous and exogenous stimuli can also 
accelerate the generation of ROS, altering the redox balance and causing oxidative 
stress to cells.  
 
One of the most frequently occurring base modification in mammalian DNA in 
response to oxidative stress is the guanine analogue, 8-oxyguanine, formed 
spontaneously by reaction of ROS with DNA either by oxidation of guanine basis or 
incorporation of oxidised dGTP into the DNA during DNA synthesis. The oxidized 
guanine has altered base pairing properties wherein adenine (A) tends to be 
incorporated into the daughter strand during DNA replication in place of cytosine 
(C). The enzymes and processes involved in the repair of 8-oxo-Gua are the most 
intensively studied amongst those enzymes that repair oxidative DNA damage due 
to the abundance of this lesion, its mutagenic potential and its use as a biomarker 
of oxidative DNA damage (Cook, Gius et al. 2004).  
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1.10.3 Repair of oxidative DNA damage 
It is assumed that ROS, in particular hydroxyl radical, is formed close to the DNA 
and that as little as 1% of the oxygen passing through the respiratory chain may 
undergo single electron transfer to superoxide and hence the potential for DNA 
damage is enormous (Collins 1999). Oxidative DNA damage greatly increases the 
potential for mutations in mammalian cells and elevated levels of oxidative DNA 
lesions have been noted in many tumours, strongly implicating a role of oxidative 
stress-induced DNA damage in the etiology of cancer (Collins 1999). The removal of 
oxidative DNA lesions is important for the limitation of mutagenesis, cytostasis and 
cytotoxicity and therefore is not surprising that the cell has evolved multiple and 
overlapping repair mechanisms to prevent lesion formation and should an lesion 
occur, to ensure rapid removal and repair (Evans, Dizdaroglu et al. 2004). 
 
The first line of defense against ROS is enzymatic inactivation by antioxidants such 
as superoxide dismutase (SOD (inactivation of superoxide), catalase (breaks down 
H2O2 into water and oxygen), glutathione (GSH) which is abundant in the nucleus 
and glutathione peroxidase (catalyses the breakdown of peroxides via reaction with 
GSH) (Collins 1999). The second line of defense addresses the misincorporated        
8-OH-Gua, and is via specialized enzymatic activities by a homologue of the enzyme 
MutY (MYH), a special adenine DNA glycosylase which removes the mispaired 
adenine from opposite 8-OH-Gua, and MutT homologue 1 (MTH1), which catalyses 
the hydrolysis of 8-OH-Gua by preventing its incorporation in the DNA template 
followed by base excision repair that is initiated by OGG1, eliminating 8-oxo-
guanine (Collins 1999). At the proof reading step the misincorporated adenine is 
removed by MUTYH, a special adenine DNA glycosylase, which initiates base 
excision repair (Cook, Gius et al. 2004). The third line of defense for oxidized DNA 
base lesions is by an intricate network of DNA repair mechanisms such as base 
excision repair (BER), mismatch repair (MMR), homologous recombination (HR) and 
non-homologous end-joining (NHEJ) (Cook, Gius et al. 2004). Lesions are removed 
by BER which involves removal of a single lesion by a glycosylase action and a more 
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complex process involving the removal of a lesion-containing oligonucleotide by 
nucleotide excision repair (NER) (Collins 1999).  
 
1.10.3 Oxidative DNA damage in disease 
One of the main consequences of oxidative lesions is DNA mutations and hence the 
role of oxidative lesions in cancer is extensively studied. Oxidative mechanisms 
have been implicated in carcinogenesis due to its ability to introduce spontaneous 
mutations in the genes encoding for tumour suppressors and proto-oncogenes, and 
incorrectly activating or silencing them. ROS are constantly generated within the 
cell and one of the crucial cellular targets of these radicals is DNA, showing 
specificity for guanine bases and corresponding to mutations in the tumour 
suppressor genes Ras and p53 (Cook, Gius et al. 2004). Oxidative free radicals have 
the ability to continuously activate transcription factors and consequently give rise 
to an increase in genomic instability, thereby creating selection pressure for 
malignancy (Cook, Gius et al. 2004). Apart from DNA base modifications, oxidative 
stress-induced lesions can also occur at chromosomal level whereby deletions and 
rearrangements can alter expression in key genes through single point mutations or 
rearrangements of the promoter/enhancer regions (Evans, Dizdaroglu et al. 2004). 
Despite circumstantial evidence establishing the role of oxidative stress in 
carcinogenesis, there have been conditions wherein increased levels of oxidative 
stress does not increase incidence of cancer. The reasoning behind such 
observations remain unclear, however it has been suggested that it could result 
from mutations being present in the non-coding regions of DNA and as such would 
have very little significance in terms of cancer mutations (Bohr, Anson et al. 1998). 
Alternative reasoning includes the theory that oxidative DNA damage is an 
epiphenomenon and elevated levels do not have any physiological role within the 
body. There is also the belief that the detection of elevated levels of oxidative DNA 
damage is not indicative of carcinogenesis and it may be due to increased cell 
proliferation and metabolic activity within the tumour itself  (Bohr, Anson et al. 
1998).  
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The role of oxidative stress in the pathology of non-cancer related disorders has 
been widely reported. Firstly, the association between oxidative stress and 
inflammation has been widely documented with cellular DNA damage occurring as 
a result of the ‘respiratory burst’ from immune cells such as macrophages and 
neutrophils in response to infection (Cook, Gius et al. 2004). This can further lead to 
chronic inflammation in which ROS-damaged tissues release cytokines, further 
promoting infiltration by inflammatory cells. Such chronic inflammation and 
oxidative stress has been linked to the pathogenesis of autoimmune disorders such 
as rheumatoid arthritis and systemic lupus erythematosus and these autoimmune 
disorders are a result of the free radicals altering the non-immunogenic DNA 
whereby they are viewed as antigens and elicit an immune response and cross-
reactivity (Cooke, Evans et al. 2003). 
 
The ‘free radical theory of ageing’ suggests a link between gradual accumulation of 
free radical damage and ageing. The concept behind the theory is that with age, the 
antioxidants defenses fail to detect, eliminate or repair all of the potentially 
damaging radical species resulting in accumulation of damage and gradual loss of 
function (Bohr, Anson et al. 1998). Other diseases in which oxidative stress has 
been implicative include neurodegenerative disorders such as Parkinsons Disease 
and cardiovascular disorders such as atherosclerosis and myocardial infarctions as a 
result of its involvement in artherosclerotic plaque development (Cook, Gius et al. 
2004). 
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1.11 The Telomere and telomerase: functions and regulation 
 
1.11.1 The telomere 
The concept of the telomere was first proposed by Hermann Muiller in 1938 
through his work on x-ray induced chromosomal damage in Drosophila wherein he 
described the presence of a specialized terminal structure responsible for 
chromosome stability (Zakian,1989). Barbara McClintock advanced the theory on 
telomeres through her work on Zea Mays when she demonstrated the difference 
between the behavior of chromosomes with broken ends that often fused and 
mispaired with other broken ends as compared to natural chromosome ends that 
were stable and did not attempt to fuse with other chromosomes (Zakian, 1989). In 
molecular terms, telomeres are specialized nucleoprotein structures providing a 
protective ‘cap’ for the ends of chromosomes, in the absence of which, ‘broken’ 
chromosomes and free DNA ends are susceptible to end-to-end fusions and 
exonucleolytic degradation (Olovnikov 1996). By protecting against these events 
the telomere acts to prevent the formation of highly unstable, dicentric 
chromosomes and potential loss of genetic information.  
 
An important feature of telomeres was discovered to be their role in what is known 
as the ‘end replication problem’ wherein telomeric DNA cannot be added by normal 
DNA synthesis because of a lack of DNA template (Olovnikov, 1996). Telomeric DNA 
is added by a telomere-specific reverse transcriptase, the telomerase, which itself 
contains the RNA template required for the synthesis of telomeric DNA (Rhodes and 
Giraldo 1995). This conserved feature seems to have come about to prevent the 
gradual loss of genetic information from the chromosome ends which became 
apparent with the gradual understanding of the role of telomeres in both ageing 
and tumour formation.  
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A comparison of telomeric DNA sequence across distantly related eukaryotes show 
highly conserved features consisting of short sequence motifs which typically 
contain a G-rich and a C-rich strand respectively (Rhodes and Giraldo 1995). In 
humans, telomeres are typically composed of tandem repeats of the base sequence 
‘TTAGGG’ between 3 to 20 kb in length although this differs with cell types and 
between individuals. In skin keratinocytes, for example, mean telomere length 
varies from approximately 10 kb in samples from infant foreskin to approximately 
6-7 kb after 30 cell divisions when the cells start to senesce (Krunic, Moshir et al. 
2009). Most of the telomere is double stranded DNA but each telomere ends with a 
short single stranded 3’ overhang, which acts as the substrate for telomerase to add 
telomeric DNA to the ends of chromosomes in elongation (Rhodes and Giraldo 
1995). Apart from their role in chromosomal stability, the conserved telomeric 
sequences have been suggested to allow for the telomeres to fold into specialized 
structures called the ‘t-loop’ which acts to protect chromosome ends and prevent 
them from being exposed to degradation enzymes (de Lange 2005). The importance 
of conserved telomeric sequences have been reinforced by studies in yeast which 
have shown telomeric DNA to not only be essential in chromosome stability but 
also demonstrated that mutations within telomeric DNA impair or prevent nuclear 
division (Rhodes and Giraldo 1995). 
 
 
 
 
 
 
 
   Chapter 1: Introduction 
74 
 
1.11.2 Role in senescence 
The main function of telomeres has been widely studied since it was originally 
proposed that there was a correlation between the Hayflick limit and the end-
replication problem in the early 1970s by Olovnikov. As mentioned previously, the 
function of the telomere is to ensure that the end of the chromosome is not 
interpreted by the cell as a DSB which can lead to chromosome instability and cell 
cycle arrest (Rhodes and Giraldo 1995). This illustrates a tightly regulated system in 
place to ensure that only cells which are supposed to be in a continuous 
proliferative state such as stem cells or cells in the germline, avoid telomere 
shortening and cell death.  
 
In contrast, somatic cells need to senesce in order to maintain the correct 
homeostasis of the tissue that they belong to, and that of the whole organism 
(Blackburn 2001). Human telomeres in somatic cells undergo progressive 
shortening with cell division through replication dependent sequence loss at DNA 
termini, culminating in cellular senescence. Despite undergoing progressive 
shortening, the integrity of telomeres in somatic cells is maintained by the 
involvement of specific binding proteins, collectively termed the ‘shelterin complex’ 
(Xin, Liu et al. 2008). These proteins work together with others to recognize the 
telomeric DNA sequence and form a protective cap structure, thereby protecting 
the chromosome ends from degradation and attempted DNA repair (Reddel 2003). 
This is necessary as without the protective cap the exposed telomeric ends are 
subject to DNA repair processes and to prevent this, the telomeres of normal and 
telomerase positive cells along with the specific binding proteins, form a loop, 
effectively hiding the chromosome ends from repair processes (Reddel 2003).  
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Figure 1.10 : Cellular consequences of telomere dysfunction. 
Telomere structure can be disrupted by direct damage, critically short telomeres or through defects 
in telomere associated proteins. In response to critically short telomeres, normal cells usually 
undergo senescence via the pRb/p53. In the presence of a pRb checkpoint, however, cells undergo 
p53-mediated cell death only. In the absence of both pRb and p53, cells survive and accumulate 
genomic rearrangements leading to genetic instability and this can lead to cancer. (Figure modified 
from (Kim, Kaminker et al. 2002). 
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1.11.3 Telomere regulation 
The protection of the telomere is achieved by a complex formed of six telomere 
specific proteins, named ‘shelterin’, which directly or indirectly bind telomeric DNA 
sequences and protect chromosome ends. The shelterin subunits include TRF1, 
TRF2 and POT1, together which directly recognize the tandem repeats sequences of 
telomeres at chromosome ends, and these are interconnected by three additional 
shelterin proteins, TIN2, TPP1 and RAP1, forming a complex which allow cells to 
distinguish telomere ends from sites of DNA damage (de Lange 2005). Amongst the 
shelterin proteins, TRF2 has been proposed to have a central role in conceding 
telomere ends from being recognized as DSBs and exposed to repair processes. The 
introduction of dominant negative alleles of TRF2 in vitro in human cells triggers 
rapid changes atypical of DSBs with the initiation of apoptosis and induction of end 
to end chromosome fusion.  The shelterin complex works to arrange the human 
telomere into the ‘t-loop’ (Griffith, Comeau et al. 1999), formed by strand invasion 
of 3’ overhang into the preceding telomere tract thereby effectively hiding the 
natural end of the DNA and protecting it from the DNA repair machinery constantly 
scanning for broken chromosome ends (Stansel, De Lange et al. 2001). 
 
 In the absence of shelterin complex, telomeres are no longer hidden from the cells 
surveillance machinery and are inappropriately recognized as DNA damage (de 
Lange 2005). Research has shown that the shelterin complex has reversible DNA 
remodeling activity that, together with several associated DNA repair factors, acts 
to change the structure of telomeric DNA and thereby protects chromosome ends 
(de Lange 2005). This ‘capping’ is generally a temporary state and is generally lost 
when the structure of telomere needs to be accessible for the replicating machinery 
to proceed (Blackburn 2001).  
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Figure 1.11 : Structure of telomeres. 
A). Telomeres visualized by fluorescence in situ hybridization (FISH). Telomeres are located at the 
end of linear chromosomes and composed of hundreds to thousands of tandem DNA repeated 
sequences and protect the chromosome ends from degradation or random fusion events (Image 
from N Engl J Med; 2009; 361:2353-2365).  
B). The schematic diagram shows the human telomeric complex. The human telomeres end in 100-
200 nucleotide protrusion of single TTAGGG repeats which are thought to end in a large ‘t-loop’. The 
structure and stability of the t-loop depends on a number of proteins such as POT1, which binds to 
single strand TTAGGG repeat DNA, and TRF1 and TRF2 that are associated with the duplex repeats 
and form part of the shelterin complex protecting the ends of the chromosomes. Proteins involved 
in the maintenance of the t-loop include TIN2 and RAP1 and proteins which indirectly interact with 
the proteins of the shelterin complex include TNAK1 and TANK2, which that associate with 
telomeres through their association with TRF1. TRF1 and TRF2 also recruit a number of proteins 
which participate in telomere repair processes such as the RMN complex, the DNA pKcs. (image 
modified from (Kim, Kaminker et al. 2002) 
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1.11.4  Telomerase   
A specialized ribonucleoprotein complex, telomerase activity was first characterized 
biochemically in 1985 in Tetrahymena  (Blackburn and Greider 1985) and four years 
later in the immortal hela cell line (Morin 1989). Telomerase directs the synthesis of 
telomeric repeats at chromosome ends and is required for the maintenance of 
telomeric repeats throughout many cycles of cell division. As previously mentioned, 
maintenance of telomere length is essential for the continued viability of 
proliferating cells as in normal human cells telomeres gradually shorten with each 
round of cell division (Collins and Mitchell 2002). Critically short telomeres are able 
to induce proliferative senescence, apoptosis or continued proliferation 
accompanied by genomic instability (Stewart and Weinberg 2000). In contrast, 
immortalization of human cells correlates with stabilization of telomere length, 
suggesting that human cancer cells achieve immortalization, atleast in part, through 
the illegitimate activation of telomerase expression (Masutomi, Yu et al. 2003). As 
mentioned previously, telomere shortening occurs in somatic human cells and this 
is because telomerase activity is strongly repressed in these cells (Kim, Piatyszek et 
al. 1994) but  it is to be found in germ-line cells as well as weak expression in bone 
marrow, gastrointestinal tissues and basal layer of skin (Fujimoto, Kamata et al. 
2001). Despite being repressed, some somatic cells exhibit detectable levels of 
telomerase activity and it is possible that this could be compensating for the 
shortening of telomeres that occurs with cell division and thus increasing the 
proliferative capacity of cell populations in tissues that require a high cell turnover 
(Reddel 2003). In addition, telomere lengthening may also occur in normal cells for 
example, the telomere length of B lymphocytes appear to increase during their 
transit through the germinal center of the lymph nodes (Toouli, Huschtscha et al. 
2002). Human telomerase is composed of RNA template encoded by the TERC gene 
and a catalytic protein subunit called hTERT. It is a reverse transcriptase which 
works by copying a template sequence carried within its integral RNA (provided by 
the catalytic subunit hTERT) and adds single-stranded telomeric repeats to the 
chromosome 3’ ends (Collins 2000) and in doing so compensates for the loss of 
telomeric sequences during DNA replication. The catalytic subunit hTERT is 
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implicated as the rate limiting component of the telomerase holoenzyme as 
telomerase activity in cells directly correlates with levels of hTERT (Masutomi, Yu et 
al. 2003) .  Most cancer cells and immortalized human cell lines express detectable 
levels of telomerase activity and exhibit stable telomere lengths in cell culture (Kim, 
Piatyszek et al. 1994).  As most malignant tumours and some precancerous lesions 
have been reported to have higher levels of telomerase activity than normal tissue, 
this is now considered to be a marker of malignancy (Fujimoto, Kamata et al. 2001). 
 
It is important to note that whilst the majority of cancer and immortalized cells 
maintain telomere lengths by illegitimate activation of telomerase, a smaller subset 
of these cells do not show detectable levels of telomerase activity yet maintain 
telomere lengths (Reddel 2003). An alternative lengthening of telomeres (ALT) 
system, a recombination-like process that allows for rapid elongation of shortened 
telomeres,  was proposed to overcome the Hayflick limit by these cells            
(Reddel  2003). The ALT process can proceed in two separate ways and results in 
the presence of highly heterogeneous telomere lengths in cells performing ALT 
(Cesare and Reddel 2008). The ALT process involves the DNA strand of an ALT cell 
annealing with the complementary strand of a nearby telomere and thereby 
priming the synthesis of new telomeric DNA using the complementary strand as a 
copy template (Reddel 2002). The ALT pathway has been observed in a variety of 
tumours and tumour-derived cell lines including breast carcinoma, glioblastoma, 
osteosarcoma and adrenocortial carcinoma and it has also been identified to be 
present in approximately 28% of immortalized cell lines in vitro (Bryan, Englezou et 
al. 1997). Experimental evidence has indicated the possibility of both ALT and 
telomerase activity co-existing together with in vitro data suggesting certain tumour 
types to exhibit both telomerase activity and extreme telomere length 
heterogeneity, typical of ALT pathway.  
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It has been suggested that this is either due to intratumoural heterogenicity with 
some areas of the tumour being telomerase positive and others possessing a ALT 
activity or, more unlikely, that both processes may reside within the same cell 
together (Reddel 2003).  
 
1.12  Primary cell culture and cellular immortalization 
The use of primary human cells for research, biotechnology and therapeutic 
purposes has been restricted mainly due to their limited replicative potential. 
Whilst epithelial cells can provide in vitro systems to investigate many biochemical 
and physiological mechanisms, they are limited due to their restricted replicative 
life span and the distortion in morphological features and gene expression that 
start to accumulate with age in culture, including increase in cell size and 
development of multiple nuclei alongside activation of tumour suppressors 
(Hanahan and Weinberg 2000). Such limitations often led to the need to                  
re-establish fresh cultures from explanted tissues, not only a tedious task but one 
which can also add variation from one preparation to another as well as disrupting 
experimental data, particularly for long term experiments. For many applications, it 
is ideal to have either an extended replicative capacity or unlimited numbers of 
characterized cells with the genotype and phenotype of the parental tissue as this 
would result in consistency throughout the research application and eliminate 
variation due to the use of different strains. The limitations posed to research by 
primary cells have since been overcome through the establishment of tumour-
derived cell lines or through the generation of immortal cell lines by various 
methods, reviewed below.  
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1.12.1 Tumour-derived cell lines 
For years, tumour-derived cell lines have been used in research for their ability to 
proliferate indefinitely, an ability which likely stems from the fact that p53 is 
inactivated in over 80% of tumours, thereby allowing abnormal cells to overcome 
cell cycle checkpoints, as well as their ability to synthesize telomerase activity 
(Harvey and Levine 1991). Downregulation of the cells’ tumour suppressors can 
account for the highly volatile and unstable characteristics displayed by cancer cell 
lines. One of the main irregularities cancer cells display is lack of contact inhibition 
when cultured on culture vessels and continue to proliferate after encountering 
neighboring cells, not appearing to co-operate with other cells in the environment. 
Cancer cell lines can also be grown in simpler growth mediums as they have a 
reduced dependence on the presence of growth factors in the culture environment 
compared to their normal counterparts. Another major feature of cancer cells 
which make them undesirable for research is their abnormal karyotypes, with cells 
being either polyploidy or aneuploid and their chromosomes appear very unstable 
with abnormal structure due to chromosomal translocations, deletions, 
duplications and inversions (Shay, Wright et al. 1991).  
 
One prime example of a commonly used tumour derived cell line is the HeLa cell 
line, derived in 1951 from a malignant cervical biopsy of Henrietta Lacks and it was 
also the first human cell line to prove successful in vitro. HeLa cells were deemed 
immortal as they are capable of unlimited proliferation in culture as long as they 
are maintained in a suitable culture environment and to date are used in multiple 
applications from testing of the first polio vaccine through to cancer research   
(Shay, Wright et al. 1991). Although immortal, HeLa cells have been characterized 
as having abnormal rates of cell proliferation, they appear to proliferate extremely 
rapidly even for cancer cells and have constantly activated telomerase activity. 
Many chromosomal aberrations have also been characterized in HeLa cells and they 
are highly unstable with gene transfer from the HPV18, an average of 82 
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chromosomes with four copies of chromosome 2 and 3 copies each of 
chromosomes 6, 8 and 17 (Shay, Wright et al. 1991).  
 
As mentioned, HeLa cells are highly unstable and so far many strains exist as they 
continuously evolve. Another issue that has arisen in the culture of HeLa is that of 
contamination, with HeLa cells often being branded as difficult to control and a ‘lab 
weed’ that interferes with research, invalidating data by infecting other cells in the 
same lab (Harvey and Levine 1991). 
 
1.12.2 Spontaneous immortalization 
Cells capable of overcoming cellular growth restraints, bypassing senescence in the 
absence of deliberately added exogenous agents and acquiring the ability to 
proliferate indefinitely are deemed to have undergone spontaneous 
immortalization. As mentioned previously, the cell division potential of any 
particular culture appears to be dependent on many factors such as the age of the 
donor and it has been suggested that the frequency at which cells escape 
senescence is species dependent (Harvey and Levine 1991). Most rodent cells show 
frequent spontaneous immortalization in comparison to human cells in which this 
event is a rarity. This is likely due to the longer lifespan of humans which has led to 
the evolvement of efficient control mechanisms for prevention of such events for 
example; less error prone replication machinery, more efficient repair systems and 
molecules being better adapted to react with free radicals (Shay, Wright et al. 
1991). A number of studies have suggested that spontaneous immortalization 
occurs by the selection of rare cells in the cell population carrying mutations in key 
genes to inactivate their tumour suppressive activity and cell cycle regulators (Shay, 
Wright et al. 1991). In keeping with this idea, it is not surprising that many of these 
spontaneously derived cell lines illustrate mutations at the p53 locus with the 
inactivation of p53 widely reported as a key event in cellular immortalization 
(Harvey and Levine 1991). 
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1.12.3 DNA tumour viruses 
For years one of the most common methods to generate immortal cells was to 
transduce human cells with genes from DNA tumour viruses such as simian virus 40 
(SV40), human papillomavirus (HPV) , adenoviruses and the epstein-barr virus (EBV) 
(Shay, Wright et al. 1991). DNA tumour viruses appear to increase the frequency of 
human cell immortalization as they encode proteins that interact with the cells 
tumour suppressive gene products and efficiently over-ride the cell cycle regulatory 
proteins (Linder and Marshall 1990). Although useful, such methodology has its 
limitations as virus induced transformation often results in loss of some aspect of 
differential cell phenotype. As mentioned, several families of DNA viruses appear to 
induced immortalization in human cells and some will be briefly reviewed below. 
 
1.12.3.1 Simian virus 40 (SV40)  
Infection of human cells with SV40 early region genes by transfection of an 
expression plasmid remains a very common immortalization technique for 
extending the replicative life span of almost any human cell type. It has now been 
recognized that the major SV40 oncoprotein encoded by early region DNA, the 
large T antigen, is responsible for the immortalization of rodent and human cells 
(Linder and Marshall 1990). The cells infected with SV40 and expressing the large T 
antigen develop altered morphology, show a reduced serum requirement for 
growth as well as acquiring extended life span in vitro (Shay, Wright et al. 1991). 
SV40 achieves this by random integration of viral DNA into host genome and 
inactivating the p53 and pRb proteins, hence cells expressing SV40 oncoproteins 
proliferate for many population doublings beyond the point at which their normal 
counterparts senesce (Linder and Marshall 1990). During this extended replicative 
lifespan, the cells continue to proliferate as their telomeres continue to shorten, 
and ultimately the cell population stops proliferating and enters into ‘crisis’. In 
some cultures, a rare dividing cell population which has acquired a spontaneous 
genetic change gives rise to an established cell line although such an event is rare, 
approximately 1 per 107 and all cells evading crisis in this way always have a 
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activated telomere maintenance mechanism, either through activated telomerase 
or ALT (Shay, Wright et al. 1991).   
 
An example of a SV40 transformed cell line displaying altered features is the normal 
human uroepithelial cells (HUC) which were transformed with SV40 in vitro 
(Reznikoff, Loretz et al. 1988). Although SV-HUC seemed to achieve 
immortalization, they displayed altered growth characteristics. In comparison to 
HUC, SV-HUC had altered ability to grow on plastic vessels, seemed to lose 
dependence on medium supplements for optimal growth as well as lack of 
requirement on feeder cells for optimal growth at clonal density. Additionally, SV-
HUC had irregularly shaped nuclei and nucleoli, a lack of cell surface marker 
glycocalyx and a inability to stratify and differentiate in culture (Reznikoff, Loretz et 
al. 1988). Another phenotype associated with SV40 transformed cells is an ability to 
induce tumours with time in passage (Reddel, Salghetti et al. 1993). 
 
1.12.3.2 Human papilloma virus (HPV) 
HPV are small DNA tumour viruses that induce epithelial proliferation and cause 
benign lesions such as warts and papillomas, as well as possible malignant tumours 
of cutaneous and mucosal epithelia (Shay, Wright et al. 1991). HPV oncogenes E6 
and E7 from high risk strains 16 and 18 have been shown to assist in the 
immortalization of a number of cell types and are found in approximately 70% – 
80% of cervical cancers and cell lines derived from them (Shay, Wright et al. 1991). 
E6 oncogene causes degradation of p53 and an upregulation of c-myc expression as 
well as partially activating telomerase activity whilst the E7 oncogene is known to 
degrade pRb (Yeager and Reddel 1997). As is the case with SV40 transformed cells, 
these cells also undergo a two step immortalization process with cells first 
undergoing crisis and then a rare population emerging. 
  
   Chapter 1: Introduction 
85 
 
A study by Shay et al (1991) showed that transfection of human foreskin 
keratinocytes with a plasmid containing HPV16 DNA produced immortalized cell 
lines, however the cells had heteroploid karyotypes and were not anchorage 
dependent (Shay, Wright et al. 1991) 
 
1.12.3.3 Epstein Barr virus (EBV) 
EBV has proved to be a very efficient method for extending proliferative capacity of   
B lymphocytes and the path to immortalization by EBV is different from those of 
SV40 and HPV (Shay, Wright et al. 1991). Experimental data has indicated that in 
some lymphoblastoid cell generations transformed with EBV, there is a significant 
increase in pre-crisis lifespan of upto 160 population doublings, exhibiting strong 
telomerase activity and hence these cell lines are more likely to become 
immortalized then those that show weaker telomerase expression. The proliferative 
capacity of these lymphoblastoid cell lines, regardless of whether they immortalize, 
makes them useful for a wide variety of applications especially as an essentially 
unlimited source of DNA for genetic studies (Yeager and Reddel 1997).  
 
Infection of human EBV-negative B lymphoma cell line by gene transfer of EBV 
resulted in increased cell size, acid production, plasma membrane ruffling and 
villous projections (Wang, Liebowitz et al. 1988).  
 
1.12.3.4 Limitations of DNA tumour viruses 
Studies with viral oncogenes have been extremely insightful for the senescence and 
immortalization processes over the years, as well as generating many useful cell 
lines, either immortalized or displaying a greatly enhanced proliferative capacity 
(Yeager and Reddel 1999).  One of the main problems encountered with 
immortalizing cells using tumour viruses, however, is that the proteins that they 
encode disrupt many cellular pathways, in particular p53 and pRb, and possibly 
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many others which as yet remain unknown. These oncogenes also cause many 
undesirable changes within the cell line such as loss of differentiated properties and 
loss of normal cell cycle checkpoint controls (Reddel, Salghetti et al. 1993).  
 
 
Cell Line Cell Type Characteristics 
HaCat keratinocyte Spontaneously derived from adult skin; initially 
hypodiploid leading to aneuploid and multiple 
chromosome alterations; ability to differentiate  
Hela Epithelial of cervix 
origin 
Tumour derived ; highly unstable in vitro ; 
chromosome aberrations and unstability 
N-TERT keratinocyte Spontaneous loss of p16INK4a 
N-TERT1 keratinocyte Reduced expression of p16INK4a 
N/Bmi/Tert1 keratinocyte P16INK4a/p14ARF repressed 
K107 keratinocyte Inherited loss in p16INK4a; deficient p53 
Table 1.4: List of commonly used epidermal immortalized epithelial cells and their characteristics. 
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Cell line Cell type Characteristics 
OKF4 keratinocyte Viral oncogene knockdown of p16INK4a and p53 
OKF6 keratinocyte Spontaneous loss of p16INK4a 
TR146 Buccal carcinoma 
cells 
Tumour derived 
SCC25 SCC Tumour derived 
POE9N keratinocyte Dysplasia derived,  deletion of p16INK4a and loss of p53 
Table 1.5: List of commonly used oral immortalized epithelial cells and their characteristics. 
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1.12.4 Activation of hTERT 
Critically short telomeres activate senescence through the p16INK4a/pRb and/or 
p53/p21WAF1 pathways to block cell cycle progression and inhibit cell division. Viral 
oncogenes such as SV40 large T antigen and the E6 and E7 proteins of HPV have 
been shown to effectively extend cell lifespan by inactivating p16INK4a and p53, 
albeit by altering cellular phenotype and gene expression patterns. It is important 
to note that apart from the cellular aberrations induced by viral oncogene 
transformations, this method alone merely extends the replicative lifespan of the 
cells and does not result in immortalization. Following extended cell divisions, these 
cells inevitably enter into a crisis state, characterized with extreme cell death, 
unless spontaneous immortalization occurs. The inability of viral proteins to 
successfully immortalize cells is due to the presence of the second type of 
senescence, one that is telomere-controlled.  
 
In respect to immortalization, the cell life cycle can be analyzed by the three 
separate stages of mortality known as M1, M2 and M0 and the different factors 
required to overcome the senescence barriers (Figure 1.12) (Lustig 1999). 
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Figure 1.12 : Barriers to mortality of primary cells. 
Primary cells derived from non-cancerous tissues display a finite lifespan when cultivated in vitro. 
Research into senescence for generation of immortalized cell lines has revealed two distinct forms of 
senescence, each representing a separate obstacle to cellular immortality. A) The two obstacles to 
all human cells preventing immortality consists of  the shortening of telomeres and stress related 
factors , mainly the induction of p16
INK4a
 through different stimuli. B) In order to achieve immortality 
it is vital for the cells to overcome these barriers. M0 stage can be overcome either by rare 
spontaneous changes in the cell or by the introduction of viral proteins such as the SV40 large T 
antigen or HPV proteins E6/E7. The second obstacle is the shortening of telomeres with cell division 
which can be overcome by introduction of exogenous hTERT, catalytic subunit of telomerase 
holoenzyme , responsible for maintain telomere length. Whilst hTERT introduction can effectively 
bypass the barrier without causing abnormal phenotypic changes in the cells, it is important to note 
that hTERT alone is not sufficient to cause immortalization in all cell types. Overcoming M0 by viral 
proteins in the absence of telomerase activation will result in cell lifespan extension but the cells will 
eventually enter crisis and cell death. Similarly, introduction of hTERT alone, whilst sufficient to 
immortalize cell types such as fibroblasts, alone they will extend replicative life span of certain cell 
types, notably the keratinocyte , prior to entering crisis.  
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An alternative method for cellular immortalization and life span extension whilst 
avoiding direct interference in cell regulatory pathways which has come to light in 
recent years is induction of telomerase activity from the cloning of the catalytic 
subunit of the telomerase gene; hTERT (Hahn and Meyerson 2001). As mentioned 
previously, telomerase activity is determined by levels of hTERT and this reverse 
transcriptase works by stabilizing telomere length and thereby greatly extends 
proliferative capacity of the cells. In most human cell types, hTERT and telomerase 
activity is either absent or present at insufficient levels for telomere maintenance 
and hence expression of hTERT in these cells suffice to reconstitute telomerase 
activity by maintaining telomere size and preventing the onset of M1 and M2 
(Harley, Kim et al. 1994). Primary cells in general are very hard to transfect and so 
hTERT is introduced into the cells by use of retroviral vectors encoded with a 
selection marker and consequently cells are selected and assayed for telomerase 
expression and lifespan extension (Shay and Wright 2005). Primary human cells that 
have so far being successfully immortalized with the introduction of hTERT include 
fibroblasts, retinal pigmented epithelial cells and endothelial cells.  
 
Despite the success of bypassing crisis and extending life span in some cell types, it 
appears that hTERT alone is not always sufficient for immortalization of primary 
cells. The main example of this is the human keratinocyte, wherein expression of 
hTERT alone was found to be insufficient to extend proliferative lifespan 
(Rheinwald, Hahn et al. 2002). Further research demonstrated that exogenous 
hTERT expression has no effect on lifespan limits of keratinocytes unless 
accompanied by downregulation of p16INK4a expression, by methods such as the use 
of viral proteins or by DNA methylation. These studies highlighted the fact that 
additional changes apart from hTERT are required to increase proliferative potential 
in cells such as keratinocytes. An important factor to consider here is that since 
these cells require disruption of the p16INK4a and/or p53 pathways, it is important to 
obtain a method of extending cellular lifespan and immortalizing cells whilst 
inducing the least amount of damage as possible. The use of common methods 
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such as viral proteins has multiple limitations and disadvantages, and it is desirable 
to disrupt the senescence pathways by other means such as use of dominant 
negative proteins or gene targeting. 
 
1.13 Project summary 
In cell based research, immortalized cell lines offer substantial benefits over 
primary or transformed cell lines. Normal primary cell lines have a finite lifespan in 
culture, limiting long term research whilst transformed lines exhibit abnormal gene 
expression and impaired metabolism thus greatly limiting their effectiveness for 
drug testing and screening. Whilst conventional methods to immortalize human cell 
lines using viral oncogenes and tumour biopsies have been successful in generating 
most of the immortalized cell lines currently used in medicine and research, it has 
various limitations and disadvantages. The use of these methods almost invariably 
gives rise to cells that display cancer associated changes such as loss of contact 
inhibition, reduced growth factor requirements, inhibition of differentiation, 
genomic instability, aneuploidy and disruptions of cell cycle checkpoints. As such, 
the presence of these characteristics pose significant limitations in the analysis of 
many cellular functions, in particular to those related to genomic integrity and cell 
cycle regulations as well as evaluation of potential drugs and pharmaceutical 
products. A novel immortalized cell line that is well characterized and does not 
show such phenotypic changes would be extremely useful for applications in tissue 
engineering and as a model for cancer research.  
 
The testing and optimization for new drug compounds/oral healthcare products 
usually involves a complex process utilizing both in vitro and in vivo models. The 
process commonly begins in vitro using primary, immortalized and/or transformed 
cell lines, followed by the use of a ‘3D’ organotypic culture model and ending with 
extensive in vivo tests prior to human clinical trials. Each of these systems have 
their own strengths and limitations.  
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Organotypic cultures reconstructed from dissociated cells were first developed in 
the 1980’s and the best characterized reconstructed organotypic culture is the 
living skin equivalent. Developed in 1980, the epidermal model is still being used 
today, where one of its main uses is in replacing damaged skin as well as to study, 
amongst others, antioxidant protection against photodamage, drug metabolism, 
differentiation, gene therapy and the immune system. Apart from the skin model, 
organotypic models are currently being used for studies of cardiovascular function, 
angiogenesis, thymus, bone, cornea and oral mucosa. The advantages and 
disadvantages of primary cell lines have been described above and some of the 
commonly used immortalized cell lines reviewed in table 1.4 and 1.5.  
 
Cells grown in monolayers on tissue culture dishes lack 3D cell-cell plus cell-matrix 
contacts and communications present in intact native tissue. Monolayer cultures 
are important for high throughput screening of compounds plus can provide 
information on the molecular mechanisms of drugs and are at high risk of providing 
results that might not hold true in the 3D environment of the tissues or whole 
bodies and discoveries have already emerged that would not have been apparent if 
only monolayer cultures had been used. Organotypic cultures provide a 3D model 
of functional tissue and can be easily made from human cell lines and the main aim 
of using these 3D models is to get a response as close as possible to normal human 
response. The major issue with each model is its relevance to the human body, thus 
highlighting the importance for developing and characterizing a primary cell line 
with minimal genetic changes which would have the potential to be used for in vitro 
studies in addition to as a base in the development of 3D cell models. This could 
potentially prevent or minimize the differences in toxicity and efficacy between in 
vitro studies as compared to animal studies and clinical trials and reduce the need 
for multiple systems that are used to increase the likelihood of accurate translation 
to human trials and avoid artifact.  
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With respect to the oral mucosa, a well characterized, normal immortalized cell line 
would be extremely valuable with many benefits in research and healthcare. A 
major benefit of such a model would be for permeability and metabolism studies in 
drug development. For the development and optimization of drug delivery systems 
it is vital to have knowledge of permeability barriers, transport pathways and 
transport mechanisms of the human mucosa.  Current models for the testing of oral 
drugs, delivery methods and pharmaceutical products involve cell lines which are 
genetically altered, either cancer-derived or spontaneously arisen with unknown 
genetic constituents. Such cell lines can be undesirable to work with when testing 
healthcare products such as toothpastes and mouthwashes as well as potential 
therapeutic drugs and currently studies need to use multiple systems to validate 
data due to lack of confidence in such systems.  Present ‘immortalized’ models of 
the oral mucosa includes one that is derived from the cell line TR146 (manufactured 
by Skin Ethics) that is a useful and valuable model for studies of drugs intended for 
buccal delivery as well as for the testing of oral healthcare products. Having been 
derived from a squamous cell carcinoma of the buccal mucosa, it cannot be 
expected to be a accurate representation of an in vivo response and hence it would 
be beneficial to have an equivalent fully characterized and non tumourigenic 
derived, easily reproducible cell line. The need for a system which utilizes a 
reproducible and easy to culture, genetically defined immortal cell line in a well 
defined culture system is very much evident in the current pharmaceutical and 
commercial setting.  This cell line would ideally retain cell cycle check points and be 
able to reproduce accurately the responses of normal cells in relation to the DDR.  
Much of the research into immortalization methodology has been done using 
epithelial cells and there is a need for an equivalent in the oral system.  
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1.14 Hypothesis 
 
Immortalized cells derive their benefits by suppressing cell cycle regulatory 
processes and consequently immortal cells are often genetically unstable having 
lost cell integrity as a direct result of cell cycle compromise. The cells main tumour 
suppressor, p53, regulates the progression from the G1 phase into the S phase of 
the cell cycle and most immortalized cells have a mutated p53 gene or else 
downregulated p53 expression. Changes in p53 expression and/or regulation leads 
to genomic instability and abnormal cellular phenotypes since DNA damage within 
the cell is replicated and the cell permitted to progress through the cell cycle. 
Initially p53 suppression was thought essential for lifespan extension of human 
keratinocytes however it has since been shown dispensable with the use of 
oncogenes such as Bmi1 to drive cell proliferation and over ride cell inhibitory 
processes.  
This study was therefore designed to test the hypothesis that a cell line 
immortalized by the novel method of Bmi1 alongside human telomerase, hTERT, 
will extend replicative lifespan of oral keratinocytes without disrupting p53 activity 
through indirect suppression of the p16INK4a/ARF locus. Since the cells will retain p53 
expression, there will be increased genetic stability alongside responsiveness to 
DNA damage stimuli in comparison to cell lines with dysfunctional p53.  
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1.15 Aims and Objectives 
 
This project aims to develop an oral keratinocyte cell line with a significantly 
extended cellular lifespan and the potential to be developed into a well defined, 
reproducible and user friendly culture system. This will be beneficial in industry and 
clinical research for the testing and development of new drugs and oral health care 
products.  
The specific objectives are as follows: 
 Generation of retrovirus for the infection of Normal Human Oral 
Keratinocytes (NHOK) by an optimized, 2 step retroviral infection protocol 
for the successful transduction of keratinocytes. The combination of 
extensive studies on lifespan and characterization in vitro of epidermal 
keratinocytes as well as being the best reconstructed organotypic culture 
made epidermal keratinocytes a highly desirable control to use alongside 
the primary study of oral cells. Normal Human Epidermal Keratinocytes 
(NHEK) will be used alongside NHOK in infection and culture studies, 
providing a basis for measuring successful infection of NHOK. Immortality of 
keratinocytes in culture will be assessed by calculating population 
doublings.  Cells are deemed immortal if they continue to proliferate for a 
minimum of 50 population doublings beyond the lifespan of parental 
control. 
 The cell lines will then be analyzed for various variables and be compared to 
the commonly used OKF6 and OKF4 immortalized oral cell lines.   
 Optimization of the culture system for the cell line and adaptation to serum 
free system. 
 Assessing ability of cells to stratify in the optimized culture conditions and 
on organotypic substrate.  
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Chapter 2 
Materials and Methods 
 
2.1 Cells and Medium 
 
Cells Supplier Medium and Culture 
Normal Human Oral 
Keratinocytes 
(NHOK)  
Early passage cells 
taken from oral 
mucosa  
-NHOK 810 
-NHOK 882 
 
NHEK ( Normal 
Human Epidermal 
Keratinocytes) taken 
from neonatal foreskin 
and released from the 
epidermis by digestion 
with trypsin-EDTA 
 
NHEK 92 ( Early 
passage 
keratinocytes) 
 
 
 
Cells kindly donated by Dr. 
Angela Hague (University of 
Bristol, UK) 
 
 
 
CDOS, BICMS 
 
 
 
 
CDOS, BICMS 
Keratinocyte FAD 
medium 
(Flavin Adenine 
Dinucleotide) medium 
supplemented with 10% 
(v/v) FCII (fetal serum 
clone II), 2 mM L-
Glutamine, 0.4 μg/ml 
hydrocortisone, 5 μg/ml 
insulin, 5 μg/ml 
transferrin, 10 -10  M 
cholera toxin, 1.8 x 10-4 
M adenine and 10 ng/ml 
epidermal growth factor 
( added after first 
medium change , 
donated as FAD+) 
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3T3 Swiss albino 
mouse fibroblasts ; 
used as ‘feeders’ after 
irradiation 
 
 
 
CDOS, BICMS 
10C Fibroblast 
Medium  
DMEM (Dulbecco’s 
Modified Eagle Medium) 
supplemented with 10% 
(v/v) FCII, 2mM L-
glutamine, pen/strep 
and 10 mM HEPES. 
 
Keratinocyte Serum 
Free Medium (KSFM) 
supplemented with 
Bovine pituitary extract, 
undiluted EGF, calcium 
chloride and pen/strep 
 
OKF4-TERT 
Immortalized Oral 
Keratinocyte cell line 
with compromised p16 
and p53 activity 
 
 
 
Kindly donated by Dr. 
James Rheinwald , Harvard 
University, Boston. 
 
 
 
 
 
 
CDOS, BICMS 
 
 
 
 
 
 
CDOS, BICMS 
 
 
OKF6-TERT 
Immortalized Oral 
Keratinocyte cell line 
with spontaneous 
down regulation of p16 
 
Phoenix E ( E, 
Ecotropic Receptor) 
Phoenix E cells are 
based on the human 
embryonic kidney cell 
line 293T  and are 
highly transfectable 
 
 
Phoenix Growth 
Medium       (GM) 10% 
(v/v) FCII in DMEM 
supplemented with 
pen/strep, and 
glutamine. 
Serum free GM for part 
of infection study 
 
 
PT67 (NIH-3T3 based 
retroviral packaging 
cell line with ecotropic 
receptors) 
 
10C Medium 
10% Medium (v/v) FCII 
and 2 mM L-Glutamine , 
pen/strep and 10 mM 
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CDOS, BICMS 
HEPES in DMEM 
SCC-25  
Tumourigenic 
keratinocyte cell line 
derived from 
Squamous Cell 
Carcinoma of the oral 
cavity 
Keratinocyte Growth 
Medium (KGM). 
Keratinocyte Basal 
Medium (KBM) 
(Cambrex) 
supplemented with 
bullet kit hydrocortisone, 
insulin, bovine pituitary 
extract, EGF ) 
(Cambrex) and 
pen/strep to make KGM. 
SVFHK 
SV40 virus 
transformed epidermal 
keratinocyte cell line 
 
 
CDOS, BICMS 
Keratinocyte Serum 
Free Medium (KSFM) 
supplemented with 
Bovine pituitary extract, 
undiluted EGF, calcium 
chloride and pen/strep 
Table 2.1: List of cell lines and culture medium used throughout this study. 
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2.2 Tissue Culture 
All tissue culture was undertaken inside a laminar flow hood using aseptic 
technique with retroviral infection conducted in a health and safety approved 
category II containment suite.  All cells were incubated at 37oC in a humid 
atmosphere containing 5% CO2, except when incubation at 32
oC was required 
during retroviral infection. 1 x phosphate buffered saline (PBS) was used 
throughout cell culture for adequate washing. 
 
 Cells were trypsinized using 0.1% trypsin (Worthington, USA) prepared either in 
PBS for fibroblasts or in PBS and 0.02% ethylenediaminetetraacetic acid (EDTA) 
(Sigma Aldrich, UK) for keratinocytes.  
 
Tissue culture plastic was supplied by BD Falcon. 
 
2.2.1 Swiss 3T3 Feeder Preparation 
Swiss 3T3 fibroblasts were cultured in 10C medium (Table 2.1) until 80% confluent 
in 10 cm dishes.  The cells were trypsinized with 0.1% trypsin and centrifuged at   
800 rpm for 5 min at 20⁰C and resuspended at a density of 1 x 106 per ml of 10C in a 
universal.  The cells were then γ irradiated with a 60 Gy dosage and snap frozen for 
storage in vapour phase. When required for keratinocyte culture, a vial was thawed 
and after plating unused feeders were maintained at 4oC and used for up to one 
week before discarded and a fresh vial thawed. 
 
2.2.2 Cryopreservation and Recovery of Cells 
Cell lines were cryopreserved to maintain stock for future experiments. Cells were 
trypsinized and between 1–2 million cells were resuspended in freezing medium, 
consisting of 10% dimethyl sulfoxide (DMSO)  (Sigma, Poole, Dorset, UK) in neat 
serum appropriate for the cell line and transferred into cryotubes. Ampoules were 
stored in Mr. Frosty and subjected to gradient freezing overnight at -80oC before 
transferring to liquid nitrogen tanks.  
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Cells were recovered from liquid nitrogen tanks by thawing the vials instantly after 
removal from tanks in 37oC water bath. Once completely thawed, cells were 
transferred to a universal containing 9 ml of warm serum-containing medium and 
centrifuged at 800rpm, 4oC for 5 min. The DMSO-containing supernatant was 
aspirated immediately and cell pellet resuspended in culture medium and re-
seeded accordingly. 
 
2.2.4 Keratinocyte Culture 
Cells were retrieved from liquid nitrogen as per routine cell recovery protocol            
and plated at the appropriate density along with feeders (Table 2.2).  Epidermal 
growth factor (EGF) was added to the culture medium from next medium change. 
 
 
Plating Diameter Keratinocyte Feeder 
60  mm plate 1 x 105 1.5 x 105 
100 mm plate 1 x 105 – 1 x 106 1 x 106 
4 well chamber slide 5 x 104 25 x 104 
Table 2.2: Keratinocyte and Feeder Seeding Densities. 
 
 
2.2.5  Feeder Layer Removal from Keratinocytes 
Feeders were removed prior to cell harvesting using PBS: 0.02% EDTA (PE) with 
force applied against the plate using a bulb attached to the pipette in a clock-wise 
motion for a total of 30 seconds. The plates were checked under microscope to 
ensure total feeder removal and washed twice with PBS and trypsinized with 
trypsin/EDTA (T/EDTA) at 37oC before being neutralized with 9 ml of a serum 
containing medium. This cell suspension was centrifuged for 5 min at 4oC, 800 rpm 
and resuspended and re-plated according to the recommended seeding density 
(table 2.2).  
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2.3 Rhodamine B staining  
Rhodamine B is a red/violet staining dye used as a histopathological stain for 
cornification and keratinization and therefore is a valuable in vitro marker of 
epidermal keratinocytes (Liisberg, 1968). In this study, keratinocyte cell lines were 
stained with rhodamine B in order to determine the colony forming efficiency and 
visualize colony morphology of cells in culture.  
 
Cells were fixed with 10% formalin in PBS for 30 min at room temperature. The cells 
were washed several times with PBS before being stained with aqueous 1% 
rhodamine B for 30 min at room temperature. Plates were then washed with tap 
water until cell colonies were clearly visible and then left to air dry. 
 
 
 
2.4 Immunofluorescence Protocols 
Cell lines were cultured in 4 well chamber slides up to approximately 70%-80% 
confluence to evaluate the expression of DNA and oxidative damage markers 53BP1 
and γH2AX by immunofluorescence. 
 
2.4.1 53BP1 and γH2AX  
Cells were fixed with 4% formalin in PBS for 15 min, rinsed with PBS and 
permeabilized using Triton-X 100 buffer (0.5% triton-X 100 in PBS (Sigma-Aldrich, 
Dorset, UK) for 15 min at RT. Cells were then rinsed with 0.05% PBS-Tween 20 and 
blocked for 1 hour with 1% (w/v) BSA in PBS (Sigma-Aldrich, Dorset, UK) followed by   
incubation overnight at 4oC with primary antibody (table 2.4). The next day, cells 
Keratinocyte Feeder 
1  x 103 1.5 x 105 
1  x 102 1.5 x 105 
Table 2.3: Seeding Densities for rhodamine B staining. 
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were washed three times with 0.05% Tween 20 in PBS for 5 min each and then 
incubated with the secondary antibody solution for 1 hour, RT in the dark (table 
2.4). After incubation, cells were washed with 0.05% Tween 20 and counter stained 
with 0.2 μg/ml Hoechst (Invitrogen, UK) constituted in PBS, in the dark for 15 min. 
Cells were then washed twice with 0.05% Tween 20 and then twice with PBS for 5 
min each before being mounted with an aqueous mounting medium Immunmount 
(Invitrogen, UK). Stained cells were then analysed using the Lecia Epifluorescence 
microscope with the appropriate filters for Alexa Fluor and Hoestch. 
Antibody Dilution 
53BP1 
(Upstate, Millipore) 
1: 1000 in PBS containing 1% BSA 
γH2AX 
(Upstate, Millipore) 
1: 1000 in PBS containing 1% BSA 
Goat anti-mouse IgG Alexa Fluor 
488 
(Sigma Aldrich, UK) 
1:500 in 1% BSA 
Table 2.4: Primary and Secondary Antibodies. 
 
2.5 Retrovirus Mediated Gene Transfer 
 
Retroviral vectors are used to efficiently induce long term, stable expression of 
genes of interest in human keratinocytes instead of routine, ineffective plasmid 
transfection methods. Retroviral vectors allow for the efficient integration of 
retroviral DNA into actively transcribing regions of the host genome, produce 
reliable and long term expression of gene of interest as well as subsequent 
expression of the protein encoded by the gene.  (Watt, Broad et al. 2004).  
 
Replication-incompetent retroviral vectors have been used in this study for the one-
time infection of target cells to minimize safety hazards from the continuous 
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spreading of replication competent retroviruses. This is achieved by incapacitating 
the self-replicating machinery of the retrovirus by removing the viral packaging 
genes from the retroviral backbone (Levy, Broad et al. 1998). To replace the 
requirement for viral packaging proteins needed for retrovirus production, 
retroviral packaging cell systems are used such as Phoenix and PT67 which provide 
the viral packaging proteins in trans (Kotani, Newton III et al. 1994). 
 
2.5.1 DNA amplification 
shp53 and shp16 (Kindly donated by Dr Emilios Gemenetzidis ( CDOS, Blizard 
Institute of Cell and Molecular sciences, Queen Mary, UK), along with the empty 
vector control, were cloned into pRetrosuperior vector ( Fig 2.1) for subsequent 
retroviral transductions. pBabe Tert-neo and the empty vector-neo control were 
kindly donated by Professor Ken Parkinson, CDOS. Bmi1 was a gift from Prof. Judith 
Campisi (LBL, University of California). 
 
2.5.1.1 Cloning 
A standard cloning protocol was followed. For ease of understanding, all the vectors 
will be termed as DNA for the cloning protocol. 10 ng/μl of DNA was added to      
100 μl of XL1 Blu bacteria and incubated on ice for 15 min. Bacterial cells were 
immersed in a pre-heated 42oC water bath for 2 min to heat shock the cells before 
incubating on ice for a further 10 min. Bacterial cells were then transferred to 
universals and 400μl of LB broth was then added per universal and incubated for 1 
hour at 37oC. If no bacterial growth had occurred after 1 hour, a further 5 ml LB 
broth was added per universal and left to incubate for a further 24 hours.  
 
2.5.1.2 Preparation of bacterial colonies  
0.5 ml of the LB broth was then spread onto ampicillin resistant plates and 
incubated over night at 37oC. Bacterial colonies were then selected and expanded 
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in 1 ml of LB-containing ampicillin with incubation in a shaking incubator at 200 rpm 
for 4 hours at 37oC.  
The DNA was then purified from the XL1 blu competent cells using the maxi prep 
protocol (Qiagen Plasmid Maxi Kit #12163). Glycerol stocks were prepared for each 
construct and stored at -80⁰C. 
 
2.5.1.3 DNA Quantification 
Isolated and purified DNA was quantified using the NanoDropTM ND-1000 
spectrophotometer (ThermoScientific, Cambridgeshire, UK). Instrument was 
blanked with 2µl of nuclease-free H20 (Sigma-Aldrich, Dorset, UK) and a sample 
volume of 2µl of DNA was used. The concentration of sample DNA is provided in 
ng/µl at 260 nm absorbance whilst the quality (purity) of DNA content was 
estimated by the nuclei acid : protein ( 260 : 280)  ratio, with values of 1.8–2.0 
considered of good quality and subsequently samples with this ratio was used for 
retroviral transduction.  
 
2.6 Retroviral Infection of Keratinocytes using a 3T3 based Feeder System 
A modified, 2-step infection protocol was devised based on the work of Fiona Watt  
to obtain a high number of cells expressing the vectors of interest  (Levy, Broad et 
al. 1998) . 
 
2.6.1 Retrovirus Production 
In the first part, the Phoenix E retroviral producer cell line was used for the 
production of retroviral particles containing the genes of interest. Phoenix cell line 
(supplied by Nolan lab, CA) was originally created by stable transfections of the 
293T cells with constructs expressing gag-pol and envelope proteins for ecotropic 
and amphotropic viruses. Second, a 3T3 fibroblast-derived retroviral packaging cell 
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line PT67 was infected using the supernatant harvested from phoenix E 
transfections and infected PT67 were used to infect human keratinocytes. 
 
2.6.2 Phoenix E Transfections 
Cells were cultured in 10% FCII medium (Growth Medium or GM). Phoenix E cells 
adhere poorly to tissue culture plastic, so during routine tissue culture the cells 
were subcultured by detaching them from the plates using fresh medium with slight 
force applied against the plate. In instances where single cell suspensions were 
required, such as cell counting, cells were trypsinized using 0.1% trypsin. Any cell 
clumps were broken up by pipetting the cell suspension up and down many times 
before centrifugation for 5 min at 800 rpm and re-plating according to the 
confluency required (table 2.2).   
 
Phoenix E cells were transfected using Fugene6 (Invitrogen, UK) with pRetrosuperior 
empty vector, shp53, shp16 and pBabe empty vectors, tert-neo and bmi1. 
Transfection was carried out in duplicates per vector with a seeding density of 2 x 
105 cells per 6 cm dish and a Fugene6 : DNA ratio of 2.5 : 1.  Transfection mix was 
prepared with 25 μl of Fugene6 added drop wise into 1 ml of serum free growth 
medium, tapped gently to mix and left to incubate for 5 min at RT. 10 μg of 
construct was added per eppendorf and again left to incubate for 20 min at RT. 
Media was then aspirated off the surface of the phoenix E cells and the Fugene-
DNA mix added to the cells and left to incubate at RT for 10 min before adding 1 ml 
of serum free GM and leaving to incubate at 5% CO2, 37
oC . After 5 hours, 2 ml of 
growth medium was added and cells left to incubate for a further 48 hours.   
 
The cells were then pooled together from the duplicate 6 cm dishes and incubated 
in Phoenix E GM containing 2 μg/ml puromycin into a single 10 cm dish per 
construct. Drug selection was continued and media refreshed regularly until cells 
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reached approximately 80% confluency at which point media was removed and 
cells were washed with PBS. 10 ml of serum free growth medium was then added 
and cells incubated over night at 32oC. Supernatant was then collected for infection 
of PT67 cells and stored in 1 ml aliquots at  -80oC until ready for infection.  
 
2.6.3 Infection of PT67 
3T3 fibroblast-derived retroviral packaging cell line PT67 was infected using the 
supernatant harvested from phoenix E transfections. PT67s were cultured in 
standard 3T3 10C medium (table 2.1). Cells were subcultured using 0.1% trypsin 
and the trypsin neutralized with addition of 10C and centrifuged for 5 min at 800 
rpm prior to re-plating.  
 
PT67 cells were plated at 2.5 x 104 per well of a 6 well plate and left to incubate 
over night at 37oC. Cells were washed with PBS and treated with 5 μg/ml of 
polybrene (Sigma, UK) in 10C medium and incubated for 15 min at 37oC. Cells were 
then treated with 2 ml of the 10C/supernatant/ polybrene (1:1:1) mix and the 
plates centrifuged for 1 hour at 350 rpm at 32oC.  The media was then removed and 
the cells washed with PBS before the addition of 2 ml of 10C medium.  The cells 
were incubated at 37oC, in 5% CO2 for 48 hours after which they were transferred 
to a 10 cm dish (one dish per construct) and once over 80% confluent, subjected to 
drug selection. pRetrosuperior constructs were selected with 2.5 μg/ml puromycin 
and pBabe constructs with 1.2 mg/ml neomycin. After the mock cells (positive 
control cells with polybrene/media only) were dead, infected PT67 cells were 
frozen down and stored in liquid nitrogen until ready for keratinocyte infection. 
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2.6.4 Retroviral Transduction of Human Keratinocytes 
2.6.4.1 γ Irradiation of iPT67  
Once confluent, infectious PT67 cells were trypsinized, resuspended in fresh 10% 
FAD medium and given a 60 Gy γ-IR dose. Cells were then re-plated at the same 
confluent density with keratinocytes (e.g. 1 x 106 keratinocyte with 1 x 106 
infectious PT67 / 10 cm dish) and cells co-cultured for 48 hours. Infectious PT67 
were then removed from the plate in the way normal feeders would be. The 
medium was replaced with FAD+EGF and fresh feeders containing the relevant drug 
resistant maker were applied.  
 
2.6.5 Keratinocyte Transduction 
Infected PT67 were cultured in 10C until confluent and treated with 60 Gy dosage 
of γ radiation. The freshly irradiated infectious cells were plated at 1 x 106 with a 
keratinocyte seeding density of 1 x 105 per 10 cm dish and medium changed at 72 
hours at which point drug selection was started with puromycin (1 μg/ml) and G418 
(7 μg/m). The irradiated infectious PT67 feeders were replaced with freshly thawed 
feeders at 72 hours post drug selection and cells subcultured and subjected to drug 
selection until confluent. Feeders were then removed and cells cultured until 
confluent and stocks frozen down.  Cells were cultured long term and population 
doublings recorded. 
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2.7 Telomere Repeat Amplification Protocol (TRAP) 
2.7.1 TRAP assay 
The Telomeric Repeat Amplification Protocol, or TRAP, is a two-step PCR based 
methodology originally developed to determine telomerase activity in vitro (Kim, 
Piatyszek et al. 1994). The first step of the assay comprises of telomerase adding 
telomeric repeats (TTTAGG) to a template substrate and in the second step there is 
amplification of these products using specific forward and reverse primers, 
together with the amplification of an internal standard PCR control ( with separate 
forward and reverse primers) (Herbert, Hochreiter et al. 2006). The internal control 
can be used to check equal loading of the lysates as the amount of telomeric 
products detected is inversely correlated with the amount of telomeric product as 
well as to identify false-negative samples due to Taq polymerase inhibitors (Herbert 
2009).  
 
Telomeric repeats representing enzymatic activity are subsequently shown on a 
polyacrylamide gel as a ladder pattern of PCR products with a spanned size of 6 bp, 
starting from a size of 50 bp. The internal control band is shown at 36 bp and the 
higher the telomerase activity, the stronger the signal of the ladder will be.  A non-
radioactive TRAP assay was adapted for use in this study (Herbert, Hochreiter et al. 
2006). 
 
2.7.2 Preparation of samples 
Semi confluent cells were trypsinized as per routine and cell extracts were prepared 
by lysing half a million cells per sample in 200 µl Chaps buffer (Sigma Aldrich) and 
incubating on ice for 20 min. Lysates were separated from cell debris by 
centrifugation at 12,000 rpm for 20 min at 4oC and 160 µl of the supernatant was 
used to determine the protein concentration. BCA protein assay was used to 
determine the protein concentration of the lysates as per the manufacturer’s 
instructions. A standard protein curve was prepared with a known Bovine Serum 
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Albumin (BSA) concentration using the CHAPS lysis buffer and following this the 
protein concentration in the samples was determined according to the standard 
and scanned for absorbance at 650 nm in a plate reader. Aliquots of the lysates 
were stored at -80oC in RNAse-free tubes until subsequent use and from which 
appropriate dilutions were made. The optimal protein concentration was estimated 
to be 100 ng/µl. 
 
2.7.3 Positive and negative controls 
The cell pellet for the positive control was provided in the Chemicon TRAPeze kit 
(Chemicon Europe Ltd, Chandlers Ford, UK) and suspended in 200 µl of CHAPS lysis 
buffer to prepare lysate for the positive control following the same protocol for 
sample preparation. The lysate was diluted 1:1 with RNAse-free water before 
loading into the assay to avoid over-loading of the system. 
A specific negative control for the absence of telomerase activity was obtained by 
the cell lysate of GM847 cells, which possess ALT phenotype and lacks detectable 
telomerase activity. A chaps buffer only negative control was utilized to check the 
presence of primer-dimer PCR artefacts or the presence of PCR contamination. 
As telomerase is heat sensitive, each sample extract was heat treated and used as a 
third negative control. Samples were incubated at 85oC for 10 min prior to the assay 
to inactivate telomerase.  
 
2.7.4 Cy5 fluorescent-based PCR reaction 
The fluorescent dye Cy5 (fluorescent in the red region (~650 nm excitation/670 nm 
emission), was attached to the 5’-end of the primer TS to permit final quantification 
of the PCR products on the gel. Primer details are shown in table 2.6. 
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2.7.5 PCR 
Sample lysates were amplified by PCR in a five-stage reaction: incubation at 30°C 
for 1 hour, where telomerase is allowed to add repeats to the substrate; 
telomerase inactivation at 95°C for 5 min; 24 cycles at 95°C for 30 sec 
(denaturation), 52°C for 30 sec (annealing) and 72°C for 30 sec (extension); final 
elongation at 72°C for 2 min; hold at 4°C. 
 
2.7.6 Visualization of PCR products 
A 12% polyacrylamide gel was cast in a disposable plastic cassette (Invitrogen, 
Paisley, UK) by mixing 12% of PolyPAGE-40 Acrylamide/Bis (19:1) (Polysciences, 
Eppelheim, Germany) with 6% of 1 x TBE (89 mM Tris base, 89 mM boric acid, 2 mM 
EDTA), 0.01% of 10% ammonium persulfate, 0.001% of TEMED and dH2O. 
 
Following PCR samples were visualized by adding 5 µl of loading dye (0.25% 
bromophenol blue, 50% glycerol, 50 mM EDTA) to each sample and 25 µl of this mix 
was loaded into the gel. The gel was run in 0.5X TBE for 1 hour at 140V and 
protected from external light. To avoid DNA diffusion the gel was fixed by 
incubation in 0.5 M NaCl, 50% (v/v) ethanol and 40 mM sodium acetate (pH 4.2) for 
15 min at room temperature (RT) in the dark. The TRAP ladder on the gel was 
visualized using a Phosphorimager scanner (Typhoon 9400 scanner, GE Healthcare, 
Chalfont, UK) reading Cy5 fluorescence at 633 nm.  
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Component Supplier Concentration Volume (ul) 
per 
reaction 
Total 50 ul 
Rnase-free 
H2O 
Qiagen, Crawley,UK - 37.7 
TRAP buffer - 10X 5 
dNTP mix New England Biolabs, 
Hitchin, UK 
10 mM each 
primer 
0.5 
Cy5-TS Eurofins, MWG Operon, 
London, UK 
100 ng/µl 1 
NT primer Eurofins MWG Operon, 
London, UK 
100 ng/µl 1 
ACX primer Eurofins MWG Operon, 
London, UK 
100 ng/µl 1 
TSNT 
template 
Sigma-Aldrich, Poole, UK 10-20 mol/µl 1 
BSA Ambion, Huntingdon, UK 50 mg,ml 0.4 
Taq 
polymerase 
New England Biolabs, 
Hitchin, UK 
5U/µl 0.4 
Sample - 100 ng/µl 2 
Table 2.5: Components of PCR reaction for TRAP assay. 
 
The main components of the PCR reaction of the TRAP assay are the 10X TRAP buffer 
(200mM Tris-HCL pH 8.3, 15 mM MgCL2, 630 mM KCL, 10 mM EGTA, 0.5% Tween-20) to 
lyse the cells of the sample and collect TERT; the different primers (see table 2.6); the 
substrate TS to which telomerase adds the telomeric repeats; and the TAG polymerase to 
amplify the product added by telomerase in the first step of the reaction.  
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Primer 
name 
Sequence Function 
Cy5-TS 5’-Cy5-AATCCGTCGAGCAGAGTT-3’ Substrate 
oligonucleotide/forward 
primer 
ACX 5’-GCGCGGCTTACCCTTACCCTTACCCTAACC-3’ Reverse primer 
TSNT 5’-AATCCGTCGAGCAGAGTTAAAAGGCCGAGAAGCGAT-3’ Template for internal 
control 
NT 5’-ATCGCTTCTCGGCCTTTT-3’ Reverse primer for 
internal control 
Table 2.6: Role of the primers used in the PCR reaction for TRAP assay. 
Each of the four primers utilized in the PCR reaction have got specific functions that allow the 
addition of the telomeric repeats and the following amplification for further detection and 
correlation with telomerase activity. Active telomerase binds to the TS substrate and a number of 
telomeric repeats (TTTAGG) are added to TS according to the degree of activity of the enzyme. In the 
PCR step of the assay, the products generated are amplified with the TS primer, that is attached to a 
fluorophore for the following detection, and with the reverse primer ACX. In addition, the sequence 
TNST serves as a template for an internal control which is amplified with the reverse primer NT and 
the forward primer TS. Therefore, using the same TS primer, this internal control competes with the 
telomeric repeats in the amplification process and its expression will be inversely correlated with the 
amount of telomeric products, thus with the activity of telomerase. 
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2.8 Western Blotting 
2.8.1 Whole Cell Extraction  
Cell pellets were washed twice with PBS and lysed with Radio-Immunoprecipitation 
Assay (RIPA) buffer (1% NP-40, 0.1% SDS, 50 mM Tris pH 7.3, 150 mM NaCl)               
(Sigma,UK) with protease inhibitors (cOmplete cocktail tablets, Roche Diagnostics) 
and incubated on ice for 20 min. The lysates were separated from cell debris by 
centrifugation at 15,000 rpm for 20 min and approximately 160 µl of supernatant 
transferred into new eppendorfs on ice. Total protein concentration was measured 
using the DC protein assay kit (BioRad, Hemel Hempsted, UK) following 
manufacturers protocol. The protein concentration in each sample was calculated 
using a standard curve calculated from BSA standards. 4x sample buffer was mixed 
with the protein sample to dilute the lysate to get the final loading concentration of 
20 µg.  The lysates were boiled for 5 min at 100oC and stored at -80oC.  
 
2.8.2 Gel Electrophoresis 
Cell lysates were prepared as above and total cellular protein was separated from 
the lysate on 4%-12% gradient SDS-PAGE gels ( NuPage novex bis-tris pre cast gels, 
Invitrogen, UK) under denaturing and reducing conditions at 130 V. The 20 x 
NuPage sodium dodecyl sulphate (SDS) running buffer (Invitrogen) was diluted 1 in 
20 to make 1x running buffer. The dual colour marker (dual colour, BioRad) was 
used to visualize respective band sizes.  
 
2.8.3 Western Blotting  
The proteins were then transferred to a 0.45 µM Immobilin PVDF membrane            
(Millipore, Watford, UK) that had been soaked first in neat methanol (VWR, 
Lutterworth, UK) and then in transfer buffer ( 25 mM Tris, 190 mM glycine and 20% 
methanol) for 3 min.  Protein transfer took place at 100 V for 90 min. The 
membrane was then blocked in 5% (w/v) skimmed milk powder (Marvel, Bristol, 
UK) prepared in wash buffer saline and tween-20 (TBS-T) (1 M Tris pH 8.0, 5 M NaCl, 
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0.05% tween-20 for 1 hour at RT. The membrane was then probed in 5% milk in 
TBS-T with the appropriate primary antibody overnight at 4oC.  The following day 
the membrane was washed extensively with TBS-T and then incubated with an 
appropriate secondary solution, prepared in 5% milk TBS-T, for 1 hour at RT. The 
membrane was washed again four times in one hour with TBS-T before being 
developed as described below. 
 
2.8.4 Developing Western Blots  
Membranes were dried and developed firstly with Amersham ECL plus (GE 
Healthcare Life Sciences) or, if the signal was weak and required > 30 min 
development time, it was washed briefly with TBS-T and then incubated with 
Supersignal West Femto maximum sensitivity substrate (Pierce, Thermo Fisher 
Scientific) on Amersham Hyperfilm ECL ( GE Healthcare Life Sciences).  
 
2.8.5 Stripping Blots 
If a second protein of a similar weight to the first protein was being examined, the 
membrane was stripped using stripping buffer for 30 min at RT. The membrane was 
then washed three times with TBS-T for a total of 30 min and re-incubated with the 
secondary antibody used (as above) to detect the first protein, before being washed 
and developed. If the first antibody had been satisfactorily stripped, the membrane 
was re-probed. If it had not, the procedure was abandoned.  
 
2.9 Senescence Associated β Galactosidase expression  
Cells were cultured and at 50%-60% confluency they were stained for β 
galactosidase (β gal) activity using the BioVision Senescence detection kit              
(Cambridge Biosciences, Cambridge) as per manufacturers protocol. The plates 
were incubated in dark for 16 hours at 37oC, washed with water, photographed 
using a light microscope and the number of senescent cells counted. The presence 
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of β gal activity was evidenced by dark green colour in the perinuclear cytoplasmic 
region and 500 individual cells were counted and the percentage of positive cells 
for each cell line was quantitated. Early and late passage cells were incorporated 
into the experiment as positive and negative controls respectively.  
 
2.9.1 Nuclear Fast Red Staining 
Cells were counterstained with nuclear fast red (NFR) (BDH Chemicals, Poole, UK) as 
per manufacturer’s instructions to easily distinguish cells that were negative for       
β gal from the dark green positively-stained cells.  
 
2.10 Metaphase Spreads with hypotonic KCL 
Cells were cultured to 70%–80% confluence, cells were medium changed as per 
routine and incubated overnight. The following day 37 µl of 10 mg/ml demecolcine 
colchizine (Sigma, UK) was added directly to the cells and culture dishes incubated 
for 3 hours at 37oC, following which medium was collected from the plates and cells 
trypsinized, followed by neutralization using the previously collected medium and 
transferred to a 15 ml centrifuge tube and centrifuged for 5 min at 800 rpm. The 
pellet was resuspended drop wise in warm hypotonic KCL solution (0.075M) with 
constant gentle agitation and incubated for 45 min at 37oC. Cold methanol-acetic 
acid fixative ( 3:1 ratio) , freshly prepared, was then added drop wise to the cell 
suspension at 20% of the total volume of the 15 ml tube with constant agitation 
and centrifuged for 3 min at 800 rpm. This fixative step was repeated 3 times to 
form turbid cell suspensions. For metaphase spreads an aliquot of cell suspension 
was added drop-wise onto a humidified slide, pre-chilled overnight, from a height 
of approximately 1 metre and the slides allowed to air-dry. Slides were 
photographed with light microscopy.  
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2.11 UVB treatment of cells for detection of apoptosis by 
Annexin V assay 
 
2.11.1 UVB Treatment 
UVB induced DNA damage is a crucial event in UVB-mediated cellular apoptosis 
(Kulms, Pöppelmann et al. 1999). Medium was aspirated from semi-confluent cells 
(50%–60% confluent) and culture dishes placed in a U.V cross-linker (UVP, 
Cambridge, UK) with the lids removed. Cells were irradiated with UVB at different 
doses (10 mj/cm2 and 20 mj/cm2) and fresh medium was replaced immediately 
following UVB exposure and cells incubated at 37oC, 10% CO2 for 24 h, 48 h and 72 
h. Non UV treated cells were used as controls and cultured under the same 
conditions. Following incubation, treated and untreated cells were either used for 
whole protein extraction followed by western blot analysis for markers of apoptosis 
and senescence (p53 and p16INK4a) or used for Cy TM5 annexin V antibody staining 
followed by FACS analysis to check apoptosis and cell death.  
 
2.11.2.1 Annexin V Apoptosis Assay 
In the early stages of apoptosis cells undergo a variety of structural and biochemical 
events which lead to changes on the cell surface. One of these altercations involves 
the translocation of the plasma membrane protein phosphatidylserine (PS) from 
the inner side of the plasma membrane to becoming exposed on the outer surface 
of the cell membrane (Vermes, Haanen et al. 1995). Annexin V is a Ca2+ dependent 
binding protein which has high affinity for PS and is fluorescein-conjugated to use 
as a probe in detection of cell apoptosis (Vermes, Haanen et al. 1995). Since the 
intermembrane translocation of PS is not unique to apoptotic cells but also a 
prominent feature of cells undergoing necrosis, due to loss of membrane integrity, 
a DNA stain such as DAPI is utilized to differentiate between the two cell types. 
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Cells were trypsinized as per usual and cell pellets washed in PBS with 
centrifugation at 1000 rpm for 6 min RT. Each pellet was resuspended in 500 µl of 
Annexin V binding buffer (beckton Dickinson), 4µl/ml of Annexin V FLUOS ( Roche 
Diagnostics) and 200 ng/ml of DAPI . Cell suspension was gently vortexed and 
transferred into sterile 5 ml round bottom FACS tubes and incubated at RT for 15 
min.  FACS analysis was carried out by flow cytometer (LSRII BD Biosciences), 
collecting 10,000 events per cell sample. The remaining cell suspension was fixed in 
70% ETOH for cell cycle analysis.  
 
2.12 Organotypic Stratification 
 
2.12.1 Polycarbonate Membrane 
For the most part of this study cells were cultured, transduced and assessed for 
population doublings on a monolayer culture system. In vivo however, 
keratinocytes are part of a stratified epithelium and to determine stratification of 
transduced cell lines the cells were cultured on top of 0.5 cm2 polycarbonate inserts 
and raised to the air-liquid interface in both serum free medium and FAD for 7 and 
14 days. 
 
Cells were gently applied to the polycarbonate epithelial surface at a density of 5 x 
104  in 150 µl of appropriate medium and incubated overnight at 37oC in humidified 
10% CO2. The next day cells were raised to air-liquid interface by aspirating medium 
off from membrane surface. Cells were medium changed every 2 days and cultured 
for the set time interval and at each time point the inserts were analyzed for cell 
viability. 
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Figure 2. 1: Diagram of reconstitute epithelium cultured on polycarbonate membrane 
insert. 
Keratinocytes were cultured atop the polycarbonate membrane surface and allowed to differentiate 
over time prior to being assessed for stratification. 
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2.12.2 MTT Assay  
The Thiazolyl Blue Tetrazolium Bromide (MTT) assay (Sigma) is a rapid colorimetric 
assay which is based on the use of [3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide] to measure cell survival and proliferation (Mosmann 
1983). It is based on mitochondrial reductase activity in metabolically viable cells to 
convert the yellow tetrazolium salt, MTT, into dark blue forazan crystals (Gerlier 
and Thomasset 1986). As the cultured cells proliferate, a reduced cellular 
environment is maintained causing the yellow MTT to change from its yellow 
oxidized form to reduced blue formazan form. This reduction only takes place in the 
presence of mitochondrial reductase activity and hence the number of surviving 
cells is directly proportional to the level of formazan product generated (Mosmann 
1983). 
 
 This assay was used to determine the number of viable cells after culture on 
polycarbonate membranes. 5x104 cells were plated onto the polycarbonate 
membrane in 100 µl of appropriate medium and the membranes were themselves 
placed in 12-well plates and 2 ml of appropriate medium was added to each well, 
enough to cover the well but not overflow the membrane. The next day cells were 
brought to air-liquid interface by removing medium from the surface of the 
membrane. The wells were medium changed every 2 days and MTT assay 
performed every 5 or 7 days upto 1 month. As MTT is highly toxic to cells it was not 
possible to use the same cells throughout the time course to measure proliferation 
and so the same number of cells had to be plated separately for each additional 
time point.  
 
 
An MTT solution (5 mg/ml) was prepared in sterile PBS and stored at 4ºC and was 
used to prepare the working concentration of 0.5 mg/ml of MTT solution as 
required and filter sterilised. Using sterile forceps, polycarbonate membranes were 
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transferred to a new 24-well plate and 500 µl of MTT working solution was added 
into the membrane and plate was incubated in the dark for 1 hour in a CO2 
incubator at 37°C. MTT solution was then aspirated off and the blue formazan dye 
was dissolved adding 500 µl of isopropanol in each well and the plate sealed with 
parafilm and incubated for a further 1 hour at 37°C to elute any formazan crystals 
that had formed. Cell membrane was then punctured with sterile pipette tip to 
allow contents to mix together and DMSO solution mixed thoroughly to ensure 
complete solubilization of formazan crystals.  Triplicates of 200 μl dissolved 
coloured aliquots from each well were transferred to a 96-well plate along with 
DMSO only control (Nunc-VWR).  
 
 
The absorbance (optical density) was measured at 570 nm optical density (OD) 
using a 96 microplate reader well on FLUOstar OPTIMA BMG Labtech plate reader. 
For each cell line, 6 replicates were prepared per time point and DMSO-only as 
control. The OD of the blank (just 200 μl DMSO) was subtracted from the sample 
OD. Cell viability was expressed as a percentage of the control cultures as: Viability 
= OD (570nm) Treated / OD (570nm) Control*100. 
 
2.12.3 Stratification  
Membrane was cut out from the polycarbonate insert and sent for sectioning and 
histology examination by the Blizard Institute of Cell and Molecular Sciences 
Pathology Group, Queen Marys, University of London.   
 
2.13 Statistical Analysis 
A two tailed T-test was used throughout this study unless stated otherwise.   
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Prior to starting the retroviral transduction process, a number of pilot experiments 
were performed to establish culture conditions for the optimum growth and 
infection of keratinocytes, with established growth conditions maintained for the 
duration of the study. Carbon dioxide is an essential requirement for the culturing 
of cells in vitro as CO2 deficient environments inhibit cell growth (Maurel and 
Pareilleux 1985) and culture environments have since been established to adversely 
affect cell growth and viability (Hu and Aunins 1997). The CO2 level at incubation 
during retroviral transfection is important for the optimum growth of cells and 
usually 5% – 10% CO2 is commonly used for cell growth with a level of 14% deemed 
as growth inhibitory (Hu and Aunins 1997), although previous studies have also 
found transfection efficiency to be better at a lower CO2 percentage of 3%  (Chen 
and Okayama 1987). To enhance growth and minimize time in culture, particularly 
for primary cells, it is important to obtain the correct seeding density as cultivation 
of cell lines on tissue culture plastic is known to be affected by high seeding 
densities (Watt 1988) . When seeded at high seeding densities, cells often fail to 
differentiate properly whilst too low a density will result in very slow growth rates 
and prolonged exposure in vitro, in both cases there is a decrease in cell growth, 
emphasizing the need for optimization. 
The aim of this study was to develop a well characterized oral epithelial cell line 
that has a significantly extended replicative lifespan and can be used in place of the 
current tumour-derived or tumourigenic cell lines as a monolayer or for the 
development of organotypic cultures. To do this, keratinocytes at early passage 
were used (table 2.1) as these are characteristically devoid of genetic mutations, 
DNA damage and other changes that accumulate with age.  
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Population doubling times have been shown to vary as a function of cell seeding 
density, growth medium and serum supplement and desirable conditions should 
allow independent growth of cell lines with multiple subcultures, maintenance of 
differentiation properties and characteristic responsiveness. 
The results in the chapter will be described in following sections: 
i) The effect of culture conditions on early passage keratinocytes  
ii) Optimization of retroviral infection protocol for successful transduction of 
keratinocytes.
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3.1 The effect of culture conditions 
Prior to starting retroviral transductions, early passage oral and epidermal 
keratinocytes were assessed for optimal growth conditions. Cells were grown for 14 
days and clonogenicity evaluated using rhodamine B staining and the number and 
size of colonies quantitated. CO2 levels along with seeding density were shown to 
influence the number of colonies formed (Appendix 1). 
 
Serum concentrations used in cell culture media are known to affect cell kinetics 
and metabolism and a direct link has been shown between media serum levels and 
cell viability (Elsayed, Demellawy et al. 2009). The serial culture of early passage 
NHOK and NHEK in an in vitro environment generated nuclear foci when stained for 
DNA damage markers 53BP1 and γH2AX across three culture mediums (Fig 3.1).  
The data indicates that keratinocytes cultured in medium supported with feeders, 
FAD+ had the highest levels of positively stained cells for 53BP1 when cultured in 
feeder supported medium (NHOK 69% ± 7.1%, NHEK 68% ± 3.8% ) compared to the 
two serum free mediums KGM (NHOK 64% ± 6.5% , NHEK 61% ± 5.5%) and KSFM 
(NHOK 61% ± 6.7%, NHEK 59% ± 7.4%). Similar trends were observed when stained 
for γH2AX, with higher numbers of positive cells for FAD+ (NHOK 69% ±4.5%, NHEK 
70% ± 5%) compared to KGM (NHOK 59% ± 8.1% , NHEK 63% ± 6.6%) and KSFM 
(NHOK 52% ± 3.6% , NHEK 58% ± 8.5%). The results are the averages of three 
independent experiments that were performed. 
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Figure 3. 1: Percentage of  (a) NHOK and (b) NHEK cells stained positive for DNA damage 
markers 53BP1 (blue) and γH2AX (red). 
Extent of DNA damage in non-transduced (a) NHOK and (b) NHEK cells after culture across the 
different culture mediums was determined by 53BP1 and yH2AX staining. A cell was classified as 
positive if it contained 3 or more nuclear foci.  The percentage of positive cells was based on a 
counting of 300 cells in total per culture medium for each antibody. Means of 3 independent 
experiments are shown. 
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3.2 Retroviral Infection  
A two-step retroviral infection protocol based on the study of Fiona Watt’s group 
for the infection of keratinocytes was optimised for the successful transfection of 
DNA into phoenix E cells (Fig 3.2). Infection of PT67 fibroblasts with phoenix E 
derived supernatant successfully generated high numbers of infectious, drug 
resistant cells. The co-culture of keratinocytes with γ irradiated infectious PT67 
generated drug resistant, infected cells. 
 
3.2.1 Optimization of retroviral protocol for keratinocyte transduction 
Retroviruses are an efficient means to transfer DNA expression constructs to a wide 
range of mammalian cell types and is a preferred method for manipulating gene 
expression in keratinocytes due to the ease with which they rapidly deliever genes 
stably to mammalian cells (Cepko and Pear 2001). A two-step retroviral protocol 
was followed using a phoenix retrovirus producer cell line (Levy, Broad et al. 1998). 
Phoenix expression vectors are highly transfectable with either calcium-phosphate 
mediated transfection or lipid based transfection protocols and is used worldwide 
for delievery of genes to cells for use in biomedical research (Morita, Kojima et al. 
2000). Based on Moloney Murine Leukemia Virus (MMLV), it allows for the 
deleivery of genes to most dividing mammalian cell types and produces virus within 
a few days. The phoenix expression system is available in two vector types and for 
the purposes of this study the Ecotropic packaging system was used  and hence will 
be referred to as phoenix E and these are capable of delivering genes to dividing 
murine and rat cells. The Amphotropic packaging system is capable of delivering 
genes to dividing cells of most mammalian species including humans (Kessels, 
Wolkers et al. 2005). Phoenix cells generate helper free retrovirus which allows for 
the production of replication defective retrovirus vectors in the absence of a helper 
virus and these vectors can infect and integrate into cells but cannot replicate and 
spread. These helper free vectors make it possible for a variety of studies to be 
conducted in which virus spread would make it difficult to interpret results and the 
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absence of helper virus prevents occurance of new integration sites and avoids 
virus spread (Kessels, Wolkers et al. 2005).  
 
Early attempts to achieve long term gene expression in retrovirally transduced 
human epidermal keratinocytes remained largely unsuccessful (Levy, Broad et al. 
1998). Keratinocytes are difficult to stably transfect with plasmid constructs but 
close to 100% infection can be achieved using retroviral vectors and there is stable 
expression of transduced gene during repeated passaging (Levy, Broad et al. 1998).   
 
Although retroviruses are easier to work with, one limitation is that the percentage 
of cells infected is not as high as with the commonly used adenovirus infections and 
hence tradionally antibiotic drug selection is used for a minimum of one week to 
ensure a pure population of cells expressing the gene of interest. Prior to 
commencing experiments, a stock of primary keratinocytes were expanded and 
frozen down at between 5.5-6.6 mpd and since each experiment used a fresh 
ampoule, keratinocytes had undergone a total of between 7-9 mpd at the time of 
infection.  
 
Following a previously established retroviral infection protocol, phoenix E cells were 
transfected for infection of PT67 but this did not prove straightforward. Phoenix E 
supernatant was used to infect PT67 but cells failed to survive drug selection. The 
following protocol was established and optimized following a series of pilot 
experiments.  
 
The optimization process for infecting keratinocytes began with transfected DNA 
vectors into phoenix E using lipid based fugene 6 transfection reagent protocol. The 
phoenix E cells were plated in the afternoon at an optimized density of 2 x 104 
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instead of the previously recommended 1 x 106 and this was denoted as day 1. On 
morning of day 2 they were washed and fed with medium and drug selection was 
introduced to select for a pure phoenix E population containing the vector of 
interest. Once selected, phoenix E cells were cultured to approximately 80% 
confluency, upon which the transfected phoenix E cells were maintained in a 32oC 
incubator overnight as the half life of the retrovirus is greater when stored at this 
lower temperature. Supernatant from phoenix E was collected and filter sterilized 
and used to infect PT67 cells. Drug selection was started with PT67 cells at 2 days 
post infection as this was found to allow for the cells to adhere to the tissue culture 
plastic thus allowing for better infection rates. Once selected, stocks were frozen 
and confluent PT67s were trypsinized and subjected to a lethal 60 Gy irradiation 
dose to prevent further replicaton prior to replating with keratinocytes and feeders 
at confluent levels.  
Keratinocytes were co-cultured with lethally irradiated PT67 and feeders in medum 
without epidermal growth factor o/n at 37oC. The inclusion of feeders alongside 
infectious PT67 allowed for better proliferation of keratinocytes rather than if they 
were cultured alone, as previously recommended. The medium was then 
supplemented with EGF and refreshed every other day. EGF is not added until the 
cells have attached to the tissue culture plate as this aides cloning efficiency 
(Rheinwald and Green 1977). Keratinocytes were co-cultured with infectious PT67 
for a minimum of 24 hours and a maximum of 72 hours. If drug-resistant feeders 
were used then selection could be started immediately otherwise resistant feeders 
were added immediately after removal of PT67s  and drug selection started. Co-
culturing proved an effective way of introducing the constructs into the cells as the 
contact between the PT67 and the keratinocytes allows the virus to pass straight 
from one cell to the other which is considered to be more efficient than direct 
retroviral infection of keratinocytes using viral supernatants. 
Once the mock cells were dead , drug selection was stopped and cell subculture 
continued with analysis of cell population doublings. 
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Figure 3. 2: Retroviral infection of keratinocytes. 
(i) Phoenix E retroviral producer cells were plated at 2 x 10
5 
a day prior to start of transfection. 
pRetro superior vectors and pBabe vectors were transfected on day 2 using fugene
6  
at 
a fugene : DNA ratio of 2:1. Cells were then drug selected from day 4 until 
approximately 80% confluent. Cells were subjected to regular medium change 
throughout the selection process. 
(ii) Medium containing retrovirus was then harvested from the phoenix E cells and used to 
infect PT67 cells, an NIH-3T3 amphotropic packaging cell line. Remaining retroviral 
supernatants were frozen as 1 ml aliquots at -80
o
C. PT67 were subjected to drug 
selection two days post transfection until mock cells died.  
(iii) Infections PT67 lethally irradiated with 60 Gy of y-IR and used as feeder layer for 
keratinocytes. 
 
 
 
 
 Chapter 3: Results 1 
132 
 
 
(a) 
 
 
 
 
 
 
(b) 
 
 
 
 
 
 
 
 
(c) 
 
 
 
 
 
 
 
 
Representative colonies of successfully transfected Phoenix E cells for the shp16/hTERT infections     
( a and b) and Bmi1/hTERT infections (c). GFP used as positive control throughout.  
 
Figure 3. 3: Transfected Phoenix E cells. 
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3.3 Discussion 
 
Keratinocytes were grown in a feeder system to optimize culture conditions in 
relation to CO2 percentage and optimal seeding density for subsequent retroviral 
infections. Cell growth was visibly enhanced and colonies better defined when 
cultured at 10% CO2 and consequently it was decided to culture keratinocytes at a 
10% CO2 for the duration of the study. 
 
Keratinocytes have typically been hard to stably transfect directly with plasmid 
constructs and it has been shown that the use of retroviral vectors results in high 
infection rates despite repeated passage in culture (Levy, Broad et al. 1998). This 
protocol was adapted and modified for the purposes of this study to infect early 
passage NHOK and NHEK cells with the vectors of choice.   
 
An initial seeding density of 1 x 106 was used for phoenix E transfection after which 
infection of PT67 was carried out using phoenix E-derived supernatant and cells 
subjected to drug selection. At such a high starting density cells become over 
confluent on day of transfection in relation to the diameter of the 60 mm tissue 
culture dish.  A series of pilot experiments were carried out to optimise the 
protocol to suit the current set of experiments. For successful transfection, phoenix 
E cells should be approximately 50%  – 60% confluent at  time of transfection and to 
determine this, cells  were plated at five different seeding densities and cultured for 
five days. It was observed that a seeding density of 2 x 105 results in cell confluency 
of approximately 60% and when used for subsequent transfection, it greatly 
enhanced transfection efficiency. Additionally, to obtain a purer culture of 
transfected cells, drug selection was started two days post-transfection and cells 
were subcultured until 80% confluency was achieved. The phoenix E cells that were 
selected with 5 μg/ml of puromycin failed to survive and optimal puromycin dose 
was calculated to be at 2.5 μg/ml (for pRetrosuperior vectors). The GFP control 
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included in the study demonstrated high levels of phoenix E transfection and the 
subsequent infection of PT67 was successful. For transduction of keratinocytes, 
infected PT67 were subjected to a 60 Gy dosage of γ radiation prior to co-culturing 
with cells. It was important to culture the irradiated PT67 with the keratinocytes as 
soon as possible after irradiation, (rather than vapour phase storage), to avoid any 
reduction in the infectious ability of PT67 as a result of storage in liquid nitrogen. 
Furthermore, although the protocol originally states to use PT67 as a substitute for 
feeder cells during infection, the addition of feeders to the cultures alongside PT67 
resulted in higher infection rates for the keratinocytes, possibly by providing 
additional growth factors. A high initial seeding density of keratinocytes at 
transduction was used, exposing higher number of initial cells available to be 
transduced and two days post transduction keratinocytes were subjected to drug 
selection prior to being assessed for PD. It was important to lower the dose of both 
puromycin and G418 for keratinocyte selection as the cells are more sensitive and 
less robust compared to fibroblasts and cannot withstand high drug doses. Drug 
selection successfully generated pure, transduced populations whereas cells 
allowed to proliferate in the absence of drug selection senesced earlier than their 
non-selected counterparts. 
 
3.4 Chapter Conclusions 
 
Early passage NHOK and NHEK were grown in presence of feeders and tested for 
optimal growth conditions which were maintained post transduction. PT67 cells 
were successfully infected from phoenix E supernatant after optimizing the 
retrovirus infection protocol and were irradiated for the transduction of NHOK and 
NHEK which were assessed for population doublings over an extended period of 
time (chapter 4, 5). 
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4.1 Keratinocyte transductions and analysis of replicative life 
span 
 
Cellular immortalization occurs when the cell acquires the ability to over-ride 
critical cell cycle regulatory mechanisms such as suppression of tumour suppressors 
16INK4a and p53 and/or escaping telomere regulation by upregulating telomerase 
expression. Keratinocytes were successfully cultured and immortalized by 
Rheinwald et al., (1992) in a study which demonstrated that apart from down 
regulating p16INK4a along with introduction of telomerase, knock down of p53 is also 
required in order to extend lifespan of keratinocytes (Rheinwald, Hahn et al. 2002).  
Many studies have since, however, achieved life span extension of cells using 
varying infection protocols and demonstrated that p53 suppression is not required 
for immortalization of epithelial cells. The next part of this study aimed to 
reproduce that experiment in oral keratinocytes with an established and improved 
retroviral infection protocol, in hope of extending cellular lifespan with p16INK4a 
knockdown combined with telomerase without silencing p53. Many studies have 
stated that keratinocytes do not respond well to drug selection and to test whether 
this has any effect on replicative potential each infection was carried out in two 
sets, with one selected with antibiotics.  
The Biovision senescent detection cytochemical assay was used to detect the 
activity of senescence-associated β galactosidase (β gal) activity (Dimri et al 1995) 
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within transduced cells that had ceased proliferation. Β gal is a hydrolase enzyme 
that catalyzes the hydrolysis of β galactosides into monosaccharides and is 
commonly used in molecular biology as a reporter marker to detect the presence of 
an active β gal. The assay is based on the production of a blue-green dye precipitate 
resulting from the cleavage of β gal substrate X gal, a colourless compound which 
produces an insoluble, blue product when cleaved by β gal, thereby providing a 
means to distinguish the presence or absence of an active β gal enzyme.  
 
Following successful optimization of the retroviral infection protocol, keratinocytes 
were transduced and subsequently assessed for replicative lifespan over an 
extended time frame with appropriate controls (table 4.1) and under different 
conditions. Two different methods were utilized to transduce keratinocytes: shp16 
with hTERT (see below) and Bmi1 with hTERT (chapter 5). The results of these two 
methods will be presented under the different cell types (oral vs epidermal) and 
under the different selective conditions (drug-selected vs non-selected).  Results 
from keratinocyte transductions on strains wherein cells failed to extend lifespan 
are not discussed here (Appendix 2).  
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Control Abbreviation Controls 
Parental Non-transduced NHOK or NHEK cells at same PD as transduced 
cells 
pRs E.V puro 
 
pRetrosuperior Empty Vector control; cells transduced 
independently with pRs vector to confer puromycin resistance 
pBabe E.V neo 
 
pBabe Empty Vector Control; cells transduced independently 
with pBabe vector to confer neomycin resistance 
shp53 
 
shp53 only control ; cells transduced independently with shp53 
to downregulate expression of p53 
shp16 
 
shp16 only control ; cells transduced independently with shp16 
to downregulate expression of p16INK4a 
hTERT  
 
hTERT only control ; cells transduced independently with hTERT 
to induce telomerase expression 
Table 4. 1 List of controls used in the transduction of NHOKshp16+hTERT and 
NHEKshp16+hTERT .  
Extensive controls were used throughout the study to ensure validity of results. NHOK and NHEK 
cells were transduced separately with each of the controls mentioned above and cultured until they 
senesced.  
 
4.1.2 Method Summary 
Successfully infected PT67 cells were irradiated to act as infectious feeders and     
co-cultured with keratinocytes alongside normal feeders. Each cell line was 
assessed for population doublings (PD) under the two different selective conditions 
and the results presented herein.   
 
4.2 NHOK shp16+hTERT  
NHOK strain 810 was transduced at early passage with shp16 and hTERT alongside 
appropriate controls (table 4.1) and assessed for proliferative capacity under two 
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conditions, with one set subjected to drug selection. Two independent experiments 
with similar results were obtained using shp16+hTERT (data not shown). 
 
4.2.1 NHOKshp16+hTERT (selected) 
 NHOKshp16+hTERT continued to proliferate for an additional 7 PD up to a total of 27 PD 
compared to the parent NHOK control which plateaud after reaching 20 PD (Fig 
4.1). Controls all ceased proliferation between 15 to 21 PD. As expected, 
NHOKshp16+shp53+hTERT continued to proliferate indefinitely until end of experiment at 
which point it had reached 95 PD.  To determine senescence, cells were analyzed 
for β Gal activity (Fig 4.2 a and Fig 4.2 b). NHOKshp16+hTERT alongside controls 
exhibited high levels of senescence as evident from the presence of blue cell 
colonies (Fig 4.2 a) with 93% of NHOKshp16+hTERT cells positive for β gal as compared 
to 5% of NHOKshp16+shp53+hTERT (Fig 4.2 b).  
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Figure 4. 1: NHOKshp16+hTERT (selected). 
Early passage NHOK cells were transduced with shp16 and hTERT and subjected to drug selection 
with population doublings assessed ( * indicates point of transduction). Appropriate controls were 
used (table 4.1). 
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Figure 4. 2: Expression of Beta-galactosidase in NHOKshp16+hTERT (selected). 
(a) Control plates all contained large, blue-green colonies positive for β Gal. NHOK
shp16+hTERT
 
ceased to proliferate indefinitely and the majority of cells were positive for β Gal. 
NHOK
shp16+shp53+hTERT 
continued to proliferate and plates contained large colonies without 
extensive β Gal staining although did contain some small, naturally occurring senescent 
colonies.  
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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4.2.2 NHOKshp16+hTERT (non-selected) 
NHOKshp16+hTERT continued to proliferate for an additional 3 PD upto a total of 23 PD 
compared to the parent NHOK control which ceased to proliferate at 20 PD (Fig 
4.3). Controls all ceased proliferation between 15.4 to 23 PD. Interestingly, 
however, it was noted that in the absence of drug selection NHOKshp16+SHP53+hTERT did 
not proliferate indefinitely, rather continued to proliferate for an additional 17 PD 
as compared to parental control and plateauing at 37 PD (Fig 4.3).  To determine 
senescence, cells were analyzed for β Gal activity (Fig 4.4 a and Fig 4.4 b). All 
transduced cell lines exhibited high levels of senescence as evident from the 
presence of blue cell colonies (Fig 4.4 a) with 88% positive cells for NHOKshp16+hTERT 
and 91% positive for NHOKshp16+shp53+hTERT (Fig 4.4 b), whilst control cell lines were in 
the ranges of 85% - 91% positive cells.   
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Figure 4. 3: NHOKshp16+hTERT (Non-selected). 
 
Early passage NHOK cells were transduced with shp16 and hTERT and assessed for population 
doublings in the absence of drug selection (* indicates point of transduction).  Appropriate controls 
were used (table 4.1). 
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Figure 4. 4: Expression of Beta-galactosidase in NHOKshp16+hTERT (Non-selected). 
(a) Control plates all contained large colonies positive for β gal. NHOK
shp16+hTERT 
and 
NHOK
shp16+shp53+hTERT  
ceased to proliferate indefinitely in absence of drug selection  with 
majority of cells stained positive for β gal. 
 
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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4.3 NHEK shp16 +hTERT  
Early passage NHEK were transduced with shp16 and hTERT alongside appropriate 
controls and assessed for proliferative capacity under two conditions, with one set 
subjected to drug selection. Two independent experiments with similar results 
were obtained using shp16+hTERT (data not shown). 
 
 4.3.1 NHEKshp16+hTERT (selected) 
NHEKshp16+hTERT continued to proliferate for an additional 3 PD up to a total of 19 PD 
as compared to the parent NHEK control that appeared to plateau after reaching 15 
PD (Fig 4.5). Controls all ceased to proliferate between 13 to 19 PD. As expected, 
NHEKshp16+shp53+hTERT continued to proliferate indefinitely until end of experiment at 
which point it had reached 92.4 PD (Fig 4.5). To determine senescence, cells were 
analyzed for β gal activity (Fig 4.6 a and Fig 4.6 b). NHEKshp16+hTERT  alongside control 
cells exhibited high levels of senescence as evident by the presence of positive cells 
(blue colonies) (Fig 4.6 a) with 91.8% of NHEKshp16+hTERT positive for β gal compared 
with 11% of positive cells for NHOKshp16+shp53+hTERT(Fig 4.6 b).  
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Figure 4. 5: NHEKshp16+hTERT (selected). 
Early passage NHEK cells were transduced with shp16 and hTERT and subjected to drug selection 
with population doublings assessed ( * indicates point of transduction). Appropriate controls were 
used    (table 4.1). 
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Figure 4. 6: Expression of Beta-galactosidase in NHEKshp16+hTERT (selected). 
(a) Control plates all contained large, blue-green colonies positive for β gal. NHEK
shp16+hTERT
 
ceased to proliferate indefinitely and the majority of cells were positive for β gal. 
NHEK
shp16+shp53+hTERT 
continued to proliferate and plates contained large colonies without 
extensive β gal staining although did contain some small, naturally occurring senescent 
colonies.  
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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4.3.2 NHEKshp16+hTERT (non-selected) 
NHEKshp16+hTERT continued to proliferate for an additional 4 PD upto a total of 18 PD 
compared to the parent NHEK control which ceased to proliferate at 14 PD (Fig 4.7). 
Controls all ceased to proliferate between 15 to 19 PD. Interestingly, however, it 
was noted that in the absence of drug selection NHEKshp16+shp53+hTERT only 
proliferated for an additional 24 PD compared to the parental control prior to 
plateauing at 39 PD (Fig 4.7). To determine senescence, cells were analyzed for β 
gal activity (Fig 4.8 a and Fig 4.8 b). All transduced cell lines exhibited high levels of 
senescence as evident from the presence of blue cell colonies (Fig 4.8 a). When 
tested for β gal activity, all cell lines showed high levels of activity with 88% of 
NHEKshp16+hTERT cells and 91% of NHEKshp16+shp53+hTERT cells positive for β gal               
(Fig 4.8 b). Control cell lines were in between ranges of 87% to 93% positive cells 
(Fig 4.8 b). 
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Figure 4. 7: NHEKshp16+hTERT (non-selected). 
Early passage NHEK cells were transduced with shp16 and hTERT and assessed for population 
doublings in the absence of drug selection (* indicates point of transduction). Appropriate controls 
were used (table 4.1). 
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Figure 4. 8: Expression of Beta galactosidase in NHEKshp16+hTERT (non-selected). 
 
(a) Control plates all contained large colonies positive for β gal. NHEK
shp16+hTERT 
and 
NHEK
shp16+shp53+hTERT 
ceased to proliferate indefinitely in absence of drug selection and 
stained positive for β gal. 
 
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown. 
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4.4 Discussion 
Early passage oral and epidermal keratinocytes were transduced with shp16 and 
hTERT and assessed for population doublings with appropriate controls. In the set 
subjected to drug selection, cells transduced with shp16+hTERT did not extend 
replicative lifespan significantly more than the control group and cells senesced 
within an additional 20 PD after parental controls senesced. Cells transduced with 
shp53 alongside shp16 and hTERT were found to proliferate indefinitely and were 
negative for β gal expression. Similarly, for the set assessed in the absence of drug 
selection, cells transduced with shp16 and hTERT did not extend replicative lifespan 
and senesced alongside controls. Surprisingly, however, even the addition of shp53 
did not extend cell lifespan indefinitely, suggesting the importance of drug selection 
when selecting for pure populations of transduced cell lines.  
 
There have been many conflicting reports into the role of p53 in the 
immortalization of human cells with some stating it is essential (Rheinwald et al. 
2002) and others claiming it is not necessary (Kiyono, Foster et al. 1998, Dickson, 
Hahn et al. 2000, Haga, Ohno et al. 2007). The results of the study confirmed the 
findings of Rheinwald and group, that despite using an optimized retroviral 
infection protocol, down regulation of p16INK4a alongside telomerase did not 
sufficiently extend cell lifespan and in both NHOK and NHEK, downregulation of p53 
was also required to extend cell growth. No rare, spontaneously immortalized cell 
clones appeared as in the case with cells such as OKF6 and NTERTs, reinstating the 
fact that spontaneously arisen cell lines are not reproducible. 
 
Imaging studies have provided evidence in vivo of ‘cross-talks’ between p16INK4a and 
p53 (Yamakoshi, Takahashi et al. 2009) , indicating that p53 normally holds p16INK4a 
in check and it is possible that the knockdown of p16INK4a alone is insufficient at 
extending replicative lifespan of keratinocytes due to a direct signalling mechanism 
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between p16INK4a and p53 that ‘alerts’ p53 when p16INK4a is directly silenced, 
resulting in a p53-mediated cell cycle arrest. Studies that have downregulated 
p16INK4a indirectly have had higher success rates at extending cell lifespan whilst 
retaining p53 expression (Dickson, Hahn et al. 2000, Haga, Ohno et al. 2007) . 
 
 
When tested for expression of β gal activity, close to 90% activity was found in  
transduced cells that ceased proliferation, in accordance with data from studies 
using β gal as a biomarker for senescent cells. It is important to note, however, that 
although initially senescence-associated β gal activity was thought to be expressed 
specifically in senescent cells, since then studies have established that expression of 
β gal in these cells is due to the over-expression and accumulation of the lysosomal 
endogenous β gal. Furthermore, it was noted that its expression is not essential for 
senescence but despite this it still remains the most widely used biomarker for 
senescence and aging cells since it is reliable and easily detectable. 
 
 
4.5 Chapter Conclusions 
 
The findings from keratinocyte transductions reveal that, interestingly, the direct 
method of downregulating p16INK4a does not allow for cellular immortalization in 
oral and epidermal keratinocytes except arising spontaneously after periods of 
crisis in culture, an unfortunate event from the perspective of reproducibility in 
research.  Cells did not witness cell growth expansion of more than 3-5 PD beyond 
controls in the absence of p53.  
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5.1 Bmi1+hTERT transductions 
 
Bmi1 is an oncogene found to be over expressed in many cancers, promoting cell 
survival and proliferation. In 2007, Haga et al demonstrated that in human 
mammary epithelial cells, bmi1 along with telomerase sufficiently immortalized 
cells without crisis or growth arrest whilst retaining near-normal chromosomal 
ploidy (Haga, Ohno et al. 2007). The next method used to transduce keratinocytes 
was by over expressing bmi1 alongside telomerase to extend cellular replicative 
lifespan whilst retaining tumour suppressive activity and cell cycle checkpoints.  
Transductions were repeated as previously (chapter 4) with a combination of 
Bmi1+hTERT and assessed for replicative lifespan over an extended time frame with 
appropriate controls (table 5.1) and under different conditions. Transduced cells 
were drug selected to elicit pure cell populations, however, as it has been reported 
that cells do not respond well to drug selection, separate transductions were also 
performed in the absence of drug selection. The results will be presented under the 
different cell types (oral vs epidermal) and under the different selective conditions 
(drug-selected vs non-selected).   
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Control Abbreviation Controls 
Parental Non-transduced NHOK or NHEK cells at the same PD as 
transduced cells 
Bmi1 + E.V neo 
 
pBabe neo empty vector control and Bmi1 only;  
conferring resistance to both selection markers 
hTERT + E.V puro 
 
pBabe puro empty vector control and hTERT only; 
conferring resistance to both selection markers 
Table 5. 1  List of controls used in the transductions of NHOK and NHEK with 
Bmi1+hTERT.  
Extensive controls were used throughout the study to ensure validity of results. To save time, NHOK 
and NHEK cells were transduced with empty vectors alongside either Bmi1 or hTERT and selected for 
both selection markers simultaneously.  
 
 
5.1.1 Method Summary 
Successfully infected PT67 cells were irradiated to act as infectious feeders and     
co-cultured with early passage keratinocytes alongside normal feeders. Each cell 
line was assessed for PDs under the two different selective conditions and the 
results presented herein.   
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5.2 NHOKbmi1+hTERT  
NHOK strain 810 was transduced at early passage with Bmi1 and hTERT alongside 
appropriate controls and assessed for proliferative capacity under two conditions, 
with one set subjected to drug selection. Two independent experiments with 
similar results were obtained using Bmi1+hTERT (data not shown).  
 
 5.2.1 NHOKBmi1+hTERT (selected) 
NHOKBmi1+hTERT continued to proliferate indefinitely until the end of the experiment 
at which point it had reached 86 PD as compared to the parent NHOK control which 
plateaued at 16 PD (Fig 5.1). Surprisingly, NHOKBmi1+EV showed significant lifespan 
extension even in the absence of hTERT, proliferating upto 35 PD before plateauing 
(Fig 5.1). With the exception of NHOKBmi1+EV, controls all ceased proliferation 
between 16 to 19 PD. To determine senescence, cells were analyzed for β gal 
activity (Fig 5.2 a and Fig 5.2 b). NHOKBmi1+hTERT exhibited low levels of positively 
stained cells (12%) as compared to controls (between 87% to 92%). 
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Figure 5. 2: NHOKBmi1+hTERT (Selected). 
Early passage NHOK were transduced with Bmi1 and hTERT and subjected to drug selection with 
population doublings assessed (* indicates point of transductions). Appropriate controls were used 
(table 5.1). 
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Figure 5. 3: Expression of β galactosidase in NHOKbmi1+hTERT. 
(a) Control plates all contained large, blue-green colonies positive for β gal. NHOK
Bmi1+hTERT 
continued to proliferate and plates contained large colonies without extensive β gal staining 
although did contain some small, naturally occurring senescent colonies. 
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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5.2.2 NHOKBmi1+hTERT (non-selected) 
In the absence of drug selection NHOKBmi1+hTERT continued to proliferate upto 45 PD 
before exhibiting plateau level compared to the parental NHOK control which 
reached plateau at 18 PD (Fig 5.3). All other controls ceased proliferation between 
17 to 20 PD with the exception of NHOKBmi1+EV that continued to proliferate until 33 
PD (Fig 5.3).   To determine senescence, cells were analyzed for β gal activity (Fig 
5.4 a and Fig 5.4 b). All transduced cell lines exhibited high levels of senescence as 
evident from the presence of blue colonies (Fig 5.4 a) with 95%  of NHOKBmi1+hTERT 
cells positive for β gal and between 93% - 96% of control cells positive cells for β gal     
(Fig 5.4 b).   
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Figure 5. 4: NHOKBmi1+hTERT (Non-selected). 
Early passage NHOK were transduced with Bmi1 and hTERT and assessed for population doublings in 
the absence of drug selection (* indicates point of transduction).   Appropriate controls were used 
(table 5.1). 
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Figure 5. 5: Expression of Beta galactosidase in NHOKBmi1+hTERT. 
(a) Control plates all contained large, blue-green colonies positive for β gal. NHOK
Bmi1+hTERT 
  
ceased to proliferate indefinitely and majority of cells stained positive for β gal.  
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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5.3 NHEK Bmi1+hTERT  
Early passage NHEK were transduced with Bmi1 and hTERT alongside appropriate 
controls (table 5.1) and assessed for proliferative capacity under two conditions, 
with one set subjected to drug selection. Two independent experiments with 
similar results were obtained using bmi1+hTERT (data not shown).  
 
 5.3.1 NHEKBmi1+hTERT (selected) 
NHEKBmi1+hTERT continued to proliferate indefinitely until the end of the experiment 
at which point it had reached 96 PD as compared to the parent NHEK control that 
plateaud at 18 PD (Fig 5.5). As with the NHOK transductions, NHOKBmi1+EV showed 
lifespan extension even in the absence of hTERT, proliferating upto 30 PD before 
plateauing (Fig 5.5). With the exception of NHEKBmi1+hTERT, all controls ceased 
proliferation between 18 to 21 PD. To determine senescence, cells were analyzed 
for β gal activity (Fig 5.6 a and Fig 5.6 b). NHEKBmi1+hTERT exhibited low levels of β gal 
activity (15%) as compared to controls (between 86% - 93%) of positive cells (Fig 5.6 
b). 
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Figure 5. 6: NHEKBmi1+hTERT (Selected). 
Early passage NHEK were transduced with Bmi1 and hTERT and subjected to drug selection with 
population doublings assessed (* indicates point of transductions). Appropriate controls were used 
(table 5.1). 
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Figure 5. 7: Expression of β galactosidase in NHEKBmi1+hTERT. 
(a) Control plates all contained large, blue-green colonies positive for β gal. NHEK
Bmi1+hTERT 
continued to proliferate and plates contained large colonies without extensive β gal staining 
although did contain some small, naturally occurring senescent colonies. 
(b) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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5.3.2 NHEKBmi1+hTERT (non-selected) 
 
In the absence of drug selection, NHEKBmi1+hTERT continued proliferation upto 53 PD 
before exhibiting plateau compared to parent NHEK which ceased proliferation at 
16 PD (Fig 5.7). All other controls ceased proliferation between 16 to 19 PD with the 
exception of NHEKBmi1+EV, that continued proliferation until 27 PD (Fig 5.7). To 
determine senescence, cells were analyzed for β gal activity (Fig 5.8 a and Fig 5.8 b). 
All transduced cell lines exhibited high levels of senescence as evident from the 
presence of blue , positively stained cells (Fig 5.8 a) with 89% of NHEKBmi1+hTERT cells 
positive for β gal and  89% - 94% of positive control cells (Fig 5.8b).   
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Figure 5. 8: NHEKBmi1+hTERT (Non-selected). 
Early passage NHEK transduced with Bmi1 and hTERT and assessed for population doublings in 
absence of drug selection  (* indicates point of transduction). Appropriate controls were used (table 
5.1).  
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Figure 5. 9: Expression of β galactosidase in NHEKBmi1+hTERT. 
(c) Control plates all contained large, blue-green colonies positive for β gal. NHEK
Bmi1+hTERT 
  
ceased to proliferate indefinitely and majority of cells stained positive for β gal.  
(d) Quantification of senescent colonies. Cells were analyzed for β gal activity using the 
Biovision senescence detection kit. A total of 300 cells were counted and cells deemed 
positive if stained blue. Means of 3 independent experiments are shown.
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5.4 Discussion 
Early passage oral and epidermal keratinocytes were transduced with Bmi1 and 
hTERT and assessed for population doublings with appropriate controls (table 5.1). 
In the set subjected to drug selection, cells transduced with Bmi1+hTERT reached 
90 PD (NHOK) and 94 PD (NHEK) compared to parental controls that proliferated 
upto 16 PD (NHOK) and 18 PD (NHEK), respectively. Similarly, in the set assessed in 
the absence of drug selection, cells transduced with Bmi1 and hTERT did extend 
replicative lifespan however eventually senesced after 50 PD and furthermore, 
when tested for β gal expression all control cells tested positive.   
 
Interestingly, cells transduced with bmi1 alone also continued to proliferate for an 
additional 19 PD in NHOK and 12 PD in NHEK and studies into mammary cells lines 
have shown over expressing Bmi1 alone leads activation of telomerase (Dimri, 
Martinez et al. 2002), although with regards to this study transient telomerase 
expression was not enough to maintain cell growth indefinitely. When tested for 
expression of β gal activity, all cells apart from those transduced with bmi1+hTERT 
stained over 90% positive for senesce associated β gal activity, in accordance with 
data from studies using β gal as biomarker for senescent cells.  
 
5.5 Chapter Conclusions 
 
The data suggests Bmi1 alongside hTERT to be an effective method of extending 
replicative lifespan of keratinocytes as compared to downregulating p16INK4a 
directly alongside hTERT. A comparison of cell proliferation in presence and 
absence of drug selection suggests the importance of antibiotic selection in eliciting 
pure cell populations without which cells ultimately senesce despite conditions 
favouring proliferation. 
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Chapter 6 
Results 4 
 
6.1 Characterization 
 
Following successful lifespan extension of cells, NHOKBmi1+hTERT and NHEKBmi1+hTERT 
lines were assessed and compared with NHOKshp16+shp53+hTERT and 
NHEKshp16+shp53+hTERT as well as the commonly used OKF6 and OKF4. Cell lines were 
analyzed for p16INK4a expression, p53 activity and telomerase expression to 
characterize the expression levels of these key elements responsible for cellular 
immortalization and compare it to non transduced cell lines alongside the OKF4 and 
OKF6 cells. Following this, the NHOKBmi1+hTERT cell line was cultured in a serum free 
environment for culturing onto organotypic substrates.  
The results of this chapter will be described in five sections: 
(i) Western Blot analysis of cell lines for p16INK4a and p53 expression 
(ii) TRAP analysis 
(iii) Apoptosis response  
(iv) DNA damage effects in different culture media  
(v) Adaption of cell line into a serum free environment 
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6.2 Western blot analysis  
 
It is well established that knockdown of p16INK4a is essential for immortalization of 
cells and that accumulation of p16INK4a in cells is indicative of senescence  
(Reznikoff, Loretz et al. 1988, Serrano, Lee et al. 1996, Lin, Barradas et al. 1998, 
Rheinwald, Hahn et al. 2002).   p16INK4a has been shown to accumulate in cells with 
time in culture and cause senescence alongside telomere shortening, whilst 
immortal cells usually have suppression of p16INK4a , allowing them to override the 
cell cycle regulation and continue to proliferate. Lysates made from cells at 
progressive PD were analyzed by western blotting to show levels of 16INK4a 
progression and allow comparison between normal cells and immortalized cells to 
observe expression levels over time in culture. It is expected that normal, non-
transduced parent cells will show an increase in p16INK4a with time in culture whilst 
the transduced counterparts will not.  
 
Western blotting allows the assessment of protein expression from a cell extract 
with denatured cell lysates separated based on size on a acrylamide gel and are 
transferred to a suitable membrane prior to being recognized with an appropriate 
antibody. Although transduced cell lines were drug selected, as an additional 
control and to determine level of protein expression, cell lysates from each cell line 
were obtained post transduction and assessed for p16INK4a and p53. Tubulin was 
used as a loading control along with SVFHK and SCC.25 for positive and negative 
controls. SVHFK is a SV40 virus-transformed epidermal keratinocyte cell line that is not 
tumourigenic at early passage (Brown & Gallimore, 1987) with normal cellular tumour 
suppressive mechanisms along with functional p16 and p53. SCC.25 is a tumourigenic 
keratinocyte cell line derived from the tongue (Rheinwald & Beckett, 1981) with 
deficient tumour suppressive mechanisms including dysfunctional p16 and 
downregulated p53.  
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As shown in Fig 6.1, both bmi1 and shp16 effectively reduced expression of p16INK4a 
as compared to control. Next, the cell lysates were examined for p53 expression 
and considering p53 levels generally remain low within the cell unless triggered by 
stress-inducing stimuli,  the Bmi1+hTERT transductions appear to express normal 
levels of p53  as shown by the presence of a light visible band (Fig 6.1) . The 
absence of detectable band in the shp16+shp53+hTERT transductions compared to 
control demonstrated shp53 to be effectively downregulated in these cells (Fig 6.1).  
 
Cell lysates were taken from progressing population doublings to illustrate levels of 
p16INK4a as cells age in culture. When tested for p16INK4a expression, normal NHOK 
and NHEK displayed a gradual increase in expression of p16INK4a (Fig 6.2a) whereas 
in contrast, there was no detectable change in p16INK4a levels in cell lysates of 
transduced cell lines Fig 6.2 b and c). Three independent experiments with similar 
results were obtained using cell lysates to analyze p16INK4a expression (data not 
shown).  
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Figure 6. 1: Expression of p16INK4a and p53 in transduced cell lines. 
Representative western blots showing expression of p16
INK4a
 and p53 in NHOK and NHEK cell lines 
after transductions. Cell lysates were obtained at 30 PD for all cell lines and p16
INK4a
 expression was 
effectively knocked down in both NHOK
bmi1+hTERT 
and NHEK
bmi1+hTERT 
(lanes 1 and 2) as well as in 
NHOK
shp16+shp53+hTERT  
and NHEK
shp16+shp53+hTERT 
(lanes 3 and 4). Weak expression of p53 is visible in 
NHOK
bmi1+hTERT 
and NHEK
bmi1+hTERT 
            (lanes 1 and 2) but completely absent in NHOK
shp16+shp53+hTERT  
and NHEK
shp16+shp53+hTERT 
(lanes 3 and 4) as compared to controls. SVFHK and SCC.25 cell lysates were 
used for positive and negative controls respectively (lanes 5 and 6). Tubulin served as loading 
control.   
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continued overelaf 
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Figure 6. 2: Expression of p16INK4a with progressive population doublings in culture. 
Representative western blots showing expression of p16
INK4a
 over progressive population doublings 
in (a) normal NHOK and NHEK , (b) NHOK
bmi1+hTERT 
and NHEK
bmi1+hTERT 
and (c) NHOK
shp16+shp53+hTERT 
and 
NHEK
shp16+shp53+hTERT
. Cell lysates were obtained over time in culture and the data showed that in 
normal NHOK and NHEK, expression of p16
INK4a
 increased progressively with time in culture (a). No 
evident change was seen in expression of p16
INK4a
 in transduced cell lines (b) and (c). 
SVFHK and SCC.25 cell lysates were used for positive and negative controls respectively (lanes 5 and 
6). Tubulin served as loading control.   
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6.3 Characterizing telomerase activity in transduced cell lines 
 
Extension of telomere length is required for the immortalization of all mammalian 
cells as well as to extend cellular lifespan by preventing telomere-dependent 
senescence in many cell types including fibroblasts, retinal epithelial cells, smooth 
muscle cells and keratinocytes (Milyavsky, Shats et al. 2003, Ramirez, Herbert et al. 
2003, Vaughan, Ramirez et al. 2006, Zhu, Mouly et al. 2007, Wieser, Stadler et al. 
2008).  
Cell lines were tested for telomerase expression using a PCR based TRAP assay to 
show level of telomerase expression within cell samples, confirming successful 
transduction and allowing comparison with controls and other immortalized cell 
lines such as OKF4 and OKF6.  
 
6.3.1 Methods 
A cy5 based TRAP assay was used to measure the activity of the enzyme in vitro by 
introducing a primer that acts as a substrate for telomerase-mediated addition of 
TTAGGG repeats in a PCR reaction. If present, active telomerase from a cell extract 
extends this 50 base pair primer as if it were a telomere with the hexameric repeat 
(TTAGGG) and when run on a gel the activity of telomerase can then be judged by 
how many hexameric repeats were added as indicated by the extent of the 6bp 
ladder created within a set time and PCR cycle program. To determine levels of 
enzymatic activity in the cultures without transduction, TRAP analysis was 
performed at 10 PD compared to lysates from transduced cells which were 
analyzed for telomerase activity from lysates taken at 50 PD. 
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6.3.2 Results 
 
Very little telomerase activity was found in both NHOK and NHEK without 
exogenous hTERT expression (Fig 6.3 b). Expression of the hTERT construct in these 
cells after transduction demonstrated far more telomerase activity, shown by 
stronger bands (Fig 6.3 a) demonstrating that telomerase activity is limited by 
hTERT expression. For each sample, a heat inactivated counterpart was included as 
an additional negative control and these were devoid of any visible bands. OKF6 
and OKF4 were also tested for telomerase activity (Fig.6.3 b) and the bands 
appeared slightly darker than those for the transduced cell lines. Three 
independent experiments with similar results were obtained (data not shown).  
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Figure 6. 3: Telomerase Repeat Amplification Protocol (TRAP) analysis of telomerase 
levels in (a) NHOKbmi1+hTERT , NHEKbmi1+hTERT,  NHOKshp16+shp53+hTERT and 
NHEKshp16+shp53+hTERT and (b) untransduced NHOK and NHEK, OKF6 and OKF4. 
(a) TRAP analysis was undertaken on cell lysates obtained at 19 PD from the transduced cell lines for detection 
of telomerase activity within cells. Positivity for telomerase activity is shown by the 6-bp incremental TRAP 
ladder.  All cells transduced with hTERT showed telomerase expression (lanes 5,7,10 and 12) which was 
absent in the negative controls (lanes 2, 3 and 4) as well as after heat inactivation of each sample (lanes 
6,8,9 and 11).  
(b) TRAP analysis was undertaken on cell lysates obtained from non-transduced cell lines at 10 PD and from 
OKF6 and OKF4 cells lines and assessed for expression of telomerase. Non-transduced cells showed weak 
telomerase expression (lanes 6 and 8) as compared to OKF6 and OKF4 cell lines which had strong 
expression (lanes 10 and 12). Telomerase expression was absent in the negative controls (lanes 2,3 and 4) 
as well as after heat inactivation of each sample (lanes 5, 7, 9 and 11).  
A positive control available with the TRAPeze kit was used as a positive and negative control (by heat 
inactivation) respectively. A separate negative control was also used from a telomerase-negative cell line, 
GM847. The 36-bp internal standard control (IC) is indicated at bottom of gel to confirm equal loading of 
the samples. 
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6.4 Induction of p53-dependent apoptosis response by UVB 
Due to its pivotal role in the cells ability to respond to a range of environmental and 
intra-cellular stresses, including agents which cause DNA strand breaks, ultraviolet 
radiation, hyperproliferation and hypoxia, it is imperative for cells to have a 
functioning and intact p53 gene (Meek 2004). The role of p53 in apoptosis has been 
well documented and the two outcomes of p53 activation include apoptosis and 
cellular senescence and both of these responses require a functional p53. There are 
many mediators of p53 induced apoptosis including the Bax protein which is part of 
the bcl-2 protein family and the cells death receptors, such as FAS that work by 
directly stimulating mitochondria to produce an excess of highly toxic ROS (Borlon, 
Vankoningsloo et al. 2008). In keeping with its regulating role in genes governing 
the cell cycle and DNA errors, presence of a functional p53 is crucial for genetic 
stability, by not only preventing replication errors but also by inducing genes that 
regulate nucleotide excision repair of DNA (Kastan, Onyekwere et al. 1991).To 
investigate the response of the cells to UVB, cells were analyzed via FACS analysis 
for protein expression after exposure to different UVB doses and cells were 
assessed for viability . Cells with some tumour suppressive activity will undergo 
apoptosis and the cell population will have lower levels of viable cells as compared 
to cells with silenced p53, hence the total cell population from these cell lines are 
expected to have higher levels of viable cells since they will continue to proliferate 
past the G1 cell cycle checkpoint governed by p53. Therefore these experiments will 
give an idea of level of p53 expression in the transduced cell lines and allow 
comparison with OKF4 and OKF6 controls.  
 
Increased p53 levels lead to cell cycle arrest in the G1 phase of the cell cycle through 
the upregulation of p21WAF1, which in turn binds to cdks and induces the G1 cell 
cycle arrest (Athar, Kim et al. 2000). In this way, cells ensure that they maintain the 
integrity of the genome and are protected from accumulating mutations. In cell 
lines derived from malignant tissues, p53 is often dysfunctional or mutated thereby 
permitting the cells to proliferate in the presence of cellular damage. Studies have 
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shown a decrease in the apoptotic response of immortalized cells with a mutated or 
dysfunctional p53 in response to treatment with DNA damaging UVC radiation 
(Latonen and Laiho 2005) . It is not clear whether the vast majority of immortalized 
cells illicit similar responses with regard to p53-linked apoptosis, however for the 
purposes of this study and its long term goals, it was important to determine a 
normal p53-dependent apoptotic response.  
 
6.4.1 Method 
Cells were treated to 10mj/cm2 and 20mj/cm2 UVB and cultured for 24h and 48h 
prior to analysis alongside appropriate controls. To allow for a comparative study,  
OKF6 and OKF4 were also investigated for their apoptotic response.  Flow 
cytometric annexin V / dapi assay was performed in order to determine whether 
the transduced cell lines demonstrated apoptotic cell death following UVB 
exposure. The annexin V assay is a high sensitivity assay with the ability to detect 
early apoptosis as the annexin V antibody binds with high affinity to PS (chapter 2). 
The results are the averages of three independent experiments that were 
performed, analyzing 10,000 cells.  
 
A representative FACS analysis experiment is shown in Figure 6.4. The scatter plot 
(A) is shown for the untreated control where SSC=side scatter and FSC= forward 
scatter and the fluorescence plots are shown for each sample (B, C, D). Untreated 
control cells are shown in (B). Cells were treated with 10mj/cm2 (C) and 20mj/cm2 
(D) for both 24h and 48h. Q3 shows the viable cell population (annexin V -ve, DAPI -
ve), Q4 shows early apoptotic cells (annexin V +ve DAPI –ve), Q2 shows late 
apoptotic and necrotic cells (annexin V +ve, DAPI +ve) and Q1 shows only necrotic 
cells (annexin V –ve, DAPI +ve). 
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Figure 6. 4: Apoptosis assay. 
Representative flow cytometry plots for annexin V FITC/DAPI for cellular viability. The scatter plot 
(A) is shown for the untreated control where SSC=side scatter and FSC= forward scatter and the 
fluorescence plots are shown for each sample (B, C, D). OKF6 cells were used in this example. 
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6.4.2 Results 
The assay showed a marked difference in the percentage of viable cells between 
untreated and treated cells for both NHOKBmi1+hTERT and NHEKBmi1+hTERT and OKF6 and 
OKF4 at 24 h and 48 h post UVB treatment (Fig 6.5 - Fig 6.7). 
 
6.4.2.1 NHOK transductions 
As shown in Figure 6.5, NHOKBmi1+hTERT cells showed a marked decrease in number 
of viable cells at 24 h between control (88% ± 3.5%) compared to cells treated to 
10mj/cm2 (82% ± 3.1% ) and 20mj/cm2 (61%  ± 4.1%) UVB with the latter being 
significantly different when compared to the untreated control. After 48 h, a 
further decrease in viable cell numbers was observed in the untreated control (83% 
± 4%) compared to 10mj/cm2 (54% ± 6 % ) and 20 mj/cm2 (39% ± 8%) , both of 
which were significant when compared to the untreated control (Fig 6.5).  
Percentage of viable cells was higher in cell lines with silenced p53 expression 
compared to those for bmi1+hTERT transductions (Fig 6.5).  At 24 h post UVB 
treatment, percentage of viable cells for NHOKshp16+shp53+hTERT control cells were 
slightly higher (92% ± 1.5 %) than those treated with 10mj/cm2 (83% ± 6% ) and 
20mj/cm2 (72% ± 4.6% ) of UVB, with the latter being significantly different 
compared to the untreated control. At 48h a slight decrease in numbers of viable 
cells was observed in the control (89% ± 5.5%), as well as with treatment at 
10mj/cm2 (72% ± 8% ) and at 20mj/cm2 (63% ± 6.4%), both of which were 
significantly different when compared to untreated controls (Fig 6.5). 
 
Early apoptotic/late apoptotic cell percentages also increased with time and UVB 
dose with NHOKBmi1+hTERT untreated control 5.3% ± 2.8% (early apoptotic) and 5.1% 
±2.6% (late apoptotic) after 48 h , compared to 15.5% ±2.4% (early apoptotic) and 
29% ±2.7%  (late apoptotic) for 10mj/cm2 and 21.8  ± 5.9% (early apoptotic) and 
30.5% ± 2.5% (late apoptotic) for 20mj/cm2 (Fig 6.8). In the case of untreated 
NHOKshp16+shp53+hTERT control cells, the viable cell percentages at 24 h post treatment 
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were  1.9% ± 1.2% (early apoptotic) and 2.5% ±1.4% (late apoptotic) and at 48h 
2.2% ± 0.5% (early apoptotic) and 3.5% ± 1.1% (late apoptotic). When treated to 
10mj/cm2, a slight increase was observed in percentage of apoptotic cells with 14.8 
%± 2.3% (early apoptotic) and 15.6% ± 2% (late apoptotic) after 48h. Similarly, 
when treated to 20mj/cm2, apoptotic cell percentages were 20.4% ± 4.4% (early 
apoptotic) and 27.5% ± 3.6% (late apoptotic) at 48 h (Fig 6.8). 
 
6.4.2.2 NHEK transductions 
As shown in Figure 6.6, NHEKBmi1+hTERT cells also showed a similar pattern at 24 h, 
with a decrease observed in viable cells at 10mj/cm2 (60% ± 11%) and 20mj/cm2 
(54% ± 6%) with the latter being significantly different when compared to the 
untreated control (85% ± 4.6%). Again, a similar decline in viable cells was observed 
after 48 h at 10mj/cm2 (59% ± 5%) and 20mj/cm2 (41% ± 8% ) and both were 
significantly different when compared to untreated controls (83% ± 4%).  
 
Similarly for the NHEKshp16+shp53+hTERT cells, viability at 24 h for control cells (91% ± 
3.2% ) was higher than in cells treated to 10mj/cm2 (79% ± 6.6%) and 20mj/cm2 
(74% ± 7%) , although there was no significant difference between the cells. At 48 h 
post UVB treatment percentages of viable cells were still higher than the 
Bmi1+hTERT transductions of untreated control cells (88% ± 5.1%) as well as cells 
treated to 10mj/cm2 (76% ± 4.6%) and 20mj/cm2 (67% ± 6.2%), with the latter being 
significantly different when compared to untreated controls (Fig 6.6).  
 
When assessed for early and late apoptotic cell percentages, NHEKbmi1+hTERT  control 
cells  were 4.1% ± 1.7 % (early apoptotic) and 2.7% ± 1% (late apoptotic) compared 
to the treated cells at 48 h , 19.4%  ± 3.65% (early apoptotic) and 22.5% ± 4.9%  
(late apoptotic) at 10mj/cm2 and in response to 20mj/cm2 UVB dose, these levels 
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increased to 29.4% ± 4.9% (early apoptotic) and 30% ± 5.3% (late apoptotic) cells 
(Fig 6.9).   
In the case of NHEKshp16+shp53+hTERT cells, untreated control percentages at 24 h were 
2.7% ± 2% (early apoptotic) and 2.5%  ± 1.1% (late apoptotic) and at 48 h 2.8%  
±0.4% (early apoptotic) and 6% ± 3.2% (late apoptotic). Similarly, when treated to 
10mj/cm2 viable cell percentages were 6.6% ± 2.9% (early apoptotic) and 11.4% 
±4.3% (late apoptotic) at 48 h and when treated to 20mj/cm2 cell percentages were 
11% ± 3.5% (early apoptotic) and 11.5% ± 5.6% (late apoptotic) at 48 h (Fig 6.9).  
 
6.4.2.3 OKF6 and OKF4 
As a control, the commonly used OKF4 and OKF6 cells were assessed for their 
apoptotic response and having a dysfunctional p53, these cell lines will provide a 
good comparison for the bmi1+hTERT transduced cell lines. As shown in Figure 6.7, 
the percentage of viable OKF6 cells at 24h for the untreated control was 89% ± 
5.6% compared to 63% ± 4.2% at 10mj/cm2 UVB and 58% ± 7%  at 20mj/cm2 with 
both cell lines displaying significant differences when compared to untreated 
controls. After 48 h, a slight decrease in number of viable cells was observed with 
61% ± 8% at 10mj/cm2 and 59%±3.6% at 20mj/cm2, with the latter being 
significantly different when compared to the untreated control at 82% ± 5.7% (Fig 
6.7). Similarly for OKF4 cells, at 24 h the viable cell percentage for the untreated 
control was 86% ± 8% compared to 81% ± 7% at 10mj/cm2 and 72% ± 6.2% at 
20mj/cm2, neither of which are significantly different from the untreated controls. 
After 48 h, a slight decrease in percentage of viable cells was observed with 67% ± 
8% when treated to 10mj/cm2 UVB and 62% ± 3.1% when treated to 20mj/cm2 
UVB, with the latter significantly different when compared to the untreated control 
at 87% ± 2.5%. 
When assessed for the percentages of early and late apoptotic cells, cell 
percentages were similar to those observed for shp16+shp53+hTERT transductions 
rather than the Bmi1+hTERT transductions.  As shown in Figure 6.10 , cell 
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percentages for OKF6 untreated control at 24 h were 4% ± 1% (early apoptosis) and 
3% ± 1.5% (late apoptosis) whilst after 48 h a slight increase was observed at 7% 
±3% (early apoptosis) and 6%  ± 1.1% (late apoptosis). As shown in Figure 6.10, even 
after treatment with UVB at 10mj/cm2 , cell percentages remained low at 13% ± 
3.2% (early apoptosis) and 28% ± 3.3% (late apoptosis). When treated to 20mj/cm2 
UVB, cell percentages were 26% ± 9% (early apoptosis) and 11% ± 3.5% (late 
apoptosis). Similar results were obtained for OKF4 cells with untreated control 
percentages after 24 h of 3% ± 1% (early apoptosis) and 3% ± 1.2% (late apoptosis)  
compared to 4.5% ± 2.2% (early apoptosis) and 3.5% ± 1.3% (late apoptosis) after 
48 h. Percentage of cells increased slightly after treatment with 10mj/cm2 UVB at 
8% ± 1.2% (early apoptosis) and 8.2% ± 3.5% (late apoptosis) and similarly when 
treated to 20mj/cm2 UVB at 11% ± 2% (early apoptosis) and 10% ± 5% (late 
apoptosis) after 48h (Fig 6.10).  
 
It is obvious that lack of p53 causes an altered apoptotic response to DNA damaging 
agents and in this case, NHOKBmi1+hTERT and NHEKBmi1+hTERT cells demonstrate 
responsiveness to such agents. The results suggest UVB is cytotoxic to the cells and 
in order to confirm expression of p53 following UVB exposure, lysates were 
obtained for each cell line treated with 10mj/cm2 and 20 mj/cm2 UVB at 24 h and   
48 h. Western blot analysis showed an increase in p53 levels in Bmi1+hTERT cells 
following exposure to UVB as expected in cells with functional p53 activity (Fig 
6.11), whilst there was no detectable p53 expression in cells with silenced p53.  
SVHFK and SCC25 were used as positive and negative controls and tubulin served as 
loading control.  
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Figure 6. 5: Proportion of viable a) NHOKBmi1+hTERT and b) NHOKshp16+shp53+hTERT 
in the apoptosis assay. 
 
Means± S.E.M of 3 independent annexin V/DAPI experiments. NHOK
Bmi1+hTERT 
and NHOK
shp16+shp63+hTERT 
were incubated for 24 h and 48 h following exposure to 10mj/cm
2
 and 20mj/cm
2
 doses of UVB prior 
to trypsinisation.  The cells were then stained with annexin V and DAPI and analyzed by flow 
cytometry with the percentage of viable cells shown above. * is significantly different from the mean 
value of untreated control of each cell line. 
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Figure 6. 6:  Proportion of a) NHEKBmi1+hTERT and b) NHEKshp16+shp53+hTERT in the 
apoptosis assay. 
Means± S.E.M of 3 independent annexin V/DAPI experiments. NHEK
bmi1+hTERT 
and NHEK
shp16+shp63+hTERT 
were incubated for 24 h and 48 h following exposure to 10mj/cm
2
 and 20mj/cm
2
 doses of UVB prior 
to trypsinisation.  The cells were then stained with annexin V and DAPI and analyzed by flow 
cytometry with the percentage of viable cells shown above. * is significantly different from the mean 
value of untreated control of each cell line. 
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Figure 6. 7:  Proportion of a) OKF6 and b) OKF4 in the apoptosis assay. 
Means± S.E.M of 3 independent annexin V/DAPI experiments. OKF6
 
and OKF4
 
were incubated for      
24 h and 48 h following exposure to 10mj/cm
2
 and 20mj/cm
2
 doses of UVB prior to trypsinisation.  
The cells were then stained with annexin V and DAPI and analyzed by flow cytometry with the 
percentage of viable cells shown above. * is significantly different from the mean value of untreated 
control of each cell line. 
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Figure 6. 8: Proportion of early apoptotic and necrotic cells in a) NHOKBmi1+hTERT and b) 
NHOKshp16+shp53+hTERT 
Means± S.E.M of 3 independent annexin V/DAPI experiments. NHOK
Bmi1+hTERT 
and NHOK
shp16+shp53+hTERT 
were incubated for 24 h and 48 h following exposure to 10mj/cm
2
 and 20mj/cm
2
 doses of UVB prior 
to trypsinisation. The cells were then stained with annexin V and DAPI and analysed by flow 
cytometry. The percentages of early apoptotic and necrotic cells are shown. * is significantly 
different from the mean value of untreated control of each cell line.  
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Figure 6. 9: Means Proportion of early apoptotic and necrotic cells in a) NHEKBmi1+hTERT 
and b) NHEKshp16+shp53+hTERT 
Means± S.E.M of 3 independent annexin V/DAPI experiments. NHEK
Bmi1+hTERT 
and NHEK
shp16+shp53+hTERT 
were incubated for 24 h and 48 h following exposure to 10mj/cm
2
 and 20mj/cm
2
 doses of UVB prior 
to trypsinisation. The cells were then stained with annexin V and DAPI and analysed by flow 
cytometry. The percentages of early apoptotic and necrotic cells are shown. * is significantly 
different from the mean value of untreated control of each cell line.  
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Figure 6. 10: Proportion of early apoptotic and necrotic cells in a) OKF6 and 
b) OKF4 
Means± S.E.M of 3 independent annexin V/DAPI experiments. OKF6
 
and OKF4
 
were incubated for   
24 h and 48 h following exposure to 10mj/cm
2
 and 20mj/cm
2
 doses of UVB prior to trypsinisation. 
The cells were then stained with annexin V and DAPI and analysed by flow cytometry. The 
percentages of early apoptotic and necrotic cells are shown. * is significantly different from the 
mean value of untreated control of each cell line.  
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Figure 6. 11 : Upregulation of p53 in test cell lines in response to UVB. 
Representative western blots showing expression of p53 in NHOK
Bmi1+hTERT 
and NHOK
shp16+shp53+hTERT
 
following UVB treatment at 10mj/cm
2
 and 20mj/cm
2
 after 12 h. As expected, p53 is not visibly 
expressed in untreated controls since it is activated in response to DNA damage or cellular stress, as 
shown by the rapid rise of p53 levels following UVB treatment at 10mj/cm
2
 and a further increase in 
expression levels at 20mj/cm
2
. Comparably, there is no change of p53 expression in 
NHOK
shp16+shp53+hTERT 
or NHEK
shp16+shp53+hTERT
 when compared to untreated control. SVFHK and SCC.25 
cell lines served as positive and negative controls respectively. Tubulin served as the loading control.  
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6.5 Evidence of DNA damage  
 
Culture conditions and the stress which they impose on cells in vitro remains an 
underappreciated problem. Cell culture is invaluable, allowing for studies on 
metabolism, signal transduction, regulation of gene expression, cell proliferation, 
senescence and cell death. It is essential to remember that cells in culture behave 
differently to cells in vivo in many ways, most importantly by imposing a state of 
oxidative stress on cells (Halliwell 2003). The ‘foreign’ culture conditions that the 
cells find themselves in during in vitro culture is pronounced by the difficulty of 
culturing primary cells in vitro; approximately 10% of cells manage to adapt and 
survive when cultured whilst the remainder enter senescence or undergo apoptosis 
(Halliwell 2003) . Consequently, and perhaps worrisome, this can lead to effects in 
cells that are in fact due to oxidation products and under certain circumstances lead 
to misleading conclusions. Hence, cells that survive and grow in culture are not 
always representative of cells in vivo, in terms of metabolism, gene expression and 
enzyme levels and there is a profound need for caution when obtaining data in cell 
culture relevant to in vivo situations. For example; it can be problematic when 
interpreting what appears to be cellular senescence in cultured cells as rarely are 
culture conditions adequate to permit cells to reach the replicative senescence of 
the cells original in vivo (Halliwell 2003). DNA damage response factors 53BP1 and 
γH2AX have been shown to bind DNA following cellular stress (Takai, 
Smogorzewska et al. 2003) and  co-localise to form nuclear foci. 53BP1 and γH2AX 
staining was carried out in keratinocytes cultured in the fibroblast feeder system 
and two types of commercially available serum free medium, KGM and kSFM. The 
number of DNA damage induced foci formed per cell in each culture medium is an 
indication of the level of DNA damage and stress caused to cells as a result of the 
culture environment.  
 
Supplementation of culture media with undefined components of serum has many 
disadvantages and there is a growing demand to develop improved serum free 
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mediums for use in research as well as for industrial applications. Serum 
concentrations used in cell medium has been shown to have an effect on cell 
kinetics and metabolism and a direct link has been shown between serum levels in 
cell media and cell viability. A study on HeLa cells demonstrated low serum levels 
slowing cell growth rates whilst increasing serum levels results in a significant 
reduction in viable cell numbers (Elsayed, Demellawy et al. 2009).  
 
6.5.1 Method 
NHOKBmi1+hTERT and NHEKBmi1+hTERT were cultured in three different culture mediums 
consisting of 10% serum plus EGF (FAD+) and two serum free mediums; KGM and 
KSFM.  Cells were stained for DNA damage markers 53BP1 and γH2AX following a 
standard immunofluorescence protocol as outlined in chapter 2 and assessed for 
generation of nuclear foci in response to cellular stress as a result of culture 
environment. 
 
6.5.2 Result 
The serial culture of early passage NHOKBmi1+hTERT and NHEKBmi1+hTERT in an in vitro 
environment generated nuclear foci when stained for DNA damage markers 53BP1 
(Fig 6.12, NHOK and Fig 6.13, NHEK) and γH2AX (Fig 6.14, NHOK and Fig 6.15, NHEK) 
in all three culture mediums. As shown in Fig 6.17, when stained for 53BP1, 
NHOKBmi1+hTERT had highest levels of positively stained cells when cultured in FAD+ 
(69% ± 7 %) and this was followed by KGM (64% ± 6.5%) and KSFM (61% ± 6.6%). 
Similarly, when stained for γH2AX, there was a slight decrease in the percentage of 
nuclear foci of NHOKBmi1+hTERT cells positive when cultured in FAD+ (67% ± 4%) , KGM 
(62% ± 8%) and KSFM (59% ± 3%) (Fig 6.17).  NHOKBmi1+hTERT fixed and processed in 
the absence of staining showed little or no immunofluorescence (Fig 6.16). 
A scoring system set up to determine percentage of positively stained cells 
illustrated that NHEKBmi1+hTERT stained for 53BP1 had highest percentage of positive 
cells when cultured in FAD+ (68% ± 4% ) compared to KGM (61% ± 5% ) and kSFM 
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(59% ± 7% ) (Fig 6.17). Similarly, NHEKBmi1+hTERT stained for γH2AX demonstrated 
highest percentage of positive cells when cultured in FAD+ (70% ± 5%) compared to 
KGM (63% ± 6%) and kSFM (58% ± 8%) (Fig 6.17).  Taken together, the data 
indicates that cells cultured in the presence of serum had higher levels of stress 
induced nuclear foci. To eliminate the possibility of false positives due to the use of 
lethally irradiated feeders, a feeder only control was also incorporated (Fig 6.16). 
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Figure 6. 12: Representative image of 53BP1 activation in NHOKBmi1+hTERT exposed to 
different culture conditions. 
Representative images of NHOK
Bmi1+hTERT 
cells staining positive with the 53BP1 antibody. Cells were 
incubated in FAD
+
, KGM and KSFM for 5 days prior to staining. (a) shows 53BP1 staining (green) , (b) 
shows nuclear staining with Hoechst 33258 (blue) and (c) is an overlay of the two. (Magnification at 
65x). 
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Figure 6. 13: Representative image of 53BP1 activation in NHEKBmi1+hTERT exposed to 
varying culture conditions. 
Representative images of NHEK
Bmi1+hTERT 
cells staining positive with the 53BP1 antibody. Cells were 
incubated in FAD
+
, KGM and KSFM for 5 days prior to staining. (a) shows 53BP1 staining (green) , (b) 
shows nuclear staining with Hoechst 33258 (blue) and (c) is an overlay of the two. (Magnification at 
65x). 
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Figure 6. 14: Representative image of γH2AX activation in NHOKBmi1+hTERT exposed to 
varying culture conditions. 
Representative images of NHOK
Bmi1+hTERT 
cells staining positive with the γH2AX antibody. Cells were 
incubated in FAD
+
, KGM and KSFM for 5 days prior to staining. (a) shows γH2AX staining (green) , b) 
shows nuclear staining with Hoechst 33258 (blue) and c) is an overlay of the two. (Magnification at 
65x). 
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Figure 6. 15: Representative image of  γH2AX activation in NHEKBmi1+hTERT exposed to 
varying culture conditions. 
Representative images of NHEK
Bmi1+hTERT 
cells staining positive with the γH2AX antibody. Cells were 
incubated in FAD
+
, KGM and KSFM for 5 days prior to staining. (a) shows 53BP1 staining (green) , (b) 
shows nuclear staining with Hoechst 33258 (blue) and (c) is an overlay of the two. (Magnification at 
65x). 
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Figure 6. 16: Representative image of Immuofluorescence Antibody Controls. 
Representative images of NHOK
Bmi1+hTERT 
cells staining. Cells were incubated in FAD, KGM and KSFM 
for 5 days prior to staining.  i) shows 53BP1 antibody control ii) shows γH2AX antibody control iii) 
shows feeder only control. (Magnification at 65x). 
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Figure 6. 17: Percentage of NHOKBmi1+hTERT and NHEKBmi1+hTERT cells stained 
positive for DNA damage markers i) 53BP1 (blue) and ii) γH2AX (red). 
A cell was classified as positive for 53BP1 or γH2AX if it contained 3 or more nuclear foci.  The 
percentage of positive cells is based on a counting of 300 cells in total per culture medium for each 
antibody. * is significantly different from the mean value of untreated control of each cell line. There 
was no significant difference observed in the number of positive cells cultured in serum free media 
from those cultured in the presence of feeders in 10% serum (FAD
+
).  
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6.7 Adaptability of cell lines to serum free system 
As discussed previously, the benefits of using cells capable of successful culture in a 
serum free medium are multiple and researchers find it beneficial to either use cells 
that already adapted for successful serum free culture or they try and adapt their 
cells to it. The absence of animal-derived medium components in the culture 
eliminates the potential for contamination by adventious agents such as viruses in 
cell culture (Do 2003).  Other benefits include economics, as generating and 
screening large stocks of sera is very expensive and the culture process is greatly 
simplified without the requirement of feeders.  Studies that have attempted to 
adapt cells to a serum free culture have found that the adaptation process can lead 
to changes in growth performance of cells with a decline observed in cell growth 
rates and viability following serum withdrawal or, in some cases, activation of 
apoptotic pathways can also occur (Gstraunthaler 2003). These observations are 
hypothesized to take place because of a change in culture conditions and 
perturbation of events associated with cell cycle progression and entry into S phase, 
in turn triggering cycle arrest or apoptosis (Sinacore, Drapeau et al. 2000). In rare 
circumstances, there have also been reports of the emergence of rare and non-
representative sub populations of cells as a result of culture stress imposed in the 
adaptation process, although this is more likely in cells going through crisis at time 
of adaptation (Song, Izumi et al. 2004).  These cells have been reported to have 
altered characteristics in terms of growth rates, viability and density (Ozturk and 
Palsson 1991). Adapting cells to serum free culture is a long adaptation process and 
it is imperative that the structural and functional integrity of expressed proteins 
should be closely monitored throughout the adaptation process. Many cells have 
either been adapted to serum free conditions or grown normally in a serum free 
media supplemented with hormones, trace elements and defined serum 
components, and as yet there is no ‘standard’ serum free media and each cell type 
requires its own medium composition (Ozturk and Palsson 1991). 
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To adapt cells to KSFM, cells from two different PD were taken and immersed 
directly from the feeder system to KSFM and cell growth was found to be slow with 
cells proliferating to a total of 7 PD (for cell lysates obtained at 15 PD) and 6 PD ( for 
cell lysates obtained at 30 PD). 
 
The benefit of using cell lines capable of cultivation in a serum free environment 
has been outlined in chapter 1 and there are two methods through which to 
achieve this. The first is known as ‘immersion’ or direct adaptation, wherein cells 
are switched directly from serum-supplemented growth media to serum free media 
and the second is sequential adaptation or ‘weaning’, wherein cells are gradually 
and sequentially weaned into serum free cultivation (Sinacore, Drapeau et al. 
2000). Both methods have been shown to result in successful transfer of cells from 
a serum supplemented culture environment to a serum free one, although some 
cells appear to adapt successfully using one method over the other.  
 
6.7.1 Method 
NHOKBmi1+hTERT cells from 15 and 30 PD were transferred to KSFM using both the 
immersion and the weaning methods of adaptation and compared to OKF6 and 
OKF4 and the results are presented below. 
  
6.7.2 Result 
 Cell morphology appeared normal and seemed similar to the OKF6 and OKF4 (Fig 
6.18). NHOKBmi1+hTERT at 15 and 30 PD were directly immersed into KSFM and 
assessed for cell population doublings. As shown in Figure 6.19, when compared to 
the cells cultured with feeders, those in KSFM proliferated for approximately 6 
population doublings before slowing down and eventually reached a plateau and 
ceased proliferation.  
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In an attempt to increase cell growth rates, cell adaptation process was repeated 
but this time the cells were weaned off from serum supplemented media by 
introducing a gradual reduction in the media serum supplementation. Cells were 
initially cultured in routine 10% FBS, followed by a week of culture in 5% FBS prior 
to complete transfer into KSFM. This weaning process appeared to improve growth 
rate (Fig 6.20) by approximately 15 population doublings but after this cell growth 
slowed down and cells ceased to proliferate. Two independent experiments were 
performed with similar results obtained in adaptation of transduced cells to serum 
free medium (data not shown).  
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Figure 6. 18: Representative NHOKBmi1+hTERT colonies cultured in KSFM for adaptation 
to a serum free culture system. 
Representative images of NHOK
Bmi1+hTERT 
adaptation into serum free culture system. (a) 
NHOK
Bmi1+hTERT 
cultured in KSFM b) NHOK
Bmi1+hTERT 
cultured in 10% serum
 
with feeders c) OKF6 and d) 
OKF4. Cell morphology of NHOK
Bmi1+hTERT 
appears similar to the established OKF6 and OKF4 cells lines 
already adapted to KSFM with normal morphology (d and c).  
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Figure 6. 19: Proliferation of NHOKBmi1+hTERT adapted to KSFM by immersion method. 
NHOK
Bmi1+hTERT 
were immersed in KSFM at 15 and 30 population doublings, respectively, and 
proliferation rates observed and compared to the same cells when grown with feeders in 10% 
serum. Cell proliferation rates declined for NHOK
Bmi1+hTERT 
cultured in KSFM after approximately 6 
PDs and ceased to proliferate further whereas the feeder control continued to proliferate 
indefinitely.  
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Figure 6. 20: Proliferation of NHOKBmi1+hTERT adapted to KSFM by gradual weaning. 
NHOK
Bmi1+hTERT 
cells were weaned into KSFM at 15 and 30 population doublings and proliferation 
rates compared to the same cells when grown with feeders in 10% serum. Cell rates declined after 
approximately 15 PD and ceased to proliferate further whereas the feeder control continued 
proliferation. (* indicates point of culture in 10% serum, ** indicates point of 5% serum and *** 
indicates start of complete serum free culture). 
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6.8 Discussion 
 
Many studies have thus far reported and confirmed that overexpression of 
telomerase allows cells to bypass telomere-dependent senescence in many cell 
types including fibroblasts, retinal epithelial cells, smooth muscle cells and 
keratinocytes (Milyavsky, Shats et al. 2003, Ramirez, Herbert et al. 2003, Vaughan, 
Ramirez et al. 2006, Zhu, Mouly et al. 2007, Wieser, Stadler et al. 2008)   . TRAP 
analysis confirmed presence of telomerase activity within the cells as compared to 
controls with normal keratinocytes demonstrating little telomerase activity, in 
accordance with current literature  (Yasumoto, Kunimura et al. 1996, Kiyono, Foster 
et al. 1998, Kyo and Inoue 2002)  . 
 
 
Interesting, cellular immortalization has been reported in the absence of detectable 
telomerase despite displaying long telomeric length (Bryan, Englezou et al. 1995), 
indicating another mechanism of telomerase reactivation, whilst in some cell types, 
telomerase fails to overcome senescence (Kiyono, Foster et al. 1998, Dickson, Hahn 
et al. 2000).  
 
 
Western blot analysis confirmed the presence of p53 with low expression, although 
it is important to consider that in normal cells p53 is often maintained at low, at 
times undetectable levels until a rapid rise following some stimuli such as DNA 
damage (Zuckerman, Wolyniec et al. 2009). This was confirmed by the UVB study 
on these cells which saw a rapid rise in p53 levels, discussed below. The results of 
this study coincides with those immortalization studies which state that 
downregulation of p53 is not a requirement for primary cell immortalization 
(Kamijo, Weber et al. 1998, Kiyono, Foster et al. 1998).   
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A comparison study to analyze p16INK4a expression in cell lines from progressing PD 
in culture revealed that in normal, non-transduced parent cells, p16INK4a expression 
increased with time in culture as compared to the test lines which showed no 
evidence of change in p16INK4a expression. Confirming down regulation of p16INK4a 
by bmi1 and shp16INK4a, these results support the many studies reporting that 
knockdown of p16INK4a is essential for immortalization of cells and that 
accumulation of p16INK4a in cells is indicative of senescence  (Reznikoff, Loretz et al. 
1988, Serrano, Lee et al. 1996, Lin, Barradas et al. 1998, Rheinwald, Hahn et al. 
2002).   It must be noted that as an additional control, the use of normal, non-
transduced cells for each cell line would have provided a comparable control in 
order to specifically conclude whether bmi1,  shp16 and shp53 successfully 
downregulated the target proteins. A similar experiment to determine p53 levels 
with time in culture was not undertaken since physiological p53 levels remain low 
within the cell unless triggered by cellular stress of DNA damage and expression 
levels are not affected by progressive population doublings. 
 
Due to its pivotal role in the cells ability to respond to a range of environmental and 
intracellular stresses, including agents which cause DNA strand breaks, ultraviolet 
radiation, hyperproliferation and hypoxia, it is imperative for cells to have a 
functioning and intact p53 gene (Meek 2004). In keeping with its regulating role in 
genes governing the cell cycle and DNA errors, presence of an functional p53 is 
crucial for genetic stability, by not only preventing replication errors but also by 
inducing genes that regulate nucleotide excision repair of DNA (Kastan, Onyekwere 
et al. 1991). 
 
To investigate the response of the cells to UVB, cells were analyzed via FACS 
analysis for protein expression after exposure to different UVB doses. From the 
results there was a clear difference in percentages of viable cells between the cell 
lines with downregulated p53 and those with functional p53. The OKF4 and OKF6 
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cells also exhibited similar results to the test cell lines in which p53 was 
downregulated, and these results confirmed higher rates of  apoptotic response in 
cells transduced with Bmi1 plus telomerase , coinciding with the increase in 
expression of p53 following UVB treatment in these cells.  
 
Irradiation by UVB exposure has been shown to cause oxidative stress and DNA 
damage with p53 playing an important role in the cellular DNA damage response. A 
study on HaCat cells immortalized with viral oncoproteins E6 and E7 showed a 
significant reduction in apoptotic response to UVC irradiation and ,furthermore, 
analysis by western blotting did not reveal any changes in levels of p53 post 
treatment (Shnitman Magal, Jackman et al. 1998). In contrast, another study which 
immortalized uroepithelial cells (HUC) with HPV16 oncoprotein E6 did not undergo 
apoptosis in response to γ irradiation and had low to undetectable expression of 
p53 levels. Interestingly, in the same experiment, two independent HPV 
immortalized cell lines demonstrated stabilized p53 and subsequent p53-
dependent apoptosis(Reznikoff, Yeager et al. 1996). It is interesting to note that 
two studies utilizing similar methods for immortalization responded differently to 
the same form of DNA damage. 
 
Western blot analysis of cell lysate samples from the UVB irradiated cells also 
demonstrated elevated levels of p53 post treatment whilst the cells transduced 
with shp53 did not appear to have any protein expression at all. It is important to 
remember ,however, that apoptosis is not limited to p53 control, and this would 
explain the lower-than-expected percentage of viable cells despite downregulating 
p53 expression. A study by Bush et al (2001) demonstrated apoptosis in human 
melanoma cells independent of p53 by a FAS-receptor / caspase 8 pathway 
suggesting apoptosis activation through other pathways including caspase 
activation and via a membrane mediated mechanism through activation of death 
receptor pathways (Bush, Cheung et al. 2001). Another study on proliferating 
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lymphoid cells demonstrated that DNA damage induces apoptosis via p53 
independent mechanisms and is inhibited by bcl-2 (Strasser, Harris et al. 1994).  
 
Doses of UVB have also been shown to impact the response of a cell and 
keratinocytes have previously been shown to repair all of UVB induced DNA 
damage at low UVB doses and continue normal cellular functions.  Similarly, in 
response to extremely high doses of UVB, there is extensive damage that cannot be 
repaired and cells respond by undergoing apoptosis, whilst with intermediate 
doses, keratinocytes have also been shown to undergo premature senescence 
(Lewis, Yi et al. 2008). 
 
 Comparison of early versus late apoptotic/necrotic cells further provided an 
accurate representation of ‘true’ apoptotic cells, essentially the proportion of cells 
irreversibly committed to programmed cell death. This is a result of the early p53-
dependent apoptotic response being reversible and if the cells repair machinery is 
able to successfully repair DNA damage, early apoptotic cells can re-enter the cell 
cycle and continue as normal (FJ Geske, 2001). In contrast, late apoptotic cells are 
not permitted to re-enter the cell cycle and often transform into necrotic cells, in 
particular if the extent of cellular damage is severe. Consequently, late apoptotic 
and necrotic cells share many morphological and biochemical properties, often 
making it difficult to distinguish between the two using analytical techniques such 
as FACS, although other techniques such as complement binding can be used to 
differentiate between the two cell types since necrotic cells are known to activate 
complement components C3 and C4 early on in the process whereas this is a rather 
late even in apoptotic cells (US Gaipl, 2001).  
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Again, it must be noted that as an additional control, the use of normal, non-
transduced cells for each cell line would have provided an additional comparative 
control in order to further conclude the extent of apoptotic response between 
normal cells and UVB-treated transduced cells alongside the untreated control. 
DNA damage response factors 53BP1 and γH2AX have been shown to bind DNA 
following cellular stress (Takai, Smogorzewska et al. 2003) and  co-localise to form 
nuclear foci. 53BP1 and γH2AX staining was carried out in keratinocytes cultured in 
the fibroblast feeder system and two types of commercially available serum free 
medium, KGM and kSFM. The number of DNA damage induced foci formed per cell 
in each culture medium is an indication of the level of DNA damage and stress 
caused to cells as a result of the culture environment.  
 
Using a standard immunofluorescence protocol where cells were fixed before being 
permeabilized, cells were stained for expression of 53BP1 and γH2AX. Analysis of 
cells using the lecia epifluorescence microscope revealed the formation of multiple 
nuclear foci in over 60% of the cells, therefore supporting the studies that tissue 
culture is a stressful environment for the nurturing of cells in vitro. It must be 
noted, however, that statistically there was no significant difference between the 
percentages of positive cells across the different culture mediums for both 53BP1 
and γH2AX although there were some subtle differences observed. At a 
magnification of 65x, cells cultured with a feeder layer in a serum environment 
seemed to display, on average, higher numbers of nuclear foci per cell in 
comparison with the cells cultured in KGM or kSFM although foci were not detected 
in every cell. The difference in the number of nuclear foci numbers between the 
cells cultured in the two different serum free environments was less pronounced 
with a slightly higher number of nuclear foci in KGM when stained for γH2AX. For a 
more accurate analysis of the extent of DNA damage across the three different 
culture conditions, a foci scoring system was set up that was used as a standard 
throughout the quantification process. Assuming that three or more nuclear foci 
were present, the cell was rated as positive for DNA damage and scored 
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accordingly, with an aim of counting a minimum of 300 cells per marker. No nuclear 
foci were visibly detectable for the antibody controls staining therefore positive 
cells were scored with confidence.  
 
In culture, cells in kSFM proliferated at a slightly faster rate than those cultured in 
KGM. This can be explained by the difference in the composition and varying 
concentrations of the growth factors, hormones and calcium used in the two 
mediums respectively, the proportions of which either promote proliferation and 
thereby limit differentiation or vice versa (Wille Jr, Pittelkow et al. 2005). Perhaps 
the main difference stems from the different calcium concentrations used of which 
KGM uses a concentration of 0.15mM whilst kSFM has a working calcium 
concentration of 0.09mM. It has been shown that at low levels of calcium 
keratinocytes tend to proliferate more rapidly, differentiate slowly and form fewer 
cornified envelopes (Song, Izumi et al. 2004) whilst as calcium concentrations 
exceed 1 mM , keratinocytes tend to differentiate more and express appropriate 
markers (Wille Jr, Pittelkow et al. 2005).  
 
To adapt cells to KSFM, cells from two different PD were taken and immersed 
directly from the feeder system to KSFM and cell growth was found to be slow with 
cells proliferating a total of 7 PD (for cells taken from 15 PD) and 6 PD ( for cells 
taken from 30 PD). Similarly, when serum was gradually eliminated from the culture 
medium, cells plateaued after proliferating for 17 PD (for cells taken from 15 PD) 
and 15 PD (cells taken from 30 PD). These results indicate that the direct immersion 
method was not suitable for the cells although the gradual weaning method 
appeared to show some potential. These results are in accordance with the 
supporting literature that cells prefer a gradual adaptation process to prevent 
culture shock, as when cultured gradually, there is a 2-fold increase in population 
doublings. It is possible that there would have been a more pronounced increase of 
population doublings had the adaptation process been longer and cells adapted 
gradually, however time restraints prevented that. Currently many cells have been 
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successfully adapted to serum free culture including keratinocytes, rat 
neuroblastoma cells (Darmon, Bottenstein et al. 1981) and fetal rat brain cells 
(Honegger, Lenoir et al. 1979). 
 
6.9 Conclusion 
After having established cell life span expansion, NHOKBmi1+hTERT were characterized 
for a variety of variables. As expected, p53 expression was almost undetectable, as 
under normal circumstances p53 levels are low within the cell, rising rapidly 
following DNA damage or external stresses on the cell, as illustrated after UVB 
treatment. p16INK4a expression was low across increasing population doublings as 
compared to controls wherein it steadily increased with time in culture, in keeping 
with its role in cellular senescence. A p53-dependent apoptotic response was 
observed in cells following UVB treatment as compared to untreated controls. Cells 
were assessed for DNA damage across three different culture mediums and levels 
of DNA damage induced foci were lower in the absence of serum in culture media, 
following which NHOKBmi1+hTERT cells were analyzed for growth in KSFM and 
demonstrated potential when weaned into a serum free system gradually. 
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7.1 Evidence of cell viability on polycarbonate membrane 
 
Keratinocytes in vivo stratify into multiple layers forming a stratified squamous 
epithelium and form distinct layers as they differentiate and mature through the 
layers, as described in chapter 1. Immortalized cell lines are often assessed for the 
ability to stratify as many studies require experiments to be done on multiple cell 
layers rather than monolayer experiments, for example drug permeation and 
delivery studies. It is essential to test cells for stratification and patterns of 
differentiation to ensure that the cell model has minimal differences from the 
native tissue, preventing results from constantly having to be reconfirmed by 
parallel studies using native tissue or primary cells, as found by a recent study of 
the growth of SV40-immortalized corneal cell on membrane tissue (Greco, Vellonen 
et al. 2010). The different organotypic substrates used to assess stratification of 
cells include DED, collagen gel and polycarbonate membranes.  
 
Polycarbonate membranes provide an easy to culture membrane surface for cells to 
stratify and can be sectioned to assess stratification patterns.  Assessment of cell 
viability by the colorimetric MTT assay indicated cellular activity levels since the 
amount of colour generated is a direct result of cellular mitochondrial activity. Cell 
lines were adapted to grow in serum free media prior to culture onto 
polycarbonate membrane inserts and assessed for cell viability using a standard 
MTT assay.  Membranes were then sectioned for analysis of cell stratification.  
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Cells were plated at a pre-determined density and grown for 7 and 14 days prior to 
being analyzed for viability, as shown by MTT absorbance values. As shown in 
Figure 7.1 a, both cell lines showed little viability when cultured in accordance to a 
standard protocol with NHOKBmi1+hTERT (absorbance 0.244 ± 0.01 at 7 days and 0.26 
±0.02 at 14 days) and NHEKBmi1+hTERT (absorbance 0.24 ± 0.01 at 7 days and 0.25 ± 
0.01 at 14 days) compared to blank control in the absence of cells (absorbance 0.2 ± 
0.01). To improve growth rates, a variety of seeding densities were tested to 
determine optimal seeding density (data not shown) and cells were then reseeded 
and analyzed for viability, once again demonstrating little difference in cell growth 
despite the increase in seeding density and no significant difference was observed 
in the cell lines compared to the control (Fig 7.1 b). 
 
To further improve cell viability, feeders were added to the culture vessels three 
days prior to culturing cells on membrane inserts and, as shown in Figure 7.2, when 
cultured in the presence of feeders, cell viability was significantly higher for both 
NHOKBmi1+hTERT (absorbance 0.44 ± 0.01 at day 7 and 0.5 ± 0.03 at day14) and 
NHEKBmi1+hTERT (absorbance 0.46 ± 0.02 at day7 and 0.48 ± at day 14) as compared to 
blank control (absorbance 0.2 ± 0.01). NHOKshp16+shp53+hTERT were also cultured on 
membrane inserts and once again demonstrated a similar increase in cell viability  
(Fig 7.2b), indicating a preference of the cells to a feeder culture environment and 
supportive growth environment. The results are the averages of three independent 
experiments that were performed. 
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Figure 7. 1: Cell viability on polycarbonate membrane assessed by MTT assay. 
a) NHOK
bmi1+hTERT 
and NHEK
bmi1+hTERT 
cultured on polycarbonate inserts show little viability and  
b) increasing seeding density did not increase cell viability significantly compared to control 
wells (no cells). * is significantly different from the mean value of the control. There was no 
significant difference observed between the cell lines and the control. 
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Figure 7. 2: Cell viability on polycarbonate membrane assessed by MTT assay. 
a) NHOK
bmi1+hTERT 
and NHEK
bmi1+hTERT  
and
 
b)
 
NHOK
shp16+shp53+hTERT 
and NHEK
shp16+shp3+hTERT  
cultured on 
polycarbonate inserts show increased viability when cultured with feeders when compared to 
control  ( no cells). * is significantly different from the mean value of the control.  
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7.2 Stratification on polycarbonate membrane 
 
The final part of this study aimed to get initial insight into whether these cell lines 
would stratify on membranes. Cells were placed onto polycarbonate membranes 
and assessed for viability by MTT assay prior to being sent for histopathological 
analysis. Cells that were seeded at the initially calculated seeding density did not 
grow on the membrane but after increasing seeding destiny cell viability seemed to 
increase slightly and this increase was also observed after membrane sectioning 
(Fig 7.3, Fig 7.4, Fig 7.5 and Fig 7.6).  
 
To increase levels of stratification, feeders were used and plated on the tissue 
culture vessel three days prior to the cells being placed onto polycarbonate 
membrane inserts at the higher seeding density of 5 x 104. Cells appeared to 
respond to the supportive culture environment provided by the fibroblasts feeders 
and a significant increase in stratification was observed with the cells forming 
multiple layers (Fig 7.3, Fig 7.4 Fig 7.5 and Fig 7.6).  
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Figure 7. 3: Stratification of NHOKBmi1+hTERT on polycarbonate membranes after 7 and 
14 days in culture i) KSFM at 2x104 ii) KSFM at 5 x 104 and iii) with feeders at 5 x 104.  
NHOK
Bmi1+hTERT 
cells were cultured on top of polycarbonate membranes under different 
conditions and seeding densities and subjected to histological analysis to assess for 
stratification. Data obtained for cells cultured in i) KSMF at 2 x 10
4
 ( a and b) ii)  in KSFM at 5 x 
10
4
  (c and d) and iii) with feeders at 5 x 10
4
 (e and f). (Image taken at 40 x magnification). 
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Figure 7. 4: Stratification of NHEKBmi1+hTERT on polycarbonate membranes after 7 and 
14 days in culture i) KSFM at 2x104 ii) KSFM at 5 x 104 and iii) with feeders at 5 x 104.  
NHEK
Bmi1+hTERT 
cells were cultured on top of polycarbonate membranes under different 
conditions and seeding densities and subjected to histological analysis to assess for 
stratification. Data obtained for cells cultured in i) KSMF at 2 x 10
4
 ( a and b) ii)  in KSFM at      5 x 
10
4
  (c and d) and iii) with feeders at 5 x 10
4
 (e and f). (Image taken at 40 x magnification). 
 
  Chapter 7: Results 5 
231 
 
 
Figure 7. 5: Stratification of NHOKshp16+shp53+hTERT on polycarbonate membranes 
after 7 and 14 days in culture i) KSFM at 2x104 ii) KSFM at 5 x 104 and iii) with feeders at 
5 x 104.  
NHOK
shp16+shp53+hTERT 
cells were cultured on top of polycarbonate membranes under different 
conditions and seeding densities and subjected to histological analysis to assess for 
stratification. Data obtained for cells cultured in i) KSMF at 2 x 10
4
 ( a and b) ii)  in KSFM at      5 x 
10
4
  (c and d) and iii) with feeders at 5 x 10
4
 (e and f). (Image taken at 40 x magnification). 
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Figure 7. 6: Stratification of NHEKshp16+shp53+hTERT on polycarbonate membranes 
after 7 and 14 days in culture i) KSFM at 2x104 ii) KSFM at 5 x 104 and iii) with feeders at 
5 x 104.  
NHEK
shp16+shp53+hTERT 
cells were cultured on top of polycarbonate membranes under different 
conditions and seeding densities and subjected to histological analysis to assess for 
stratification. Data obtained for cells cultured in i) KSMF at 2 x 10
4
 ( a and b) ii)  in KSFM at      5 x 
10
4
  (c and d) and iii) with feeders at 5 x 10
4
 (e and f). (Image taken at 40 x magnification). 
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7.3 Discussion 
Stratification studies allow for a phenotypic assessment and characterization of cell 
lines and the different organotypic substrates used to assess stratification of cells 
include DED, collagen gel and polycarbonate membranes. Due to time restraints, it 
was not possible to use a variety of substrates and cells were cultured onto 
polycarbonate membranes and assessed for viability by MTT prior to membrane 
sectioning and histopathological analysis. MTT analysis demonstrated little growth 
when cultured in KSFM however this was significantly increased when cultured with 
feeders and in presence of serum, with cells stratifying into multiple layers.  This is 
unsurprising as the cells were unable to adapt to KSFM beforehand and illustrates 
the need to fully adapt the cells to KSFM prior to culture on membrane inserts.  
 
The methods by which cells are immortalized and their genetic constituents results 
in various patterns of cell stratification, for example; human cervical and foreskin 
epithelial cells immortalized by HPV proteins exhibit dysplastic differentiation in 
vivo (Woodworth, Waggoner et al. 1990) whereas similar studies in mice showed 
normal cells to form a well differentiated epithelium within 2-3 weeks. In contrast, 
a study immortalizing cell lines by 4 types of HPV found all 4 lines to exhibit 
dysplastic morphology and molecular alterations in gene expression, for example; 
delayed commitment to terminal differentiation, altered involucrin expression plus 
reduction in levels of involucrin plus keratin RNAs (Dürst, Bosch et al. 1991). 
 
A comparison of the transduced cells with the normal pattern of NHOK and NHEK 
differentiation illustrates a different growth pattern and lack of appropriate 
terminal differentiation, instead displaying phenotype similar to that of pre-
malignant or malignant cells. Studies on OKF6 cells have shown that despite 
exogenous hTERT expression and loss of p16INK4a function , the cells were still able 
to initiate program of terminal differentiation, express suprabasal differentiation-
specific proteins and form differentiated epithelia in both in vitro ( cultured on 
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collagen gel ) and in vivo ( grafted onto athymic mice) (Dickson et al, 2000).  An 
initial attempt made at growing OKF6 and OKF4 cell lines on polycarbonate 
membranes did not demonstrate growth in serum free media and due to time 
constraints could not be optimized further under different conditions, thus 
highlighting the importance for optimizing the process prior to making final 
conclusions regarding NHOKBmi1+hTERT and NHEKBmi1+hTERT  differentiation patterns. 
Additionally, it would have been useful to have included normal, non-transduced 
NHOK and NHEK cell lines as controls alongside NHOKBmi1+hTERT and NHEKBmi1+hTERT to 
allow comparison of growth rates and patterns of differentiations between cell 
lines in the same set of experiment. 
 
7.4 Conclusions 
NHOKBmi1+hTERT and NHEKBmi1+hTERT demonstrated little viability when cultured in 
serum free media, however, a slight increase was observed after increasing initial 
cell seeding density. There was a two- fold increase in viability when cultured with 
the support of feeders, thus pointing towards inadequate culture conditions for 
poor viability rather than an inability to stratify on cells behalf. When subjected to 
H&E, cells retained ability to stratify into multiple layers with feeders support 
although exhibited dysplastic differentiation patterns indicating need for further 
investigation.  
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 Chapter  8 
Discussion 
 
8.1 Discussion and Future Work 
 
The hypothesis for this study had proposed that a cell line immortalized with intact 
p53 expression would result in genetically stable cells with similar characteristics to 
the parental lineage in comparison to currently available cell lines with silenced or 
spontaneously downregulated p53. As discussed below, this hypothesis has been 
proved correct from the acquired monolayer data demonstrating p53 expression 
alongside a p53-dependent apoptotic response and normal rates of cell 
proliferation however further analysis is required to determine genetic stability and 
make conclusions regarding 3D culture (discussed below). The first part of this 
study investigated optimum culture conditions for the growth of keratinocytes 
which were then maintained for the duration of the study. This was important in 
order to generate reliable, accurate and reproducible data as culture conditions 
have been shown to affect cell growth and proliferative potential with cell lines 
exhibiting an increase in population doublings with improved culture environments 
as well as minimizing the rate of stress-induced cellular transformations (Todaro and 
Green 1963) (Von Zglinicki 2002). 
 
Keratinocytes were cultured in 10% serum (FAD) as well as two commercially 
available serum free culture mediums, KGM and KSFM, and assessed for DNA 
damage foci but did not show a significant difference between the percentage of 
positive cells across the three mediums. It had been expected that higher levels of 
stress-induced foci would be observed for cells cultured in 10% serum since serum 
has been reported to cause stress in cultured cells (Halliwell 2003). It is possible 
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that since the keratinocytes used in this study were being cultured in a feeder layer 
and directly immersed into a serum free culture environment as opposed to a 
gradual adaptation, this sudden change of culture environment may have subjected 
cells to high levels of internal stress thus explaining the higher percentage of 
damage induced foci levels found in serum-free cultured cells. As an additional
comparative control, keratinocytes already established for growth in a serum free 
environment may have been a more accurate representation of serum free cells, 
although it is important to note that every cell line responds differently to serum 
free adaptation therefore this alone may not have sufficed as a control. 
Additionally, it would have been interesting to directly assess effects of serum 
reduction on cells by culturing cells in a range of serum concentrations to 
determine whether lowering the serum concentration had any effect on percentage 
of DNA damage positive cells.  
 
An alternative approach to determine DNA damage-induced foci can be to co-stain 
with both 53BP1 and γH2AX markers as in vivo both of these seem to co-operate 
and work together in the DNA damage response by localising at sites of DNA 
damage and forming part of the protein group that initiates the DNA damage 
response (Fernandez-Capetillo, Lee et al. 2004). A comparison of p53 expression 
levels and its target genes such as P21WAF or p16INK4a by western blot analysis on 
lysates obtained from cells grown in the different culture mediums will be useful in 
determining extent of cellular stress. Alternative markers of DNA damage can also 
be used, for example; staining for the growth arrest- and DNA damage-inducible 
gene 153 (GADD153), shown to be induced by culturing cells in nutrient-depleted 
media, a condition that causes growth arrest (Kim, You et al. 2002). 
 
Cells in culture behave differently from cells in vivo and one of the main reasons for 
this is that cell culture imposes a state of oxidative stress on cells, effectively 
resulting in a ‘culture shock’ that hinders growth potential (Halliwell 2003). Most 
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cells in vivo are exposed to low O2 concentrations in the range of 1-10 mm Hg with 
some exceptions (including the epidermis and the cornea) and in contrast cell 
culture is normally performed under 95% air and 5% - 10% CO2 which is 
approximately 150 mmHg O2 tension. It has been shown that the higher the levels 
of oxygen tension, the higher the rate of ROS production (Collins 1999). Such 
oxidative stress results in cell death, cellular senescence, aberrant cell growth and 
inaccurate population doublings, for example; total lifespan of fibroblasts in culture 
was originally thought to be approximately between 40-50 PD but a recent study 
has shown that if cells are cultured at low O2 tension, many more population 
doublings are possible and that this culture related oxidative stress has been linked 
to accelerated telomere shortening (Shay and Wright 2005).  
 
Cells grown closer to physiological O2 levels have been shown to have increased 
rates of cell proliferation and although a pilot study demonstrated a decrease in the 
percentage of DNA damage induced foci formed with culture in low O2 (data not 
shown), due to large volumes of culture plates it was not possible to conduct an 
entire experiment within the available low O2 culture facilities. It will be interesting 
to culture the successfully transduced cells alongside controls such as parent cells 
as well as OKF6 and OKF4 and compare growth rates to each other in low O2 as well 
as in normal culture conditions. 
 
Keratinocytes are deemed immortal if they continue to proliferate for an additional 
50 PD beyond the parent cell line (Dickson, 2000). As discussed in Chapters 4 and 5, 
the transduction of cells with bmi1 plus hTERT resulted in successful lifespan 
expansion of both oral and epidermal keratinocytes whereas those transduced with 
shp16+hTERT required additional downregulation of p53. To further analyse the 
benefits of both immortalization protocols, a set of infections using both methods 
immediately prior to the onset of senescence will be beneficial in determining 
whether the proposed method rescues the cell from entering senescence, thereby 
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indirectly assessing its effectiveness at over-riding cell cycle regulatory mechanisms. 
Since tumourigenic lines are often unstable, with minimal dependence on growth 
factors and a tendency to proliferate rapidly, it will be interesting to culture 
transformed cell lines such as OKF6 and OKF4 as well as DNA tumour virus 
transformed cells alongside parental controls, thereby allowing for a direct 
comparison of the rate of proliferation with the transduced cells. Senescence 
associated β gal expression was noted in all of the cells that ceased proliferation 
although in hindsight the results of the β gal assay would have benefited from 
having an additional comparative control of non-transduced oral and epidermal 
keratinocytes at early and late passage.  
 
Analysis of cell lysates via a PCR based TRAP assay demonstrated telomerase 
activity in the transduced cell lines, confirming successful introduction of hTERT into 
the cells. Weak telomerase expression was detected in normal, non-transduced 
cells and although somatic cells do not express telomerase per se, weak telomerase 
expression has sometimes been detected in normal epithelial and endothelial cells, 
for example after wound healing or for telomere maintenance. As an additional 
control, parent control cells from early and late passage could have been 
incorporated to show telomerase expression at different replicative time points 
since weak telomerase expression would be expected in culture unless there is 
reactivation of telomerase within the cells. Similarly, lysates from a variety of 
different population doublings from the transduced cells could have been tested to 
assess the differences in telomerase levels with time in culture to correlate with the 
transduction data.  
 
As discussed in chapter 6, transduced cells were assessed for p16INK4a expression 
over time but it would have been helpful to add an additional comparative control 
of non-transduced cells when assessing p16INK4a expression over time, allowing for a 
direct comparison. Transduced and non-transduced cell lines can also be assessed 
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for expression of p14ARF and as it is expressed from the same locus as p16INK4a  it will 
be interesting to see whether it is completely silenced or partially down-regulated 
in regards to its connection with p16INK4a as well as its role as a regulator of p53.  
 
UVB is known to result in the generation of reactive oxygen species and induction 
of potentially mutagenic DNA damage and has been shown to induce p53 
expression in cells (Hall et al., 1993). Interestingly, FACS analysis of cells treated 
with UVB damage displayed higher numbers of viable cells not only in the 
transduced cells expressing p53 but also, albeit to a lesser extent, in cells with 
silenced p53 which, although surprising, can be explained by many reasons. Firstly, 
DNA damage can induce p16INK4a methylation which can potentially induce the p53-
dependent DNA damage response, often observed in immortal cells which have 
arisen spontaneously out of crisis (Al-Mohanna, Al-Khalaf et al. 2007). Additionally, 
it is important to remember that the apoptotic response is not completely p53 
dependent but cells can also undergo apoptosis via death receptor pathways. This 
mode of p53-independent apoptosis occurs via regulatory proteins known as 
caspases which, once activated, bring about a number of changes within the cell 
leading to programmed cell death. A study on human diploid fibroblasts with 
silenced p53 found that treatment with UVB still resulted in G1 cell cycle arrest, 
indicating that p53-independent mechanisms also control UVB-induced growth 
arrest (Borlon, Vankoningsloo et al. 2008) 
 
Analysis for p53 target proteins involved in the DNA damage response for example 
gadd45, whose expression is linked to G1 cell cycle arrest following DNA damage, 
and p21WAF1 will provide additional data to support analysis of apoptosis in these 
cells since higher levels of expression in these proteins would be expected if 
apoptosis is indeed occurring via the p53-dependent apoptotic pathway. 
Furthermore, FACS analysis of cell samples can be performed to analyse cell cycle 
content revealing which phase of the cell cycle the cells are in. As before, if the 
apoptotic response is via p53 then a high G1 cell content would be expected since 
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p53 regulates the cell cycle at the G1 cell cycle checkpoint. As a cell responds to 
DNA damage by inducing either senescence or apoptosis depending upon cell type 
and extent of damage, the UVB treated cells can also be assessed for senescence 
associated β gal activity to determine level of senescence in these cells. 
Additionally, analysis of initiator and effector caspases by western blotting can be 
performed to allow a comparison of expression levels in cells treated to UVB and 
compared to untreated as well as non-transduced cells. If the cells were undergoing 
p53-independent apoptosis, the expression levels of initiator and effector caspases 
are expected to be much stronger than untreated controls.  Such a combination of 
experiments would give an extensive overview of apoptosis analysis in these cells. 
 
As mentioned in previous chapters, the use of serum in cell culture media is 
controversial for both ethical and scientific reasons and often results in 
phenotypical differences in cells leading to variation of the results. Since in vitro 
methods are among the most favoured methods to replace animal methods, there 
is a demand for reliable and scientifically better defined cell and tissue culture 
methods including quality assurance (Coecke, Goldberg et al. 2007). 
 
 
Unfortunately the transduced cells did not adapt to serum free medium and there 
was not sufficient time remaining in the study to allow for an extensive adaptation 
study. It is important to remember that every cell type differs in cellular 
requirements and two approaches can be taken to adapt cells to serum free for 
future experiments. The first is the development of a novel serum free media 
specifically optimized for the growth of the specific cell type however this is a long 
and arduous process requiring meticulous consideration of use and concentration 
of many ingredients, for example basal medium, growth factors, supplements and 
fatty acids as well as ensuring that adapted cells retain native tissue biomarkers. For 
this reason it is recommended that, where possible, to adapt the cells to already 
established culture mediums and many transformed or newly transfected cell lines 
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can successfully be maintained in these enriched serum-free environments without 
adaptation.  
A review of the literature has shown that the gradual reduction of the serum 
concentration increases the chances for successful adaptation of cells to a serum-
free environment (Schröder, Matischak et al. 2004). Previous studies have 
successfully adapted cells to serum free media by stepwise decreasing the serum 
concentration in every other passage by 50% to wean cells off serum and in this 
way the serum concentration could be easily reduced from 10% (v/v) to 1.25% (v/v) 
(Schröder, Matischak et al. 2004). To further decrease the serum concentration, the 
study discovered that it was necessary to switch to a basal medium formulation 
richer in nutrients as well as coating the dishes with fibronectin and replacing 
HEPES buffer with a sodium carbonate buffer that gave higher cell densities 
(Schröder, Matischak et al. 2004). The literature favours a slow adaptation process 
for cells to adapt to the medium over an extended time frame and since the 
transduced cells showed promise when grown in 5% serum as opposed to the direct 
immersion method it is possible that they will be able to adapt in a similar manner. 
 
 
As demonstrated in chapter 7, transduced cells failed to proliferate on 
polycarbonate membrane inserts in a serum free environment, but demonstrated 
potential when cultured with fibroblast feeders. Furthermore, despite proliferating 
in the presence of feeders, cells did not retain the differentiation patterns of native 
tissue but instead resembled phenotypes of differentiated transformed cells and 
this can be further confirmed by keratin profiling to assess patterns of 
keratinization through the stratified cell layers and compare with normal epithelia 
(Boukamp, Petrussevska et al. 1988). 
 
It is possible that the transduced cells were subjected to cellular stress induced by 
the changeover to serum free media (Sinacore, Drapeau et al. 2000) or it may be that, 
unfortunately, retaining some cell cycle regulation does not necessarily translate 
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into a normal cellular phenotype. It is important to note that a pilot study using 
OKF6 and OKF4 cells on polycarbonate membrane inserts (data not shown) 
demonstrated poor proliferation, confirming the need to optimize serum free 
adaptation of cells and their culture onto polycarbonate membranes alongside 
other substrates such as matrigel or collagen gel. 
 
8.2 Conclusions 
To conclude, growth rates and cellular morphology of NHOKbmi1+hTERT was similar to 
parental cell lines in a monolayer and furthermore, as shown by UVB data, when 
compared to cells with downregulated p53 expression, these cells had higher levels 
of apoptotic cells. To further elucidate genetic stability of these cells, chromosomal 
karyotyping will be required to determine cell ploidy and potential chromosomal 
aberrations since immortalized cell lines often result in chromosome instability, as 
discussed in chapter 1. Finally, it is important to emphasize again that many of the 
experiments would have benefitted from parental, non-transduced controls to 
allow proper comparison with the transduced cells. Experiments would also have 
benefitted from aliquots of NHOK and NHEK cells frozen down regularly and used 
for additional controls. Furthermore, different NHOK strains could have been 
analyzed to assess reproducibility of immortalization methods however it must be 
noted that this was done on NHOK strain 882 but cells failed to evade senescence 
(Appendix 2). 
 
This study confirmed the findings of Rheinwald and group on oral keratinocytes 
using a more established, developed and optimized retroviral infection protocol for 
the transduction of keratinocytes. This line will be useful for in vitro studies wishing 
to use a genetically stable alternative to current oral cell lines displaying alterations 
in p53, and possibly other spontaneous changes, as well as optimized further for 
organotypic studies. The optimized methodology can be utilized to reproduce the 
cell line for studies from different age groups and racial backgrounds that is not 
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possible to do for cell lines which have arisen spontaneously after culture crisis or 
are tumour-derived.  
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Appendix 1 
 
 
 
 
 
 
Appendix 1.2   Quantification of colony number and sizes. Cells cultured at 1 x 102 and 1 x 103 
were cultured for 14 days and then colony counts performed. 2 plates were assessed per 
variable. 
Appendix 2 
261 
 
 
Appendix 2 
 
 
 
Appendix 2.1 Transduction of NHOK 882 (selected). 
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Appendix 2.2 Transductions of NHOK 882 (non-selected). 
 
 
 
 
 
 
